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Background: The efficacy of behavioural activation (BA) treatments for 
depression has been demonstrated in various clinical trials (e.g. Dimidjian et al., 
2006). Although a single session of BA intervention has shown significant 
changes in symptoms of depression in a college student population (Gawrysiak 
et al., 2009), this has not been evaluated with a clinical population. Despite a 
clear behavioural rationale and research evidence underlying BA treatments, 
questions regarding mechanisms of change remain unanswered. From a BA 
perspective, a key aim is to reduce depressive avoidance behaviours and 
increase healthy non-avoidance behaviours (Trew, 2011). 
Method: This study investigated the impact of one treatment session of Brief 
Behavioural Activation Treatment for Depression (Lejuez et al., 2001) on 
depressive symptomatology, self-reported avoidance and behavioural approach 
and avoidance tendencies measured using the Approach Avoidance Task 
(AAT; Rinck & Becker, 2007). A sample of 40 depressed participants from 
primary care psychological therapies services were randomised to either 
treatment or control group. Self-reports of symptoms and cognitive factors were 
assessed before (Time 1) and after the one-week intervention phase (Time 2), 
and at one-month follow-up (Time 3). Approach and avoidance behavioural 
tendencies were assessed at Times 1 and 2 using the AAT.   
Results: There was a significant decrease in depressive symptoms between 
Time 1 and Time 2 for the treatment group but not the control group. 
Performance on the AAT showed the expected pattern, with increases in 
approach to positive valence stimuli (happy faces), although effects failed to 
reach significance. Meditational analyses indicated small indirect effects of self 
reported change in activation and avoidance as mediators of the effect of 
condition on depressive symptoms.  
Discussion: This is the first study to demonstrate the efficacy of one session of 
BA for depression using a clinical sample. There was preliminary support for the 
hypothesis that reduced avoidance may mediate treatment effect. The 
theoretical and clinical implications of the study findings are discussed. Further 
replication of this study is needed, with changes in avoidance measured prior to 
changes in symptom outcomes to help establish a causal relationship. 
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Overview of study 
As one of the most prevalent mental health disorders, depression has attracted 
a large body of research, with different treatments in vogue at varying points 
during the last several decades. Treatment dominance has fluctuated between 
behavioural treatments (1970s), to cognitive therapies (1980s), moving onto 
contemporary behavioural treatments and third wave treatments most recently.  
There has been a burgeoning interest in Behavioural Activation over the last 
decade. Efficacy of this treatment has been demonstrated in several research 
studies, leading to its inclusion in national guidelines for depression. Despite 
recent proliferation of studies on behavioural activation, research has not 
progressed to understanding what drives change in this treatment. What is the 
active ingredient in Behavioural Activation? This remains an important yet 
unanswered question. 
 
This thesis identified that a possible mechanism of change could be changes in 
approach and avoidance behaviours. Depression is characterised by reduction 
in activities leading to low self-esteem and self-confidence and hopelessness. 
Key to Behavioural Activation treatment is addressing behavioural avoidance as 
this helps maintain low mood. The treatment encourages individuals to engage 
in healthy behaviours, promoting a sense of achievement and pleasure, to help 
break the cycle of depressive symptoms. 
  
Avoidance in relation to depression has not been heavily researched, and 
studies exploring possible mechanisms of change in Behavioural Activation are 
fewer still. This study begins with Chapter 1, which reviews the relevant 
literature, mapping the course of behavioural treatments of depression, and 
research findings in relation to approach and avoidance behaviours in 
depression. Chapter 2 outlines the design and measures utilised in the current 
study. Chapter 3 describes the findings whilst Chapter 4 outlines these findings 
in relation to the current literature, with a discussion of possible theoretical and 




2.  Introduction 
2.1 Depression  
2.1.1. Epidemiology of Depression  
Depression was once described as “the common cold of psychiatry” by 
Seligman (1975), to reflect the high prevalence of this disorder. The World 
Health Organisation (WHO) has estimated that depression affects around 121 
million people worldwide and is one of the leading causes of disability. 
Prevalence of depression in the population is high, with the latest Adult 
Psychiatric Morbidity study estimating that around 17% of the UK population 
experience depression and/or anxiety at any given time (McManus et al., 2009). 
Consequently the combined economical cost of depression and anxiety is high 
in the UK. Layard et al. (2006) estimates that it costs £17 billion a year, 
equivalent to 1.5% of the UK’s total national income. 
 
Depression is often a chronic relapsing condition, with relapses expected to 
occur in 50–80% of individuals who have previously experienced an episode of 
clinical depression (Judd, 1977).  Gender differences have been found within 
depression, with higher prevalence rates among women (e.g. Nolen-Hoeksema, 
1987, Angst & Merikangas, 1997). Depression has been associated with low 
socio-economic status (e.g. Dohrenwend, Levav, Shout & Schwartz, 1992; 
Lorant et al., 2003).  Extending the idea of this association further, Weich et al. 
(2002) found that areas of greater social incivilities e.g. graffiti, litter, vandalism 
and gangs, were associated with higher levels of depression. 
 
Studies have frequently found a strong pattern of diagnostic co-morbidity 
between depression and other mental health disorders (Kessler, Nelson, 
McGonagle & Lui, 1996). It has been argued that depression not complicated by 
another mental health disorder is the exception rather than the norm 
(Hirschfield, 2001). One of the highest reported co-morbidities has been with 
anxiety disorders, Kessler et al. (1996) found that 50% of patients meeting 
criteria for major depression also met criteria for a concurrent anxiety disorder. 
Higher anxiety co-morbidity figures have been reported within primary care 
settings, with 75% of patients diagnosed with depression within a primary care 
environment meeting criteria for an anxiety disorder (Olfson et al., 1997). Co-
morbidity with other psychiatric disorders has also been found, e.g. substance 
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misuse (Miller, Klamen, Hoffmann & Flaherty, 1996; Mezzich, Ahn, Fabrega & 
Pilkonis, 1990) and eating disorders (Braun, Sunday & Halmi, 1994).  
 
2.1.2. Diagnosis of Depression 
There are two main schedules which are used to diagnosis psychiatric 
conditions such as depression; International Classification of Mental and 
Behavioural Disorders (ICD-10; World Health Organisation, 1992) and 
Diagnostic and Statistical Manuals of Mental Disorders (DSM-V; American 
Psychiatric Association, 2013). A high degree of comparability exists between 
the two diagnostic systems (see Table 1), with only one symptom difference 
(reduced self-esteem and self-confidence in the ICD-10).  
 
 
Table 1. Comparison of DSM-V and ICD-10 criteria for depression. 
 DSM-V ICD-10 
Core symptoms  Depressed mood  
Loss of interest or pleasure 
Depressed mood  
Loss of interest or pleasure 
Reduced energy/activity 
Additional symptoms Reduced energy  
Appetite or weight change  
Disturbed sleep  
Psychomotor agitation/retardation  
Feelings of worthlessness/guilt 
Reduced concentration or 
indecision  
Suicidal ideation 
Appetite or weight decrease 
Disturbed sleep  
Psychomotor 
agitation/retardation  
Feelings of unworthiness/guilt 
Reduced concentration or 
attention  
Suicidal ideation  
Reduced self esteem and self 
confidence 
Duration for diagnosis  2 weeks 2 weeks 
Distress/impairment Symptoms must cause 
distress/impair one important area 
of functioning 
Not specified  
 
 
A formal diagnosis of depression using the ICD-10 classification system 
requires four out of ten depressive symptoms. In contrast the DSM-IV system 
requires four out of nine symptoms for a diagnosis of ‘Major Depression’. Both 
diagnostic schedules stipulate that individuals should have been experiencing 
symptoms for at least 2 weeks.  
 
2.2. Clinical Presentation of Depression 
Depression is characterised by many symptoms affecting all areas of the 
individual’s life (see Table 1). Symptoms can be broadly conceptualised into 4 
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domains: physical, behavioural, cognitive and affective. Physical symptoms 
include diminished appetite and disturbed sleep. Behavioural symptoms include 
reduced engagement in activities and withdrawal from social situations. 
Cognitive symptoms include reduced concentration, attention, self-esteem and 
self-confidence. Affective symptoms such as ideas of guilt and hopelessness 
about the future and themselves are also present in the individual.  
 
2.2.1. Approach-Avoidance behaviours in depression  
As the clinical presentation of depression includes reduced engagement in 
activities, several models of depression have focused on the role of approach 
deficits and increased avoidance (e.g. Ferster, 1973; Hopko, Lejuez, Ruggiero 
& Eifert, 2003; Jacobson, Martell & Dimidjian, 2001). Such changes likely to be 
influenced by a range of different factors, including the physical, affective and 
motivational features mentioned above.   
 
2.2.2. Role of Approach deficits in depression  
Approach deficits have been linked to symptoms of depression, with Fowles 
(1988) suggesting an association between hopelessness, anhedonia, loss of 
energy and loss of appetite when rewards have been reduced or are no longer 
present.  
 
Approach deficits are associated with depression in a number of different 
manners. Research has shown links between depression and reduced 
appetitive motivation (e.g. Eastman, 1976). Other approach deficits have been 
highlighted in relation to personal goals. Depressed individuals are less likely to 
generate approach goals. Approach goals that are developed are likely to be 
less specific, attainable and adaptive (Dickson & MacLeod, 2004a, 2004b). 
Reduced generation of approach goals, or indeed appropriate approach goals, 
could lead to the development of a depressive cycle with diminishing 
expectations of achieving a pleasurable outcome, leading to decreased 
generation of approach goals which contributes to maintenance of depressive 
symptoms. This cycle prevents the individual from experiencing the very 
activities that could actually function as a reinforcer for increasing approach 
goals. Dickson and MacLeod (2004a) argued that the approach goal deficits 
displayed by depressed individuals within their study maybe a reflection of 
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hopelessness. They suggested that hopelessness would inhibit the 
development of approach goals, as this would be viewed as a futile exercise 
when failure has been predicted as the most likely outcome. Over time, 
increased exposure to approach deficits may aid facilitation of heightened 
rumination e.g. “What’s the point of even trying when my plans never work”, “I 
didn’t manage to do it last time, why bother trying again?” locking the individual 
into a cycle of rumination and maintaining depression.  
 
Whilst the idea of an approach deficit model has been suggested in relation to 
depression, other researchers have argued for an approach perseveration 
model (e.g. Pyszczynski & Greenberg, 1987a, 1987b). The Self-Regulatory 
Perseveration Theory (Pyszczynski & Greenberg, 1987a, 1987b) posits that 
individuals can have difficulty separating from goals important to their sense of 
self, despite being unattainable or loss of the expected outcome. Perseveration 
of this goal can lead to failure, increasing negative affect or increasing 
awareness of personal shortcomings. Over time this can manifest as a 
depressive attributional style, leading to the development of depression.  On the 
surface, these two models conflict each other, however closer examination by 
Trew (2011) has led to the suggestion that the two models are not mutually 
exclusive. Approach perseveration may lead to reduced expectations, which 
may then contribute to approach deficits. Furthermore, Pyszczynski and 
Greenberg’s (1987a, 1987b) model does not imply an absence of approach 
goals and behaviours.  
 
2.2.3. Role of Avoidance in depression 
Within the context of depression, two key broad domains of avoidance – 
(behavioural and cognitive) have emerged (Ottenbriet & Dobson, 2004). 
Behavioural avoidance refers to the behavioural ways in which an individual 
may seek to escape or refrain from participating in an event, action or person 
e.g. staying at home rather than going to meet a friend for lunch. In contrast, 
cognitive avoidance refers to the cognitive measures an individual may utilise 
as a way of attempting to avoid thinking of a particular situation, problem, 
emotion or person e.g. using distraction to avoid thinking of relationship 
difficulties. Research findings have supported the association between 
behavioural and cognitive avoidance with depression, even after controlling for 
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rumination and anxiety as possible confounders (Moulds, Kandris, Starr & 
Wong, 2007; Williams & Moulds, 2007).  
 
Avoidance is associated with reduced exposure to positive experiences 
(Pyszcynski & Greenbery, 1987), with less opportunity of positive reinforcement 
for adaptive behaviours (Hopko, Lejuez, Ruggiero & Eifert, 2003). Depressed 
individuals are likely to engage in less rewarding activities or events due to the 
clinical presentation of depression. They are more likely to predict situations as 
being difficult or anxiety provoking and avoid these situations. However, 
avoidance of such situations prevents the individual from accessing potential 
sources of positive reinforcement, thus maintaining depression and reducing the 
likelihood of experiencing a positive event. Dickson and MacLeod (2006) have 
found that depression is associated to avoidant goals and plans, with dysphoric 
adolescents describing more avoidance goals than approach goals. 
 
The coping literature has also contributed to increasing understanding of the 
role of avoidance and depression. Using a coping strategies framework, Grant 
et al. (2013) explored the relationship between avoidance coping strategies and 
symptoms of anxiety and depression. Their results showed that there was a 
significant reciprocal relationship between behavioural avoidance coping and 
depressive symptoms. Other longitudinal studies have suggested that 
avoidance coping directly adds to the development and maintenance of 
depressive symptoms (Cronkite, Moos, Twohey, Cohen & Swindle, 1998; 
Holahan & Moos, 1986; Holahan, Moos, Holahan, Brennan & Schutte, 2005).  
 
Some researchers (e.g. Martell, Addis & Jacobson, 2001; Carvalho & Hopko, 
2011) have argued that rumination, an important internal process in the 
maintenance of depression (e.g. Nolen-Hoeksema, 2000) should also be 
viewed as a form of avoidance. Rumination refers to a pattern of behaviour 
whereby an individual repetitively engages in thinking about the symptoms of 
their distress (e.g. “Why can’t I be bothered to do anything”) and meanings and 
consequences of their distress (e.g. “I’m a bad person”) (Nolen-Hoeksema, 
Larson & Grayson, 1999). Martell et al. (2001) have suggested that engaging in 
rumination, although often intended to help the person make sense of their 
situation, may inadvertently prevent the individual from being able to effectively 
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problem solve, restricting engagement in healthy behaviours and reinforcing 
symptoms of depression.  
 
2.2.4. Models of approach and avoidance 
Within the literature there are several theoretical models of approach and 
avoidance, linking these constructs to affect and emotion (Gray, 1987a, 1990; 
Carver & Scheier, 1990; Higgins, 1987, 1997). The most prominent of these is 
Gray’s (1987, 1990) model of three motivational systems (Behavioural Inhibition 
System, BIS; Behavioural Activation System, BAS; Fight, Flight, Freeze 
System, FFFS), coined Reinforcement Sensitivity Theory (RST). From a 
depression perspective, only two of systems are of primary concern; BIS and 
BAS.  
 
Research has shown that different brain structures are associated with each 
motivational system (Gray 1986, 1987b, 1990).  The BAS has been linked to 
areas of cortical and sub-cortical structures within the cerebral cortex, thalamus 
and striatum. In contrast, the BIS has been linked to brain areas including the 
medial and lateral septal areas, hippocampus and dentate gyrus (Gray, 1986a, 
1987, 1990). When presented with appetitive stimuli, it has been hypothesised 
that the BAS becomes activated, leading to increased approach behaviours 
(Depue & Zald, 1993). In contrast, the BIS has been hypothesised as becoming 
activated when presented with aversive stimuli or conditioned signals of 
punishment, leading to increased avoidant responses (Gray, 1971, 1982). The 
two systems are thought to regulate two types of experiences. The BIS has 
been suggested as regulating punishment and aversive experiences, whilst the 
BAS has been associated with reward and appetitive experiences. 
Consequently different feelings are associated with the two systems. Feelings 
of elation, hope and desire have been linked to BAS (Depue & Zald, 1993); in 
contrast feelings of anxiety and arousal have been connected to BIS. These two 
motivational systems have been theorised to explain a number of different 
psychiatric disorders, including anxiety (Gray, 1982), attention deficit 
hyperactivity disorder (Barkley, 1997) and conduct disorder (Quay, 1993). 
 
Extending Gray’s (1987, 1990) work further, Depue and Iacono (1989) 
proposed an association between depression and deficits in the BAS system. 
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They argued that individuals with depression are likely to have lower BAS 
functioning, with research studies supporting this suggestion (e.g. Henriques & 
Davidson, 2000; Kasch, Rottenberg, Arnow & Gotlib, 2002). For example, 
Henriques and Davidson (2000) used a laboratory setting to explore the 
behavioural responses of depressed and non-depressed individuals. 
Participants were asked to recall previously presented words, linked to either 
monetary reward or punishment. Changes that occurred as a function of reward 
were conceptualised as an analogue of BAS functioning whilst behavioural 
changes occurring as a function of punishment were viewed as an analogue of 
BIS functioning. In line with Depue and Iacono’s (1989) suggestion of reduced 
BAS functioning in depression, depressed participants did not modify their 
pattern of response to the reward condition.  
 
Carver and Scheier’s (1990) model of approach and avoidance, known as 
cybernetic control theory, places greater emphasis on self-regulation and 
feedback loops, linking these constructs with affect. This theory postulates that 
approach and avoidance behaviours are embodied within discrepancy-reducing 
and enlarging feedback loops, in relation to reference values (e.g. goals) 
(Carver, 2006). Discrepancy-reducing feedback loops essentially represent 
approach processes whereby an individual would endeavour to reduce the 
perceived discrepancy between their current state and desired state. For 
example, if an individual wished to achieve the goal of being a car owner they 
would engage in processes such as looking in car magazines, to take them 
from their current state from being a non-car owner to the desired state of 
owning a brand new car. In contrast, discrepancy-enlarging feedback loops are 
viewed as avoidance processes, as these loops seek to create distance from 
the reference value, thought of as ‘anti-goals’, representing values which the 
individual does not wish to embody. In psychological terms, an example of an 
anti—goal is a feared or disliked possible self (Markus & Nurius, 1986; Ogilvie, 
1987), others include public embarrassment or being terminated by your 
employer. For example, an adolescent wishing to be different from a sibling will 
assess his/her own behaviour, then compare this to their perception of their 
siblings behaviour and seek to create as much as discrepancy as possible 
between the two. Affect is linked to these feedback loops, with affect conveying 
information about progress towards the desired state as well as modifying 
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behavioural output (Carver, Avivi & Laurenceau, 2008; Carver & Scheier, 2008). 
Essentially it is proposed that exceeding a set of criterion (e.g. goal 
expectations) will result in positive feelings leading to increased effort whilst 
performing below a set of criterion will lead to the experience of negative affect 
with reduced or withdrawing effort.  
 
More recently, Trew (2011), drawing on existing literature, has proposed a 
conceptual model of approach and avoidance processes in relation to 





Figure 1. Trew’s (2011) integrative model of approach and avoidance processes in relation to 
depression.  
 
Within this comprehensive integrative model, Trew has utilised previous 
research and suggested several different ways in which avoidance relates to 
depression. The model emphasises the importance of three key processes; (i) 
deficits in approach behaviours, (ii) the role of avoidance behaviours, (iii) 
approach perseveration and factors linking these processes to depression. By 
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using an integrative method Trew has included both cognitive processes and 
biological components.  
 
In this model, Trew argues that (i) decreased approach and increased 
avoidance contributes to the development and maintenance of depression by 
reducing potential access to sources of positive reinforcement, (ii) avoidance 
contributes to several negative information processing biases observed in 
depression (e.g. Gomez & Gomez (2002) found that BAS activation led to 
retrieval of pleasant emotional memories whilst BIS activation led to retrieval of 
unpleasant emotional memories), and lastly (iii) avoidance processes and 
dysregulated approach and avoidance system connections lead to approach 
perseveration, whereby an individual continues to follow unachievable goals 
leading to maintenance of depression.  
 
2.3 Behavioural treatment approaches to Depression  
With high prevalence rates and economical costs, depression has attracted a 
large body of research. Many theorists have used different psychological 
approaches to describe the onset and maintenance of depression. Treatment 
approaches have been developed from these proposed models and theories. 
Given the focus of this study on the role of approach- and avoidance-related 
processes, this review of the literature will focus predominately on the 
contribution of behavioural theories and treatment approaches (see Appendix A 
for a brief overview of national guidelines for depression and a summary of 
other recommended treatments).  
 
2.3.1 Early Behavioural approaches of depression  
There are three key concepts which can be found in all behavioural models of 
depression: behaviour, environment and contingent relationships between 
behaviour and environment. Contingent relationships are akin to ‘if-then’ 
relationships whereby a behaviour will lead to an environmental consequence. 
Central to behavioural theories is the development of behaviour-environment 
relationships over time.  
  
Models by Ferster (1973) and Lewinsohn (1974) have been highly influential in 
the early behavioural literature relating to depression. In essence, their 
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behavioural models have suggested that the development and maintenance of 
depression occurs as a consequence of a vicious cycle of decreased 
environmental reward and associated reductions in instrumental behaviour and 
response-contingent positive reinforcement. 
 
Ferster’s (1973, 1981) work was based on Skinner’s (1957) radical 
behaviourism principles with an emphasis on functional analysis of behaviour. 
Two behavioural patterns were highlighted as being central to the development 
of depression: (1) low number of positively reinforced social behaviours and (2) 
increasing number of escape or avoidance behaviours. According to Ferster, 
depression occurs in a learning context whereby the individual either does not 
receive positive environmental reward for a behaviour or when escape from an 
aversive behaviour is reinforced.  Over time behaviours, which would have 
resulted in positive consequences, cease to do so. For example, an individual 
may stop attempting to form close relationships if this behaviour is not positively 
reinforced by others, e.g. other people do not respond to their attempts at 
conversation.  
 
With reduced response-contingent positive reinforcement (RCPR)1 occurring, 
Ferster suggested that there are three consequences, which help facilitate the 
development of depression. The initial consequence of the above learning 
context involves an individual no longer attending to potential sources of 
positive reinforcement within their environment as they have already learned 
that their efforts are not successful. Secondly, an individual’s repertoire of 
adaptive behaviours diminishes as the number of positively reinforced 
behaviours reduces, with a more passive role adopted as they learn that their 
attempts have not produced positive consequences.  Lastly, Ferster suggested 
that increasing frequency of aversive consequences to behaviours leads to 
individuals becoming more preoccupied with escape and avoidance behaviours, 
with more effort expended on these latter behaviours rather than seeking 
possible positive reinforcement.  
 
1 RCPR refers to a behaviour resulting in a positive or pleasurable outcome. 
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Following on from Ferster, Lewinsohn (1974) added another element to the 
early behavioural work on depression. Like Ferster, Lewinsohn and colleagues 
(Lewinsohn, 1974; Lewinsohn, Youngren, & Grosscup, 1979; Lewinsohn, 
Hoberman, Teri, & Hautzinger, 1985) highlighted the importance of RCPR in the 





Figure 2. Lewinsohn’s behavioural model of depression (Lewinsohn, 1974) taken from Dimidjian, 
Barrera Jr, Martell, Munoz and Lewinsohn (2011).  
 
 
Lewinsohn et al. (1974, 1979, 1985) postulated that depression would occur 
when a stressor or environmental factor, e.g. bereavement, marital breakup, 
disrupted typical behaviour patterns, leads to reduced RCPR. Three factors 
were suggested as impacting on the rate of RCPR: (i) number of potentially 
reinforcing behaviours for the individual, which could vary depending on several 
different factors, e.g. age or gender, (ii) availability and frequency of reinforcing 
behaviours within the environment, e.g. would the reinforcement occur on a 
sufficiently frequent basis to shape and maintain the non-depressive behaviour, 
and (iii) instrumental behaviour required from the individual to receive the 
reinforcement and whether this behaviour exists within the individual’s 
repertoire to then receive positive reinforcement from others. The addition of a 
negative feedback loop of social reinforcement highlights the role of family 
members or friends reinforcing depressive behaviours. Social reinforcement 
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and reduced RCPR then lead to a decrease in pleasant events and an increase 
in aversive events, both associated with the onset of depression.  
 
2.3.2. Contemporary Behavioural treatment models of depression 
In recent years interest has returned to behavioural approaches in the treatment 
of depression. Two groups of researchers have been central in the development 
of contemporary behavioural models of depression, based on behavioural 
activation: Martell, Addis and Jacobson (2001) and Lejuez, Hopko, LePage, 





Figure 3. Contemporary behavioural model of depression (Manos, Kanter & Busch, 2010). 
 
 
The psychopathology model shown in Figure 3 has provided the foundation of 
both Martell et al.’s (2001) and Lejuez et al.’s (2001) work and gone on to 
inform Behavioural Activation (BA) and Brief Behavioural Activation Treatment 
for Depression (BATD) interventions, respectively. Both models are based on 
early behavioural approaches to depression (e.g. Ferster, 1973 and Lewinsohn, 
1974). Traditional behavioural principles have been extended to enable the 
models to: (i) become more idiographic in nature, with greater emphasis placed 
on the environment, (ii) help better understand functional aspects of behaviour, 
(iii) utilise a balanced acceptance-change paradigm. The differences between 
the models occur within the reinforcement box. Whilst decreased positive 
reinforcement is a key component of both models, each model has a different 
emphasis. Key to both models is the idea of targeting behavioural avoidance, as 




Within the BA model proposed by Martell et al. (2001), the trigger of a 
depressive episode is located within the individual’s life, with an event acting as 
the causal critical event e.g. breakdown of relationship. Reduced RCPR 
opportunities lead to depressed mood as increasing negative reinforcement 
occurs. Avoidance behaviours are utilised as a way of managing low rates of 
RCPR opportunities. Increasing avoidance patterns narrow an individual’s 
repertoire of behaviours, creating secondary problems which help maintain 
depression, e.g. withdrawing from social situations (avoidance behaviour) 
leading to reduced invitations to social events (secondary problem) and limiting 
opportunities of RCPR. Related to avoidance patterns are routine disruptions, 
which Martell et al. suggested maintain depression as individuals feel out of 
sync with their environment.  
 
The BATD model proposed by Lejuez et al. (2001) extended the work of 
Lewinsohn to include matching theory (Herrnstein, 1970; McDowell, 1982) to 
understand depression. Matching theory was originally proposed by Herrnstein 
(1970) as a mathematical account of behaviour and applied to non-human 
behaviours. McDowell (1982) extended this to human behaviours. Based on a 
concurrent reinforcement schedule, matching theory posits the ratio of 
behaviour as being equal to the ratio of received reinforcement. When applied 
to depression, matching theory suggests that the time and effort related to 
engaging with depressed/healthy behaviour is proportionate to the relative value 
of the reinforcement received for these behaviours. Using the psychopathology 
model in Figure 3, Lejuez et al proposed that as changes in reinforcement 
contingencies occur (more specifically as positive reinforcement decreases), the 
number of depressive behaviours increase leading to subsequent depressed 
mood.  The focus on increasing healthy behaviours is positioned within a 
values-driven framework, borrowed from Acceptance and Commitment therapy 
(ACT; Hayes, Strosahl & Wilson, 1999) so that healthy behaviours align with an 
individual’s values and beliefs.  
 
2.4. Behavioural treatments for depression 
2.4.1. Early Behavioural treatments of depression  
Behavioural treatments for depression were developed based on the 
reinforcement explanation of depression, which is evident in both Ferster (1973) 
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and Lewinsohn (1974) work. Essentially this explanation suggests that 
depression occurs when there is a reduction or lack of response contingent 
positive reinforcement behaviours. This decreasing reinforcement leads to 
fewer behaviours being rewarded.  Behaviours subsequently reduce in 
frequency, intensity and quality (Lewinsohn et al., 1974; 1979; 1985). The 
results of several studies provided support for this proposed explanation. A 
significant relationship was found between mood and engagement with pleasant 
activities (Lewinsohn & Graf, 1973; Lewinsohn & Libet, 1972), later leading to 
the development of the Pleasant Events Schedule (PES; McPhillamy & 
Lewinsohn, 1972). Other studies showed that when individuals are depressed 
they find fewer activities pleasant, engaging in pleasant activities less often and 
receiving less positive reinforcement (McPhillamy & Lewinsohn, 1974).  
 
Following on from this, Lewinsohn, Biglan and Zeiss (1976) developed one of 
the seminal treatments for depression from a behavioural perspective. They 
consolidated previous research into a treatment whereby individuals monitored 
their mood and engagement with daily activities in order to understand the 
association between these.  Intervention involved increasing frequency of 
pleasant activities and interactions with the environment and decreasing 
frequency and subjective experience of unpleasant activities, with a focus on 
social skills and interactions with other people. Several studies demonstrated 
the efficacy of this activation-based approach to depression (Barrera, 1979; 
McNamara & Horan, 1986; Zeiss, Lewinsohn & Munoz, 1979).  
 
As interest in cognitive therapies increased over the latter part of the twentieth 
century, there was a move away from purely behavioural approaches in the 
treatment of depression. However activation-based elements of treatment 
remained within interventions of depression. Two key examples of this were 
Coping with Depression (CWD; Lewinsohn, Antonuccio, Steinmetz & Teri, 
1984) and Cognitive therapy of depression as developed by Beck, Rush, Shaw 
and Emery (1979) (see Appendix A for further information). Both of these were 
multi-component treatments with a primarily cognitive focus but included 
behavioural techniques such as activity scheduling, graded task assignment 




2.4.2. Contemporary behavioural treatments of depression  
With the integration of behavioural techniques into treatments of depression, 
there was a changing zeitgeist that pure behavioural approaches were 
inadequate in the treatment of depression. Cognitive therapies enjoyed a long 
tenure as the treatment of choice for depression, however interest in 
behavioural treatments was revitalised following two key studies by Jacobson et 




Figure 4. Cumulative number of behavioural activation related publications. (Dimidjian et al., 2011). 
 
 
Figure 4 highlights the revived interest in behavioural activation, showing the 
number of publications related to behavioural activation published over the last 
four decades. Since the late 1990’s research has been increasing both in 
frequency and breadth of interest, with more recent studies exploring the 
application of behavioural activation to populations with medical and psychiatric 
co-morbidity, use of different mediums in the delivery of treatment and 
development of culturally diverse versions of behavioural activation treatment.   
 
Key to this renewed interest was work by Jacobson et al. (1996), who were 
interested in dismantling cognitive behavioural therapy (CBT) treatment for 
depression in order to compare the relative efficacy of each treatment 
component. 150 participants meeting DSM-III-R (American Psychiatric 
Association, 1987) diagnostic criteria for Major Depressive Disorder were 
randomised to (i) Behavioural Activation, (ii) Behavioural Activation with 
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modification of dysfunctional thoughts or (iii) the full CBT package. Participants 
received a maximum of 20 treatment sessions. The results showed that the 
behavioural component of CBT, called Behavioural Activation was comparable 
in its effect to the full version of CBT, with no significant differences between the 
treatments at 6 month follow up.  These results suggested that behavioural 
treatments alone could be as effective as the full package of CBT in the 
treatment of depression. Furthermore, the results started to raise interesting 
questions about the necessity of cognitive components in treatments of 
depression. 
  
More recently, Dimidjian et al. (2006) undertook a comprehensive randomised 
controlled study comparing Behavioural Activation, Cognitive therapy (CT), anti-
depressant medication (ADM; Paroxetine) and placebo treatments. Dimidjian et 
al. utilised an expanded version of the Behavioural Activation treatment 
described in Jacobson et al.’s (1996) study. The results of Dimidjian et al.’s 
study showed that Behavioural Activation was comparable to ADM and more 
efficacious than CT, for participants with severe depression. Participants in the 
BA condition were found to stay in treatment for longer, with lower attrition rates 
in relation to ADM, with higher rates of participants in remission. There were no 
treatment differences amongst participants with less severe depression. The 
results of this study added to the growing number of questions about use of 
cognitive components and directly targeting cognitions to achieve a treatment 
response for depression. Dimidjian et al. highlighted the value of behavioural 
strategies, e.g. goal setting, activity scheduling and graded task assignment in 
bringing about change in depression symptomatology. Furthermore, the results 
of this study indicated that the use of an expanded model of behavioural 
activation was more advantageous than simply utilising behavioural strategies 
as in Jacobson et al.’s (1996) study.  
 
Both Jacobson et al. (1996) and Dimidjian et al. (2006) highlighted the value of 
stand alone behavioural treatments, instead of behavioural treatments being 
integrated into CBT. Following on from these studies, contemporary behavioural 
treatments started to emerge. Two parallel treatments have arisen: BATD 
(Lejuez, LePage, Hopko & McNeil, 2001) and BA (Martell, Addis & Jacobson, 
2001). Both treatments are rooted in traditional behavioural models and 
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treatments of depression, but have extended these ideas leading to two 
treatments with differing components. Both research groups have contributed 
heavily to recent literature relating to behavioural activation. This research study 
has focused on the BATD model rather than the BA model, however a brief 
description of BA is provided below for greater depth and understanding.  
 
2.4.2.1. Behavioural Activation (BA) 
Martell et al. (2001) developed BA treatment, focusing on the functional facets 
of depressive behaviour. One of the key components of BA involves 
understanding the environmental triggers and ineffective coping responses 
utilised by an individual, which help to maintain depression. Martell et al. 
highlighted the importance of behavioural avoidance, and how depressed 
behaviours become coping strategies in order to avoid environmental situations. 
This leads to low levels of positive reinforcement being provided for the 
individual leading to depressed mood.  
 
BA treatment involves the identification of recurrent avoidance patterns using 
the TRAP (trigger, response, avoidance pattern) method. TRAP involves 
increasing an individual’s awareness of triggers, which lead to negative 
emotional responses. In turn, these contribute to the development of avoidance 
patterns, which over time become the individuals’ default way of coping. The 
main focus of treatment lies in helping the individual to develop alternative and 
more healthy ways of coping as well as re-engaging in these behaviours 
(TRAC; trigger, response and alternative coping). Another core part of the BA 
treatment involves enabling individuals to learn to recognise the functions of 
behaviours. By understanding the functional aspect of behaviour, individuals 
can learn about the relationship between different types of behaviours 
(avoidance, escape or continued engagement) and impact on mood, forming a 
key part of relapse prevention.  
 
2.4.2.2 Brief Behavioural Activation Treatment for Depression (BATD) 
Whilst Martell et al. (2001) were developing the BA treatment model, another 
group of researchers, Lejuez et al. (2001), developed the BATD treatment 
protocol using matching theory (Herrnstein, 1970; McDowell, 1982) as its 
primary framework. BATD suggests that increasing reinforcement relating to 
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healthy behaviours leads to subsequent decreased reinforcement of depressive 
behaviours. Change in reinforcement is sought through environmental change. 
By targeting reinforcement of healthy behaviours, frequency of depressive 
behaviours should reduce, with decreasing depressive symptomatology. In line 
with this view, Lejuez et al. have labelled behaviours as being either healthy or 
depressive within their treatment protocol.  
 
BATD treatment aims to create an environment of increasing frequency and 
reinforcement of healthy behaviours e.g. by asking other family or friends to 
notice and respond positively to healthy behaviours, whilst simultaneously 
reducing reinforcement of depressed behaviours. Underpinning BATD is the 
ACT principle of value-driven behaviour, with healthy behaviours developed to 
fit an individual’s values and beliefs. Using this framework, goals are identified 
from major life areas e.g. education, employment, social life, family life or 
hobbies. For example, the goal may be to spend time daily playing with their 
child to fit the value of wanting to be a good parent.  
 
Once a range of goals has been ascertained, these are positioned within an 
activity hierarchy, in terms of level of difficulty. This is a key aspect of BATD as 
patients are expected to progressively work through this activity hierarchy using 
a structured activity scheduling approach. Individual goals are set out as activity 
schedules, specifying frequencies and durations, to gradually build up towards 
the level of activity specified in the long-term goal. 
 
2.4.2.3. Differences between BA and BATD intervention  
Whilst BA and BATD have both extended the work of traditional behavioural 
theories and therapies (Ferster, 1973; Lewinsohn, 1974), some differences exist 
between the two interventions in terms of strategies and processes of change. 
BA utilises a functional behavioural analytical approach to understand 
avoidance patterns whereas BATD does not specifically focus on this. BA 
includes a number of additional components, which are not present within 
BATD, e.g. mental rehearsal and mindfulness training. Differences also exist in 
treatment components common to both BA and BATD. This can be most easily 
highlighted using the example of activities in graded tasks/goals. Within BA this 
task has an open structure whereby the therapist has greater flexibility in 
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suggestion of activities, assessment of life goals and deciding whether 
additional treatment strategies are required. In contrast, within BATD this is 
completed using a more structured approach using the ACT principle of value-
driven behaviours. Once the activity hierarchy has been developed, individuals 
are required to take more of a primary role involving goal selection and 
maintaining behavioural check out sheets (to monitor completion of activities).  
 
2.4.2.3. Evidence for contemporary behavioural activation for depression 
treatments 
In a meta-analysis of 34 studies Mazzucchelli, Kane & Rees (2009) concluded 
that behavioural activation treatments were as effective as cognitive therapy, 
with effects equivalent to cognitive therapy and CBT lasting until 24 months. 
Mazzucchelli et al. (2009) noted that all variants of behavioural activation 
treatment produced similar effects, with differences between variants of 
behavioural activation not statistically significant. Mazzucchelli et al.’s (2009) 
results echo the results of previous meta analyses (Cuijpers, van Straten & 
Warmerdam, 2007; Ekers, Richards & Gilbody, 2008), which found behavioural 
activation treatments equivalent to the current recommended treatments for 
depression.  
 
Behavioural activation has been found to have lower rates of attrition during 
treatment (Daughters, Braun, Sargeant, Reynolds, Hopko et al., 2008), with less 
attrition than CBT (Cuijpers, van Straten, Andersson & van Oppen, 2008), 
reduced likelihood of relapse or reoccurrence of depression in comparison to 
medication (Dobson, Hollon, Dimidjian, Schmaling, Kohlenberg et al., 2008) and 
superior performance to CBT in the treatment of cognitive therapy non-
responders (Coffman, Martell, Dimidjian, Gallop & Hollon, 2007). Behavioural 
activation has been successfully extended across the lifespan, with studies 
showing reduced depressive symptoms post treatment for older adults (Meeks, 
Looney, Van Haitsma, Teri, 2006; Teri, Logsdon, Uomoto & McCurry, 1997). At 
the other side of the lifespan, research has started to explore the use of 
behavioural activation with adolescents (McCauley, Schloredt, Gudmundsen & 
Martell, 2011) with promising results although this remains an emerging 




Research evidence for BATD largely comes from case studies and small-
randomised controlled trials, which have shown favourable results. In their 
meta-analysis Mazzucchelli et al. (2009) have therefore suggested that BATD 
would benefit from high quality randomised controlled trials, as would other 
versions of behavioural activation treatment.  
  
Hopko, Lejuez, LePage, Hopko and McNeil (2003) compared BATD to 
treatment as usual (non-directive therapy) at an inpatient psychiatric hospital. 
Their results showed greater changes for depressive symptomatology, 
measured by the Beck Depression Scale (BDI; Beck & Steer, 1987) for the 
BATD group. Gawrysiak, Nicholas and Hopko (2009) looked at the efficacy of 
one session of BATD. Participants (university students with moderate 
symptoms of depression) received a single 90-minute session of BATD which 
was followed by a two week treatment interval. The results showed significant 
reductions of depressive symptoms in comparison to the non-treatment group.  
 
BATD has been successfully applied to other clinical populations where there is 
co-morbidity with depression, highlighting the wide generalizability of this 
treatment protocol. Applications to other disorders include; co-morbid 
depression and substance use (Daughters et al., 2008), co-morbid anxiety and 
depression (Hopko, Lejuez & Hopko, 2004) and depressed cancer patients 
(Hopko, Bell, Armento, Hunt & Lejuez, 2005). Kanter et al., (2010) have noted 
that BATD has been primarily used in settings where financial or time efficiency 
is required.  
 
The use of BATD in the present study was driven by the reduced complexity of 
this treatment protocol in comparison to BA, thus lending itself more easily to 
investigating the mechanisms of change. Whilst BATD is more structured and 
uses fewer additional strategies beyond those directly related to activation, BA 
utilises additional secondary strategies and techniques e.g. mental rehearsal, 
likely increasing the likelihood of confounding factors. This would present 
greater difficulties in disentangling the effect of individual component parts.  In 
contrast, BATD provides a less complex and more structured framework within 




2.5. Mechanisms of change in behavioural activation treatments of 
depression   
As outlined above, behavioural treatments for depression have developed over 
the course of several decades, with initial treatments in the 1970’s (e.g. 
Lewinsohn, 1974) to more recent treatments (e.g. Martell et al., 2001; Lejuez et 
al., 2001). Research has predominately focused on demonstrating the efficacy 
of these behavioural treatments (e.g. Cuijpers, van Straten & Warmerdam, 
2007; Mazzucchelli, Kane & Rees, 2009), with results indicating positive 
outcomes. However, despite a clear rationale there is little understanding of the 
processes implicated in behavioural activation treatments. Research has not yet 
investigated possible mediators or mechanisms of action of behavioural 
activation treatment.  
 
Mediators refer to the psychological processes which may be responsible for 
therapeutic gains that has occurred. Kazdin (2007) described a mediator as the 
intervening variable between the independent and dependent variables 
relationship. The study of mediators within treatments provides a wealth of 
information. Mediational analysis helps test the proposed theoretical 
mechanisms underlying change in a treatment. Understanding and identifying 
mediators are a key aspect of the evaluation of treatments as this can help with 
improvement of therapeutic techniques (e.g. equipping clinicians with the 
knowledge about which techniques may result in the most change) and 
maximise treatment effectiveness. Furthermore, knowing about mediating 
changes is important as results can potentially guide decision making between 
different therapies. 
 
2.5.1. Approach, avoidance behaviours and BATD 
Understanding the mechanisms of change of behavioural activation has been 
suggested as the next step by several researchers (e.g. Dimidjian et al., 2006; 
Martell, Addis & Dimidjian, 2004). As approach and avoidance behaviours have 
been explicitly targeted as a focus of treatment, Martell et al. (2004) proposed 
that this could be a possible active ingredient of behavioural activation 
treatments. Whilst avoidance has been highlighted in earlier theories relating to 
depression, e.g. Ferster (1973) who proposed that avoidance has a key role in 
maintaining depression, this has been overlooked in subsequent research. With 
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the development of newer variants of behavioural activation treatments such as 
BA and BATD, there has been a greater emphasis on reducing avoidance 
behaviours. The advent of such interventions provides an opportunity to explore 
the role of approach avoidance behaviours, and whether these changes can 
affect the treatment of depression.  It is conceivable that changes in approach 
and avoidance behaviours during the course of behavioural activation treatment 
may mediate changes in depressive symptomatology, leading to decreased 
depressive symptoms at post treatment.  
 
2.5.2. Measuring approach-avoidance behavioural tendencies  
Within the literature, attempts have been made at measuring activation during 
the course of treatment. Activation can be viewed as a measure of approach 
behaviours, as behavioural activation treatments aim to increase approach 
whilst reducing avoidance. Several questionnaire measures of 
approach/avoidance have been developed, specifically in relation to behavioural 
activation, whilst experimental measures of approach/avoidance behavioural 
tendencies also exist.  
 
2.5.2.1. Questionnaire measures of approach avoidance  
As research has highlighted the multidimensional nature of avoidance 
(experiential, behavioural and cognitive; e.g. Cribbs et al., 2006) measures 
should aim to capture some information about each of these different types of 
avoidance. Potentially this may help to guide future research pathways, as 
some types of avoidance may have stronger associations with behavioural 
activation treatments. Ottenbriet and Dobson (2004) have developed a measure 
to reflect this multifaceted nature of avoidance – Cognitive Behavioural 
Avoidance Scale (CBAS). It should be noted that whilst CBAS measures 
avoidance, it was not specifically designed for treatment studies.   
 
Rumination has been conceptualised by behavioural researchers as another 
type of avoidance (Goldiamond & Oyrud, 1968; Martell et al., 2010). One of the 
most widely used measures within the literature remains the Ruminative 
Response Scale (RRS; Nolen-Hoeksema & Morrow, 1991). Recently, research 
studies have attempted to dismantle the construct of rumination (e.g. Treynor, 
Gonzalez & Nolen-Hoeksema, 2003) to identify the maladaptive aspect of 
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rumination. In a factor analytic study of the RRS, Treynor et al. (2003) identified 
two factors, labelled reflection and brooding, with differential effects on 
depression. The brooding factor, Treynor et al. found was associated with 
greater depression both concurrently and longitudinally. In comparison, the 
reflection factor was associated with greater concurrent depression but less 
depression longitudinally. Moulds, Kandris, Starr and Wong (2007) explored the 
relationship between avoidance, depression and rumination using the CBAS 
and RRS. Their results showed that avoidance was able to predict unique 
variances in depression scores over and above anxiety and depression. The 
brooding RRS subscale was correlated with the Behavioural Social subscale of 
the CBAS, after anxiety was partialled out, whilst reflection was not correlated 
with any avoidance measures. This adds to Treynor et al.’s (2003) suggestion 
that the brooding subscale links most closely to depression, indicating that this 
maybe the most toxic and maladaptive aspect of rumination, contributing to the 
maintenance of depression.  
 
Despite renewed interest in behavioural activation treatments this has not 
translated into development of specific outcome measures. As a way of 
addressing this issue, Kanter, Mulick, Busch, Berlin and Martell (2007) 
developed the Behavioural Activation for Depression Scale (BADS), to help 
explore the process of change in behavioural activation treatments. The BADS 
measures activation (reflecting level of goal directed activation), 
avoidance/rumination (measuring avoidance of aversive thoughts and feelings), 
work/school impairment and social impairment. It was designed for use weekly 
during treatment and is sensitive enough to capture weekly changes in 
behaviour (Manos, Kanter & Busch, 2010).  
 
2.5.2.2. Experimental measures of approach avoidance  
Experimental measures can provide useful information, as questionnaire 
measures can be prone to demand characteristics and social desirability, 
affecting responses on a measure. Experimental measures often use reaction 
time tasks, with responses thought to indicate more automatic processes. The 
advantages of using experimental measures over self-report measures have 
been noted by Krieglmeyer and Deutsch (2010) as being; (i) a valid measure of 
behavioural reaction, (ii) measuring behavioural reactions beyond the 
36 
 
individuals’ awareness, which even if they wished to report, they may not be 
able to do so, (iii) more ethically viable and less challenging in comparison to 
any natural study of approach or avoidance behavioural tendency.  
 
One paradigm that has been used in experimental measures incorporates use 
of facial expressions. Previous research studies have illustrated that different 
facial expressions are associated with approach and avoidance. Davidson 
(1992) found that a joyful face was likely to elicit a similar, congruent expression 
in the observer, increasing the likelihood of approach behaviour. In contrast, 
others have found that negative emotions are avoidance oriented, with 
expressions of anger more likely to elicit avoidance from an observer (Marsh, 
Ambady & Kleck, 2005). 
 
Building on such findings, Rinck and Becker (2007) recently developed an 
approach/avoidance task (AAT) that measures implicit approach and avoidance 
tendencies. Utilising previous research findings, the AAT, a joystick reaction 
time task, is based on the premise that positive stimuli will elicit approach 
behaviours (pull on the joystick) and negative stimuli will elicit avoidance 
behaviour (push away on the joystick) (Cacioppo, Priester & Berntson, 1993; 
Chen & Bargh, 1999). The AAT consists of individuals being presented with a 
series of stimuli e.g. faces with different facial expressions, which they are 
asked to respond to using a joystick attached to the screen. A zooming function 
is employed whereby pulling the joystick towards you will result in the picture on 
the screen increasing in size until it fills the entire screen. Pushing the joystick 
will lead to the picture decreasing in size until it has significantly shrunk in size.  
This zooming effect creates a visual impression of a picture coming close 
towards you when pulling the joystick or a picture moving away from you as the 
joystick is pushed.  
 
Studies have highlighted the usefulness of using this experimental framework 
for investigating behavioural approach and avoidance tendencies. The AAT 
research paradigm has previously been used to investigate approach and 
avoidance behaviours in the study of anxiety (e.g. Heuer, Rinck & Becker, 2007; 
Lange, Keijsers, Rinck & Becker, 2008; Lange, Salemink, Windey, Keijsers, 
Krans, Becker et al, 2010; Roelofs, Putman, Schouten, Lange, Volman & Rinck, 
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2010), spider phobia  (e.g. Klein, Becker & Rinck, 2007; Rinck & Becker, 2007) 
and addictions (Wiers, Rinck, Kordts, Houben & Strack, 2010). When exploring 
approach and avoidance in samples of socially anxious individuals (Heuer, 
Rinck & Becker, 2007; Lange, Keijsers, Rinck & Becker, 2008), results have 
indicated that highly socially anxious individuals display stronger avoidant 
behavioural tendencies to smiling and angry faces in comparison to control 
participants.  
 
Vrijsen, van Oostrom, Speckers, Becker and Rinck (2012) have extended the 
AAT paradigm further by incorporating the use of emotional faces. In their study 
participants were induced to either happy or sad mood using film clips, 
behavioural approach and avoidance tendencies were then explored using the 
AAT. The AAT consisted of ten pictures of individuals displaying sad, angry, 
neutral or happy facial expressions, as well as ten control pictures (chessboard 
pattern). All pictures received a blue or purple colour filter, resulting in 100 
stimuli pictures. The task was completed on a computer with an attached 
joystick. Pictures were presented to individuals after the mood induction task. 
They were asked to push pictures with a blue filter and pull pictures with a 
purple filter. Results showed that behavioural approach avoidance tendencies 
were related to depressive characteristics, with happy faces avoided the most 
by participants with the highest depressive symptomatology. These results 
suggest that the use of AAT would help to provide information about approach 
and avoidance tendencies in depression.  
 
2.6. Aims of the current study  
Within the literature, behavioural activation treatments have been demonstrated 
as being effective in the treatment of depression (e.g. Dimidjian et al., 2006; 
Hopko et al., 2003). As efficacy has been shown, the next logical direction of 
research lies in understanding the processes implicated in changes in 
depressive symptomatology, following treatment. There has been little research 
investigating the mechanisms of change within behavioural activation 
treatments. Research has illustrated that a relationship between depression and 
approach avoidance does exist (e.g. Aldao, Nolen-Hoeksema & Schweiser, 
2010; Grant, Wingate, Rasmussen, Davidson, Slish et al., 2013). This study 
aims to extend this idea further by exploring whether changes in approach and 
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avoidance behavioural tendencies occur following a single treatment session of 
BATD. Use of a single session of BATD will build on research by Gawrysiak et 
al. (2009), who demonstrated significant effects in a sample of students 
experiencing moderate symptoms of depression. Their results indicate that such 
minimal intervention may have sufficient impact on individuals to allow 
investigation of the mechanisms of action of BATD, although this has yet to be 
replicated using a clinical sample.  
 
Bearing in mind this gap within the literature regarding approach avoidance 
behavioural tendencies and mechanisms of change within behavioural 
treatments of depression, the present study set out to  investigate (a) the impact 
of one session of BATD for a clinical sample of depressed participants from a 
primary care psychology service, (b) changes in participant’s tendencies 
towards approach and avoidance as tested using an experimental task and self-
report questionnaires  following one session of BATD, and (c) whether these 
approach / avoidance changes mediate symptom change.  
 
2.6.1 Hypotheses of the current study  
Based on review of the relevant literature it is hypothesized that; 
(i) In comparison to control participants, participants in the treatment 
condition will show greater changes in depressive symptomatology, 
(ii) Compared to control participants, patients in the treatment condition will 
show significant increases in approach towards positive emotional 
faces and reductions in avoidance of negative emotional faces, and 
greater improvements in avoidance and rumination on self-report 
questionnaires 
(iii) That the degree of these approach / avoidance changes will mediate the 
impact of treatment condition on changes in depressive symptoms. 
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3. Methods  
3.1. Design  
A two group comparison design was utilised for this study, with assessment 
measures completed before treatment (Time 1), after treatment (Time 2) and at 
one month follow up (Time 3). Participants were recruited from primary care 
psychological therapies services in Southwark and Lambeth. Participants were 
randomised to either treatment or waiting list control at Time 1. Participants in 
the treatment condition received one session of a modified form of BATD. 
Participants in the waiting list control condition did not receive treatment until 
their participation in the study ended. 
 
The two primary dependent variables were PHQ-9 (Kroenke, Spitzer & 
Williams, 2001) scores and reaction time scores on the Approach Avoidance 
Task (AAT; Rinck & Becker, 2012) at Time 2. Secondary dependent variables 
were scores on the other self-report measures; Behavioural Activation and 
Depression Scale (BADS; Kanter, Mulick, Busch, Berlin, & Martell 2006), 
Acceptance and Action Questionnaire (AAQ; Hayes, Strosahl, Wilson, Bissett, 
Pistorello, et al., 2004), Ruminative Response Scale (RRS; Nolen-Hoeksema 
and Morrow, 1991), Cognitive Behavioural Activation Scale (CBAS; Ottenbreit & 
Dobson 2004).  
 
3.2. Participants   
3.2.1. Recruitment  
Participants for the study were recruited from primary care psychological 
therapy services in the London boroughs of Lambeth (Lambeth Psychological 
Therapies Service; LPTS) and Southwark (Southwark Psychological Therapies 
Service; SPTS). As part of the initial assessment for these services, patients are 
asked for consent for researchers to contact them. Only participants who had 
consented to being contacted for research were invited to participate in the 
study.  
 
Allocated workers in SPTS and LPTS created spread sheets with details of 
patients using the following filters on their computer system; consented to 
research contact, scored above 10 on the PHQ-9 and had a diagnosis of 
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depression recorded. These lists were generated on a three weekly basis and 
forwarded to the researcher using password-protected emails.  
 
3.2.2. Inclusion and exclusion criteria  
Participants were only included in the study if they had a current primary 
diagnosis of major depression, aged between 18 and 60, able to speak fluent 
English and scored above 10 on the PHQ-9. Patients over 60 were excluded 
due to differences in clinical presentation for depression e.g. greater expression 
of somatic complaints (Blazer, Hughes & George, 1987).  
 
A number of exclusion criterion were utilised in this study, which are outlined 
below; 
• History of psychosis or mania 
• Self-harmed in the last four weeks 
• Current diagnosis of eating disorder or OCD 
• Current drug/ alcohol/ medication abuse or dependence 
• History of traumatic brain injury or epileptic seizures 
• High risk for suicide in the absence of any on-going support  
• Unable to refrain from taking benzodiazepines 48 hours before 
completing the experimental tasks. This was a necessary criterion 
because of research evidence suggesting that taking benzodiazepines 
can decrease recognition of facial expressions (e.g. Blair & Curran, 
1999), possibly impacting on participant’s responses on the experimental 
task in this study.   
• Psychotherapy/counselling at a frequency of more than once a month  
 
Participants currently taking antidepressants were included in the study, with 
the caveat that medication had not been changed during the four weeks before 
starting the study.  
 
3.2.3. Sample Size  
A preliminary power analysis was conducted (using statistical software G*Power 
3.0.10,) to establish the necessary sample size. The power analysis calculation 
was based on the results achieved by Gawrysiak et al. (2009). An a priori t-test 
power analysis indicated that 10 participants would be needed in each of the 
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two groups to have 95% power for detecting a large sized effect (as found by 
Gawrysiak et al., 2009 which is the closest existing study to the one proposed 
here) when employing the .05 criterion of statistical significance.  
 
3.3. Outcome Measures  
Several different outcome measures were used at different stages in the study 
which are described in detail below.  
 
3.3.1. Clinical interview  
The Mood module of the Structured Clinical Interview for DSM-IV (SCID; First, 
Spitzer, Williams & Gibbons, 1995) was used to confirm that participants met 
diagnostic criteria for Major Depressive Disorder. The SCID is a semi-structured 
interview measuring lifetime and current Axis I disorders, as defined by the 
Diagnostic Statistical Manual – 4th edition (DSM-IV; American Psychological 
Association, 2000). The Mood module takes around 10-15 minutes to 
administer.  
 
3.3.2. Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 
2001)  
The PHQ-9 (see Appendix B) is based on the diagnostic criteria for Major 
Depressive Disorder in the DSM IV. Designed for primary care settings, this 
self-administered questionnaire consists of items derived from the DSM-IV 
classification system and pertaining to; anhedonia, depressed mood, trouble 
sleeping, feeling tired, change in appetite, guilt or worthlessness, trouble 
concentrating, feeling slowed down or restless and suicidal thoughts.  
 
It consists of nine items, which are used to measure depression 
symptomatology over the last two weeks. Items are answered using a 4-point 
Likert scale, from 0 (‘Not at all’) to 3 (‘Nearly every day’). Scores range from 0 to 
27. The PHQ-9 has cut-off points of 5, 10, 15 and 20, which represent 
symptoms of mild, moderate, moderately-severe and severe depression 
respectively.  
 
The PHQ-9 has been validated with several different clinical populations, 
including primary care populations (e.g. Kroenke, Spitzer & Williams, 2001). 
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Kroenke et al (2001) found that the majority of their sample with no depressive 
disorder (93%) had a PHQ-9 score below 10. In contrast, most participants 
meeting criteria for a depressive disorder (88%) scored above 10 on the PHQ-9. 
In line with this, the guidelines for Improving Access to Psychological Therapies 
(IAPT) services, like the services used for recruitment in this study, suggest that 
individuals scoring 10 or above can be considered as experiencing clinically 
significant symptoms of depression (National IAPT Programme Team, 2011).  
 
The PHQ-9 has been shown to have good sensitivity to change over time 
(Löwe, Kroenke, Herzog, & Gräfe 2004). A score of above 10 has been found to 
have 88% sensitivity and 88% specificity for major depression (Kroenke, et al. 
2001). Kroenke et al. (2001) found high internal consistency using two different 
populations (Cronbach’s α= 0.86 and 0.89). The scale showed good internal 
consistency in the current study at Time 1 (Cronbach’s α= 0.77), Time 2 
(Cronbach’s α= 0.89) and Time 3 (Cronbach’s α= 0.81).  
 
3.3.3. Behavioural Activation and Depression Scale (BADS; Kanter, Mulick, 
Busch, Berlin, & Martell, 2006)  
The BADS (see Appendix C) was developed to measure when and how 
individuals become less avoidant and more activated over the course of 
treatment. A self-administered questionnaire, it consists of 25-items, producing 
a total scale score and 4 subscale scores.  The subscales are: “Activation”, 
representing focused, goal-directed activation and completion of scheduled 
activities e.g. “I engaged in a wide and diverse range of activities”; 
“Avoidance/Rumination” representing avoidance of negative aversive states and 
engaging in rumination rather than active problem solving e.g. “I did things to 
avoid feeling sadness or other painful emotions”; “Work/School Impairment”, 
representing inactivity and passivity regarding work and school responsibilities 
e.g. “I stayed in bed for too long even though I had things to do”; and “Social 
Impairment” representing similar social consequences and social isolation e.g. 
“I did not see any of my friends”. Items are answered using a 6-point Likert 
scale ranging from 0 (‘Not at all’) to 6 (‘Completely’). Higher scores represent 




The BADS was originally validated using an undergraduate college sample 
(Kanter et al., 2006). This study demonstrated good internal consistency (α = 
0.79) and test–retest reliability (r = 0.74). Further validation by Kanter, Rusch, 
Busch and Sedivy (2008) has been undertaken using a community sample of 
individuals experiencing elevated levels of depressive symptoms. They 
demonstrated that the BADS had good psychometric properties with good 
construct validity with measures of avoidance  (CBAS) and depression (Center 
for Epidemiological Studies – Depression Scale, Radloff, 1977). Kanter et al. 
(2008) found the BADS total scale had good internal consistency (Total scale 
α= 0.92, Activation α= 0.84). The total scale scores in the current study showed 
good internal consistency at Time 1 (Total scale α= 0.84), Time 2 (Total scale 
α= 0.89) and Time 3 (Total scale α= 0.92).  
 
3.3.4. Acceptance and Action Questionnaire (AAQ; Hayes, Strosahl, Wilson, 
Bissett, Pistorello, Toarmino, et al., 2003)  
The AAQ (see Appendix D) was designed to measure experiential avoidance 
and psychological flexibility. It was originally developed by Acceptance 
Commitment Therapy (ACT) therapists, who generated items based on the 
clinical processes targeted by ACT. The items relate to key aspects of the 
experiential avoidance construct and link experiential avoidance to inaction, the 
literalness of thoughts, controlling private events in the same manner as real-
world events, and escape or avoidance of negatively evaluated content. 
Example items include “When I feel depressed or anxious I am unable to take 
care of my responsibilities; It’s ok to feel depressed or anxious; When I compare 
myself to other people its seems that most of them are handling their lives 
better than I do”.  
 
Whilst the AAQ was originally developed to measure experiential avoidance and 
psychological flexibility, Hayes, Luoma, Bond, Masuda and Lillis (2006) have 
suggested that the AAQ is in fact a broader measure of ACT processes which 
influence psychological flexibility.  As the BATD protocol incorporates an 
element of ACT, with emphasis on increasing healthy behaviours positioned 
within a values driven framework borrowed from ACT, the AAQ provides a way 




The original, longer (16 item) version of questionnaire was used in order to 
capture more information and allow greater comparability with previous studies. 
The 16-item has been found to load onto two factors; the first factor has been 
interpreted as measuring mindfulness and acceptance whilst the second factor 
measures  values-based actions. These two factors then load onto a secondary 
factor labelled “psychological flexibility” (Bond & Bunce, 2003).  
 
Items are answered using a 7-point Likert scale, ranging from 1 (‘Never true’) to 
7 (‘Always true’). Higher scores are intended to indicate a higher level of 
experiential avoidance and a lower level of acceptance of private events. The 
AAQ has been found to have moderate to high correlations with measures of 
depression, anxiety, general psychopathology and quality of life (Hayes et al., 
2003). Correlations with the White Bear Suppression Inventory (Wegner, 1994), 
a measure of experiential avoidance ranged between 0.44 and 0.5. Hayes et al 
(2003) demonstrated that it had adequate internal consistency (α = 0.70) and 
good test-retest reliability (α= 0.64 over 4 months).  The scale showed adequate 
internal consistency in the current study at Time 1 (Cronbach’s α= 0.70), Time 2 
(Cronbach’s α= 0.62) and Time 3 (Cronbach’s α= 0.72).  
 
3.3.5. Ruminative Response Style Questionnaire (RRS; Nolen-Hoeksema and 
Morrow, 1991) 
The RRS (see Appendix E) is a subscale from the Response Styles 
Questionnaire (RSQ; Nolen-Hoeksema & Morrow, 1991) measuring ruminative 
responses to depressed mood by asking individuals what they generally do 
when they are feeling depressed. The items describe responses that are self-
focused (e.g., "I think, 'Why do I react this way?' "), symptom focused (e.g., "I 
think about how hard it is to concentrate"), and focused on the possible 
consequences and causes of their mood (e.g., "I think, 'l won't be able to do my 
job if I don't snap out of this' "). The RRS is comprised of 22 items, with each 
item rated on a four-point Likert scale, ranging from 0 (‘Almost never’) to 4 
(‘Almost always’). Higher scores indicate a greater degree of rumination in 
response to depressive mood. 
 
The predictive validity of the RRS in relation to future depression has been 
demonstrated in both clinical and non-clinical populations (e.g. Nolen-
45 
 
Hoeksema & Morrow, 1991; Nolen-Hoeksema & Davis, 1999; Nolen-
Hoeksema, 2000). Studies have demonstrated the RRS to have good 
convergent validity (e.g. Roberts, Gilboa and Gotlib, 1998). High internal 
reliability for the RRS has been found, with Cronbach’s α ranging from 0.89 
(Nolen-Hoeksema & Morrow, 1991) to 0.92 (Nolan, Roberts & Gotlib, 1998). 
The RRS has been found to have good internal consistency, Cronbach’s α= 
0.89 (Nolen-Hoeksema & Morrow, 1991). The scale showed adequate to 
excellent internal consistency in the current study; Time 1 Cronbach’s α= 0.88, 
Time 2 Cronbach’s α= 0.63, Time 3 Cronbach’s α= 0.91.  
 
3.3.6. Cognitive Behavioural Avoidance Scale (CBAS; Ottenbreit & Dobson 
2004) 
Ottenbreit and Dobson (2004) developed the CBAS (see Appendix F) as a 
multidimensional measure of avoidance in relation to depression. It is a self-
report measure consisting of 31 items, which are answered using a 5-point 
Likert scale. Items relate to one of four domains; Behavioural Social, Cognitive 
Nonsocial, Cognitive Social and Behavioural Nonsocial avoidance. Higher total 
scores are an indication of more avoidant behaviours. 
 
Ottenbriet and Dobson (2004) demonstrated that the CBAS had good test-retest 
reliability (α = 0.92) over a 3-week period, using an undergraduate student 
sample population.  The CBAS has been shown to have good convergent and 
divergent validity, with CBAS scores correlating positively with self-report 
measures of avoidance and negatively with an index of approach coping 
(Ottenbriet & Dobson, 2004). Ottenbriet and Dobson (2004) found the CBAS to 
have good internal consistency for the total scale and subscale scores. The 
Cronbach alpha’s were as follows; Total score (α = 0.91), Behavioural Social (α 
= 0.86), Cognitive Nonsocial (α = 0.80), Cognitive Social (α = 0.78) and 
Behavioural Nonsocial (α = 0.75).  In the current study, the total scale showed 
good to excellent internal consistency at all time points (Time 1 Cronbach’s α= 




3.3.7.  Sociodemographic data 
Sociodemographic information was collected during the Time 1 session; 
education level, marital status, previous experience of depression, other mental 
health difficulties and previous therapy experiences  (see Appendix G).  
 
3.3.8.  Approach-Avoidance Task (AAT; Rinck & Becker, 2007) 
Rinck and Becker (2007) developed an experimental computer task to measure 
implicit approach and avoidance behaviours using a joystick. Initially used in the 
study of phobia disorders (e.g. Rinck & Becker, 2007), Vrijsen, Van Oostrom, 
Speckers, Becker and Rinck (2012) extended this experimental paradigm 
further to explore the impact of mood towards different emotional faces. Various 
research studies have already demonstrated that individuals will usually 
approach a reference object or stimulus when a positive outcome or affect is 
expected but avoid the reference objects or stimuli where a negative outcome 
or affect is expected to occur (e.g. Carver, Avivi & Laurenceau, 2008).  
 
The aim of the AAT in this study was to explore whether approach and 
avoidance tendencies, as measured by the speed of the joystick in response to 
different facial expression faces presented on a computer screen, was affected 
by mood. Participants reaction times from initiation of a trial to disappearance of 
the picture was recorded and used as the primary dependent variable for this 
task. The speed of the joystick movement indicated the individual’s behavioural 
approach and avoidance towards the presented picture.  
 
The task was presented on a laptop using a screen resolution of 1024 x 728 
pixels. A joystick was attached to the laptop and fixed on the table and 
moveable only within its Y-axis (front-back). Participants were instructed to 
either push or pull a joystick as fast as possible depending on the colour 
shading of the presented item. (See Figure 5 for the introduction screenshot of 





Figure 5. Introduction screenshot of the AAT. 
 
Participants were instructed to pull the joystick towards them for grey shaded 
pictures, and push the joystick away from them for brown shaded pictures 
displayed. The 10 control pictures consisted of checkerboard patterns, shaded 
















After completing the control pictures, participants were presented with a screen 
advising that they would be presented with 200 more pictures (see Figure 7), 
with a possible break, if required after 100 pictures.  
 
 




Photographs of 8 individuals were used (4 male and 4 female). Each individual 
expressed five different facial expressions; happy, disgust, sad, angry and 
neutral (see Figure 8). Two versions of each picture were created, using both 
brown and grey shading. The 10 control checkerboard patterns were also 
included.  As instructed for the practice trial, participants were required to push 
the joystick away from them for brown shaded pictures or pull the joystick 









Figure 8. Five facial expressions as displayed by each individual in AAT. 
 




A ‘zooming effect’, using five different sizes of each picture, was employed to 
create a visual impression of participants either approaching or avoiding the 
pictures. Pulling the joystick increased the size of the picture until it appeared to 
fill the entire screen (see Figure 9) and was classified as approach behaviour. 
Pushing the joystick decreased the size of the picture (see Figure 9), and was 


























Once the joystick had been moved all the way in the correct direction, the 
picture would disappear. Participants were instructed to press a ‘fire’ button 
(located at the back of the joystick) to load the next picture onto the screen.  
Pulling joystick – approach behavioural tendency  
Pushing joystick – avoidance behavioural tendency  
Figure 9. 'Zooming' effect to create visual impression of behavioural approach or avoidance. 
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3.3.9. Timing of assessments 
The use of the outcome measures at the different time points are summarised 












3.4. Procedure   
The experimental procedure consisted of five stages;  
(i) Pre-screening - to invite participants to take part in the study. 
(ii) Telephone screening - to establish if interested individuals met the 
inclusion criteria for the study.  
(iii) Time 1 - Pre-treatment outcome measures were completed and 
participants randomised to a condition. Participants in the treatment 
condition received the treatment session at this time point.   
(iv) Time 2 - Post treatment outcome measures were completed one week 
after Time 1.  
(v) Time 3 – Follow up outcome measures were completed four weeks after 
Time 2 via an email link or post, depending on participant preference.  
 
3.4.1. Invitation to participate in study 
Allocated workers in the two psychological therapies services created spread 
sheets with details of patients using the following filters on their computer 
system; consented to contact for research purposes, scored above 10 on the 
Patient Health Questionnaire (PHQ-9) and had a diagnosis of depression 
recorded. These lists were generated on a 3 weekly basis and forwarded to the 
researcher using password-protected emails. Patients on these lists were 
Figure 10. Use of outcome measures at different stages of the study. 
Telephone 
screening 























contacted via telephone by the researcher. Information about the study from the 
Participant Information Sheet (see Appendix H) was given and patients were 
asked if they wished to participate. Participants were given the opportunity to 
ask questions and given time to think before making the decision to participate 
in the study.  
 
3.4.2. Telephone screening  
Patients who wished to participate completed a telephone screening process 
with the researcher. This took approximately 20-30 minutes. The screening 
process consisted of the administration of the Major Depressive Disorder 
module from the SCID and the PHQ-9. Patients were also asked if any of the 
exclusion criteria applied to them e.g. did they have a current diagnosis of an 
eating disorder or were they currently receiving any therapy. If patients met the 
inclusion criteria they were invited to take part in the study and attend two 
sessions. Participants were either sent a confirmation email or letter, which 
contained a copy of the Patient Information Sheet. 
 
If patients did not meet criteria, then this was explained to them and they were 
thanked for their time. If any risk issues came up during the screening process, 
further information was sought in order to provide the relevant service with 
detailed information. Patients with suicidal ideation assessed to be at risk were 
signposted to the necessary services e.g. local Accident and Emergency 
service or Samaritans telephone number and explained that these risk issues 
would be passed onto the relevant service. An email with the identified risk 
issues was sent to a clinician within the relevant service following the end of the 
screening call. Clinicians would make a note of the risk issues on the 
participants file and make follow up calls if necessary.  
 
3.4.3. Time 1  
Participants were given a verbal overview of what the session would entail and 
advised that they could leave the study at any time, without providing a reason 
and that this would not affect their care. Participants were given a Participant 
Information sheet to read and a Consent Form (see Appendix I) to sign. They 
were given a further opportunity to ask questions or to take additional time if 
they were unsure about participating in the study.  
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Once participants signed the consent form, they were asked to complete the 
self-report measures and demographic information sheet. Participants were 
asked for their GP contact details in order to let their GP know about their 
participation in the study (see Appendix J). After completion of the questionnaire 
pack, participants completed the AAT. Whilst the participant was completing the 
AAT, the researcher undertook the random allocation to either the treatment or 
waiting-list condition.  A sealed envelope method was used, which involved 
having 40 sealed, brown envelopes with a treatment or waiting list control 
typewritten note inside. It was not possible to read anything through the 
envelopes. The envelopes were shuffled into a random order and an envelope 
was opened during the second half of the AAT. Randomisation was completed 
at this stage so that allocation could not bias any responses on the pre-
treatment measures or the way in which the researcher interacted with the 
participant earlier in the procedure.  
 
Treatment condition - Participants in the treatment condition were provided 
with one session of BATD, which lasted between 60 and 90 minutes. A modified 
version of the manualised treatment (see Appendix K), by Gawrysiak and 
Hopko (2009) was utilised. Gawrysiak and Hopko (2009) undertook major 
modifications in order to reduce the comprehensive BATD treatment manual 
(Hopko & Lejuez, 2007; Lejuez, Hopko, & Hopko, 2001) down to one treatment 
session. As a result of this reduced form of treatment and shorter time period, a 
non-progressive approach to behavioural activation was used whereby a larger 
number of behaviours were immediately targeted for change instead of utilising 
a graded approach to activity scheduling. In addition, the behavioural 
contracting strategies were omitted from this shortened treatment form, which 
would have been used to address and decrease the rewards associated with 
depressive behaviours.  
 
BATD was introduced to participants, with a discussion of the different 
symptoms of depression, and an opportunity for participants to discuss their 
experience of symptoms.  A rationale for how BATD works, extracted from the 
BATD protocol was provided. This was facilitated using a diagram from the 
original BATD manual (Lejeuz, Hopko & Hopko, 2001), as seen in Figure 11. 
Particular emphasis was placed on engaging in activities which would bring 
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either a sense of pleasure or accomplishment to help to reduce feelings of 
depression and self-esteem. Some psycho-education was provided, whereby 

















The session then focused on identifying and scheduling potential activities using 
the “life goal/area assessment” approach. This involved discussion of the 
following life areas; family relationships, social relationships, intimate 
relationships, education/learning/training, hobbies/recreation/leisure, 
physical/health issues, spirituality and mental health issues. By discussing 
these different life areas, goals were collaboratively generated by the participant 
and researcher. Participants were encouraged to think of specific, measureable, 
action-orientated, realistic and time limited goals e.g. ‘I will go running in the 
local park for 20 minutes on 3 days’.  An assessment sheet was used to help 
facilitate this and to ensure that all participants were being asked similar 
questions (see Appendix L). Using this approach, participants were guided 
towards identifying activities which would bring them a sense of pleasure and/or 
accomplishment, in line with their values and beliefs.  
 
Once structured and appropriate activities for the coming week were identified, 












Figure 11. 'How Behavioural Activation works': Diagram to help explain treatment rationale 
(Lejuez et al., 2001). 
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were encouraged to think of 3 to 5 activities to implement over the next 7 days. 
On the behavioural checkout sheet participants were asked to specify the 
frequency and duration of each goal. This sheet was used as a monitoring tool 
during the one-week treatment interval.  Participants were asked to attempt to 
engage in the selected activities over the coming week. The importance of 
monitoring and completing the behavioural checkout sheet on a daily basis was 
emphasised. Potential barriers to success were discussed and problem solved. 
Participants were then invited to complete these goals over the coming week 
and return for their Time 2 session with the completed behavioural checkout 
sheet.  
 
Waiting list control condition - Participants were advised that they would be 
receiving the treatment session in one month’s time. They were thanked for 
their time and reminded that the Time 2 appointment would take place the 
following week. 
 
3.4.4. Time 2 
Participants were invited to attend a Time 2 appointment one week after their 
Time 1 session. Where this was not possible, an appointment was made when 
the participant was next available. Participants were asked whether they had 
received any treatment from IAPT during the one-week interval period. One 
participant did start treatment during this time period and was excluded from the 
study. Preference for contact (email or post) was established with participants 
for the follow up questionnaires. Participants also received £20 reimbursement 
during this session.  
 
Treatment condition – Participants were asked to complete the outcome 
measures. Their completed behavioural checkout sheet was then reviewed. 
Participants were asked for feedback on the treatment session and the 
treatment interval. If participants wished to continue setting weekly goals for 
themselves, they were given blank copies of the behavioural checkout sheet. 
After this discussion participants were provided with their reimbursement.  
 
Waiting list control condition – Participants were asked to complete the 
outcome measures. Participants were reminded that after completing the follow-
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up questionnaires they would be able to receive the BATD treatment if they 
wished to do so.  
 
3.4.5. Time 3 
Four weeks after attending the Time 2 (post-treatment) appointment, 
participants were contacted by their preferred method of contact to complete the 
follow up outcome measures. Participants contacted via email were sent a link 
to an online survey website where they completed the five questionnaires.  
Once participants completed the questionnaires, a notification email was sent to 
the researcher. Participants contacted via post were sent a hard copy of the five 
questionnaires as well as a prepaid envelope to return the questionnaires in, to 
the researcher.  
 
3.4.6. Waiting list control treatment sessions 
Once participants in the waiting list control group completed the follow-up 
questionnaires, the researcher contacted them to offer the shortened BATD 
treatment session. If participants wished to receive the session, then an 
appointment was booked with them.  
 
3.5. Ethical Issues 
3.5.1. Ethical approval 
Ethical approval for the study was granted by the London City Road and 
Hampstead NRES ethics committee (REC reference – 13/LO/0018) on 15th 
April 2013 (see Appendix N).  
 
3.5.2. Ethical considerations 
All potential participants were given detailed information about what would be 
involved in the study and had the opportunity to ask questions and have time to 
consider whether or not to participate. Written consent was provided before 
participation in the study. To ensure confidentiality, data was anonymised on 
the computer file. Data was stored according to university guidelines. 
 
Potential risks to participants were identified prior to the start of the study and 
steps were taken to minimise any possible risks or burdens that could occur as 
a result of participating. The task procedures had all been used in previous 
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studies with no reported problems or unnecessary burden on participants. 
However, it was judged that participation in the research study would not be 
suitable for participants at significant risk of imminent self-harm or attempted 
suicide, who should be receiving urgent assessment and care. As clinical 
responsibility was with the psychological therapy services, it was agreed that 
details of patients who scored above 2 on item 9 of the PHQ-9 (“Thoughts that 
you would be better off dead, or of hurting yourself”) at the telephone screening 
stage would be passed on to the service for recording onto their information 
system and to undertake further assessment if necessary. However the 
researcher could use their clinical judgement to invite these participants to take 
part in the study if this was felt to suitable, following assessment of their suicidal 
risk and protective factors. Participants were invited to participate if there were 
no clear means, intention or plans to act on their suicidal ideation thoughts. For 
participants whom it felt that participating in the study would not be suitable, 
they were signposted to services e.g. local A&E that they could access in case 
these thoughts or feelings escalated to the point that they would be unable to 
guarantee their safety. 
   
3.6. Data Handling and Statistical Analyses  
The main focus of the statistical analyses was on Time 1 and Time 2 data, 
across all measures. This was due to the primary interests of this study in 
exploring changes following one session of behavioural activation and one 
week treatment interval. Supplementary statistical analyses were completed 
using Time 3 data.  
 
3.6.1. Data screening  
The identified approach was to screen all data for missing values, accurate 
input and normality. Assumptions of normality were checked using frequency 
histograms, Q-Q plots and boxplots.  Data for the self-report measures (PHQ-9, 
CBAS, RRS, AAQ and BADS) was normally distributed. Data for the AAT was 
skewed, which was corrected for using procedures described by Vrijsen et al. 
(2012). Participants with an overall mean reaction time of >1000 ms across both 
time-points (n=3) and with more than 20% error rate (n=1) were excluded, 




3.6.2. Planned statistical analyses 
The planned statistical analyses aimed to: (a) examine group differences on a 
self report measure of depression, (b) explore group differences on reaction 
times for approach and avoidance behaviours using data from the AAT and self 
reported rumination, behavioural activation and avoidance, (c) explore whether 
changes in approach and avoidance mediated changes in depression 
symptomatology as measured by the PHQ-9.  
 
All analyses were completed using the Statistical Package for the Social 
Sciences (SPSS 22, SPSS Inc., Chicago, IL, USA). Parametric statistical tests 
were used for normally distributed data, otherwise non-parametric equivalent 
tests were employed. Chi square analyses were used to establish any baseline 
differences in terms of demographic variables to ensure that both groups were 
not significantly different. Analyses of variance and multivariate of analyses 
were used to explore differences between the treatment and control group 
across the three time points on self report measures of avoidance and the 
experimental task. Associations between questionnaire scores and reaction 
time scores on the experimental computer task were explored using 
correlational and regression analyses. Meditational analyses were used to 
explore whether changes in approach or avoidance could predict changes in 
depressive symptoms.  
 
The PROCESS program was used for mediational analysis (Hayes, 2013) using 
the Preacher and Hayes (2004) bootstrapping approach. PROCESS is a freely 
available computational tool, which once downloaded as a syntax file, is used to 
complete mediation and moderation analysis within SPSS. PROCESS extends 
the capabilities of SPSS by generating direct and indirect effects in single and 
multiple variable mediation and moderation models. Kappa squared was used 
as a measure of effect size, which is defined as the ratio of indirect effect 
relative to the maximum possible value in the data, given the observed 
variability in all factors and their intercorrelations (Hayes, 2013). Values closer 
to 1 represent bigger indirect effect sizes. Supplementary analyses were used 
to explore the data further by looking at associations between experimental and 




4. Results   
Statistical analyses focused on Time 1 and Time 2 data, across all measures. 
This was due to the primary interests of this study in exploring changes 
following one session of behavioural activation and one week treatment interval. 
Additional statistical analyses were completed using Time 3 data.  
 
4.1 Participant characteristics of the sample  
A total sample of 48 patients was recruited from two local primary care 
psychology services. Eight participants were excluded due to non-attendance 
(n=5), receiving treatment between Time 1 and Time 2 (n=1) or no longer 
meeting inclusion criteria at Time 1 (PHQ-9 score below 10, n=2). A sample of 
40 participants was used for analyses relating to the self-report measures. A 
sample of 36 participants was used for analyses relating to the Approach 
Avoidance task (4 participants were excluded following procedures described 
by Vrijsen et al., 2012, see Methods section for further details). Figure 11 










Assessed for eligibility via telephone screening (n =123) 
Excluded (n=63) 
   n= 14    Scored <10 on PHQ-9 
   n= 13    Declined to participate 
   n= 11    Below MDD criteria on SCID 
   n= 10    Risk issues 
   n= 3      Commenced/ing treatment 
   n= 2      Drug dependence 
   n= 2      Screening not completed 
   n= 2      Prescribed benzodiazepam  
   n= 1      Alcohol dependence 
   n= 1      Hx of traumatic brain injury  
   n= 1      Illiterate  
   n= 1      Under 18  
   n= 1      Housebound  
   n= 1      Diagnosis of OCD 
 
Lost to Time 3; 
-  Did not return questionnaires (n=4) 
Lost at Time 2 (n=2) 
-   Did not attend (n=2) 
 
Allocated to treatment condition (n=22) 
-  Received allocated intervention (n=22) 
-  Excluded (n=0) 
 
 
Lost at Time 2 (n=4) 
-   Did not attend (n=3) 
-   Started alternative treatment (n=1) 
 
Allocated to control condition (n= 26) 
-  Received allocated intervention (n=26) 
-  Excluded (n=2) as PHQ-9 >10 
Lost to Time 3; 
-  Did not return questionnaires (n=4) 
-  Offered BA treatment (n=16); received 
treatment (n=4), did not attend treatment 





















Randomised (n= 60) 
Excluded (n=12) 
-  Did not attend session (n= 12) 
Analysis of self report measures (n=20) 
-   Excluded at Times 1 and 2 (n=0)  
-   Excluded at Times 3 (n=4) 
 
Analysis of AAT (n=19) 
-   Excluded (n=1) using Vrijsen et al 
(2012) criteria  
 
Analysis of self report measures (n=20) 
-   Excluded at Times 1 and 2 (n=0)  
-   Excluded at Times 3 (n=4) 
 
Analysis of AAT (n=17) 
-   Excluded (n=3) using Vrijsen et al 







1 week time lapse 
4 weeks time lapse 
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 4.1.1. Exploring baseline differences in demographic variables  
Tests of baseline differences in terms of socio-demographic variables were 
investigated using chi square test of independence for categorical variables. In 
cases where the assumptions of the chi-square test of independence were 
violated due to the small sample size, the exact chi-square figure has been 
reported instead.  The two sample groups did not differ as a function of the 
baseline socio-demographic characteristics e.g. gender and marital status (see 





 Table 2. Group differences on demographic characteristics. 









and p value 
Borough 
    Lambeth 







χ2 = 1.91, 
p=0.17 




Wilks  =0.58, 
p=0.55. 
Gender 
    Female 







χ2 = 0.11, 
p=0.74 
Screening PHQ-9 score (mean) 
    Moderate symptoms (10-14) 
    Moderately severe symptoms (15-19) 









t= 0.82, p=0.42 
Marital status 
    Single  
    Married 
    Divorced  
    Widowed 













χ2 = 2.62, 
p=0.77a 
Ethnicity 
    White  
    Black African 
    Black Caribbean 
    Pakistani 













χ2 = 3.04, 
p=0.69 a 
Occupational status 
    Full time employed 
    Part time employed  
    Self employed 
    Unemployed 













χ2 = 3.03, 
p=0.50 a 
Education level 
    High school 
    NVQs 
    A levels 
    Diploma 
    Undergraduate degree 















χ2 = 8.48, 
p=0.14 a 
Previous experience of depression 
    Yes 
    No 









χ2 = 1.03, 
p=1.00 a 
Previous access to psychological 
treatment 
    Yes 







χ2 = 0.42, 
p=0.52 
Prescribed anti-depressant medication 
    Yes 







χ2 = 0.00, 
p=1.00 a 
History of  other mental health 
problems 
    Yes 











4.1.2. Exploring baseline clinical characteristics in relation to demographic 
variables  
Analyses were undertaken to investigate differences on baseline clinical 
characteristics in relation to gender, ethnicity (white versus non-white) and age. 
A series of multivariate analyses of variance (MANOVAs) were conducted. The 
demographic variables were used as the independent variables whilst total 
scores on self-report measures at Time 1 were used as the dependent variables 
(PHQ-9, CBAS, AAQ, RRS and BADS).  
 
The multivariate effect of the combined dependent variables on gender was 
non-significant, Wilks  =0.76, F (5, 34)= 2.16, p=0.08. The multivariate effect of 
the combined dependent variables on ethnicity was non-significant, Wilks  
=0.96, F (5, 34)= 0.32, p=0.89. The multivariate effect of the combined 
dependent variables on age was also non-significant, Wilks  =0.58, F (20, 
104)= 0.93, p=0.55.  
 
As there were no main effects of gender, ethnicity or age, subsequent analyses 
did not need to adjust for these factors. 
 
4.2. Pre- to Post (Time 1 to Time 2) Treatment Changes  
Hypothesis 1 suggested that in comparison to control participants, participants 
in the treatment condition would show greater changes in depressive symptoms 
during the intervention period. Figure 13 shows changes in PHQ-9 symptoms 
for both groups from Time 1 to Time 2 (see Table 3 for mean scores on all self-
report outcome measures at Times 1 and 2).                   
 




Figure 13. PHQ-9 scores at Time 1 and Time 2. 
 
 
A repeated measures ANOVA assessed the impact of condition (treatment or 
control group) on participants’ scores on the PHQ-9, across two time periods 
(Time 1 and Time 2). There was a significant main effect of time, F (1, 38) = 
29.85, p<0.01, partial 2=0.44. There was a significant main effect of condition, 
F (1, 38) = 4.43, p=0.04, partial 2=0.10. There was a significant interaction 
between condition and time, F (1, 38) = 15.82, p<0.01, partial 2=0.29.   
 
Post hoc comparisons were used to explore the data further. A Bonferroni 
correction was used to control the familywise error rate. Using the Bonferroni 
correction the adjusted critical alpha level was p=0.01 (0.05/4). Post hoc 
comparisons indicated that the two groups (treatment and control) were 
significantly different in PHQ9 scores at Time 2, t (38) = -3.12, p=0.003 but not 
at Time 1, t (38) = -0.59, p=0.56.  Paired t-tests indicated that there was a 
significant difference between Time 1 and Time 2 PHQ-9 scores for the 




Table 3. Test statistics and scores on PHQ-9, CBAS, AAQ, RRS and BADS at Times 1 and 2. 
 Time 1 Time 2 Test statistics† 
Measure Treatment (n=20) Control  (n=20) Treatment (n=20) Control  (n=20)  
Patient Health Questionnaire-9 
 
16.15 (4.78) 17.00 (4.32) 10.75 (5.60) 23.85 (8.92) Effect of time – F (1, 38) = 29.85, p<0.01** 
Effect of condition- F (1, 38) = 4.43, p=0.04* 
Interaction – F (1, 38) = 15.82, p<0.01** 
 
Cognitive Behavioural Avoidance Scale 
  Behavioural social 
  Behavioural non-social 
  Cognitive social 
  Cognitive non-social 

























Effect of time – F (1, 38) = 5.76, p=0.02* 
Effect of condition- F (1, 38) = 0.00, p=0.95 
Interaction – F (1, 38) = 2.41, p=0.13 
 
 
Acceptance and Action Questionnaire  
 
79.10 (11.13) 80.30 (12.27) 72.25 (9.92) 77.20 (11.35) Effect of time – F (1, 38) = 9.98, p<0.01** 
Effect of condition- F (1, 38) = 0.22, p=0.64 
Interaction – F (1, 38) = 0.12, p=0.74 
 
Ruminative Response Scale  
  Depression 
  Reflection 
  Brooding 






















Effect of time – F (1, 38) = 0.004, p=0.95 
Effect of condition- F (1, 38) = 0.12, p=0.74 
Interaction – F (1, 38) = 2.15, p=0.15 
 
 
Behavioural Activation for Depression 
Scale    
  Activation 
  Avoidance/Rumination 
  Work/school impairment 
  Social impact 

























Effect of time – F (1, 38) = 7.13, p=0.01** 
Effect of condition- F (1, 38) = 2.68, p=0.11 
Interaction – F (1, 38) = 7.85, p<0.01** 
 
 
†Analyses computed using total scale scores only; * = significant at p=0.05 level, ** = significant at p=0.01 level.  
ANOVA completed with PHQ-9. MANOVA completed with CBAS, AAQ, RRS and BADS – univariate analyses reported.
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4.3. Changes in Approach Avoidance Task (AAT) scores  
The second hypothesis suggested that in comparison to participants in the 
waiting list control condition, participants in the treatment condition would show 
significant increases in approach of positive emotional faces and reductions in 
avoidance of negative emotional faces, and greater improvements in avoidance 
and rumination self report measures after one session of behavioural activation 
and one week treatment interval.  
 
4.3.1. Change on other self-report measures (CBAS, RRS, AAQ and BADS) 
Differences between the treatment and waiting list control group on the self-
report measures (CBAS, AAQ, RRS and BADS) were investigated (see Table 
3). 
 
A series of repeated measures mixed design ANOVAs were performed using 
the self-report measures (CBAS, RRS, AAQ and BADS) to investigate 
differences between groups (treatment and control) across time points (Times 1 
and 2) (See Table 3 for test statistics). The within subjects factor was the total 
scale score for the self-report measure and the between subjects factor was 
condition.  
 
There were no significant main effects of condition. There was a significant 
main effect of time on the CBAS. All other main effects of time were non-
significant. There was a significant interaction between time and condition for 
BADS scores. All other interactions were non-significant. Post hoc comparisons 
using the Bonferroni correction were completed to investigate the significant 
interaction for BADS scores further. The adjusted critical alpha level was 
p=0.025 (p=0.05/2). Paired samples t-tests indicated non-significant differences 
between Time 1 and 2 BADS scores for the waiting list control group, t (19) = 
0.10, p=0.93. Paired samples t test found a significant difference between Time 
1 and Time 2 BADS scores for the treatment group, t (19) = -3.75, p=0.001, with 




4.3.2. Group differences on behavioural approach and avoidance behavioural 
tendencies (AAT) 
Table 4 shows the mean reaction times for different facial expressions (happy, 
sad and angry) on the AAT before and after the treatment interval of one week.  
 
 
Table 4. Mean reaction times in milliseconds (with standard deviations) depending on condition, 
picture type and response direction at Times 1 and 2. 






 747.63 (112.34) 
629.62 (76.33) 
 667.24 (124.60) 
653.39 (131.50) 
691.53 (164.82) 
Happy Push  
Happy Pull 
737.47 (125.84) 
 767.47 (136.71) 
723.37 (104.61) 
735.18 (103.17) 




Sad Push  












Figure 14 shows the AAT effect scores for both groups, before and after 
treatment. Effect scores were calculated for each participant by subtracting the 
mean reaction time of the pull trials from the mean reaction time of the 
corresponding push trials (see Figure 3). Separate effect scores were 
calculated for each type of facial expression. Effect scores indicate the relative 
strength of approach and avoidance behavioural tendencies: more negative 
values indicate more negative reactions, indicating stronger avoidance. In 
comparison, positive values indicate more positive reactions, that is, stronger 
approach behaviours.  The values shown on Figure 3 indicate that the 
strongest behavioural responses occurred in relation to angry valence stimuli at 





Figure 14. AAT effect scores for each condition and time-point 
Notes on Figure 14 
More negative values indicate more negative reactions, indicating stronger avoidance. Positive 
values indicate more positive reactions, that is, stronger approach behaviours.  
 
 
A series of repeated measures mixed design ANOVAs using different valence 
factors (sad, angry, happy) were performed to investigate differences between 
condition (treatment and control) across different time points (Times 1 and 2). 
(See Table 5 for test statistics). The within subjects factor was the valence 
effect score and the between subjects factor was condition.  
 
 
Table 5. Test statistics for series of repeated measures ANOVAs using AAT valence effect scores. 
Valence  Effect of time Effect of condition Interaction  
Angry F (1, 34) = 0.25, 
p=0.62 
F (1, 34) = 0.02, 
p=0.97 
F (1, 34) = 0.001, 
p=0.97 
Happy F (1, 34) = 1.27, 
p=0.27 
F (1, 34) = 0.001, 
p=0.98 
F (1, 34) = 4.13, 
p=0.05* 
Sad F (1, 34) = 0.71, 
p=0.41 
F (1, 34) = 0.20, 
p=0.66 
F (1, 34) = 0.02, 
p=0.90 




























There were no significant main effects of time or condition for each of the 
valence factors. There were no significant interactions between time and 
condition for sad and angry faces. There was a significant interaction between 
time and condition for happy faces, F (1, 34) = 4.13, p=0.05. Post hoc 
comparisons using the Bonferroni correction were completed to investigate this 
interaction further. The adjusted critical alpha level was p=0.025 (p=0.05/2). 
Paired samples t-tests indicated non-significant differences between Time 1 and 
2 for the waiting list control group, t (18) = 0.65, p=0.53. The paired samples t-
test for the treatment group was initially significant but the use of the adjusted 
critical alpha level rendered the results non-significant, t (16) = -2.21, p=0.04.  
 
4.4. Mediation of change in symptoms of depression by changes in 
approach avoidance  
The third hypothesis suggested that the degree of changes in approach and 
avoidance would predict changes in depressive symptoms and unhelpful 
beliefs.  
 
Correlations were initially used to explore associations between changes in AAT 
effect scores and PHQ-9 scores. Mediational analyses were then computed 
using AAT effect change scores and PHQ-9 change scores2. This analysis 
utilised Time 2 data instead of Time 3 data, as Time 2 data was the main 
outcome time-point in this study.  The possibility of confounding factors at Time 
3, such as start of treatment, either in a private service or the primary care 
psychology service, meant that it was not suitable to use data from this time-
point. Furthermore, attrition at Time 3 led to a reduced sample size (n=36) 
thereby limiting the feasibility of conducting mediational analyses. 
 
4.4.1. Correlations between changes in symptoms of depression and change 
in AAT effect scores  
Correlations were used to explore associations between change on AAT effect 
scores (across all valences) and change in PHQ-9 scores (see Table 6).  
 
2 Change scores were calculated by subtracting Time 1 score from Time 2 score for AAT and 
self report measures.  
69 
 
                                            
 
Table 6. Correlations between change on AAT effect scores and depressive symptoms between 
Times 1 and 2. 
 
Change score 
(Time 1 to 2) 







Sad effect score 
 Patient Health 
Questionnaire-9 
0.002 -0.332* -0.034 -0.052 




There was a significant negative correlation between change for the happy 
valence stimuli and change in PHQ-9 score, r= -0.33, p=0.05. This suggests 
that more positive reactions to happy valence stimuli (indicating stronger 
approach behaviour) was associated with a decrease in PHQ-9 scores between 
Times 1 and 2. Correlations for the other valence stimuli were non-significant.   
 
4.4.2. Mediation analyses using AAT effect scores  
An exploratory analysis was undertaken in order to explore whether changes in 
depressive symptoms were mediated by changes in approach and avoidance 
behavioural tendencies on the AAT task (see Figure 15). The initial causal 
variable was condition (treatment or control) outcome variable was change in 
PHQ-9 symptoms (between Time 1 and Time 2) and proposed mediating 
variables were changes in approach avoidance behavioural tendency (between 
Time 1 and Time 2) by valence (happy faces). Mediational analysis was 
completed with happy valence stimuli as this was the only significant correlation 
(see Figure 16). 
 
Mediational analyses were computed using the PROCESS program for SPSS 
(Hayes, 2013) using the bootstrapping approach developed by Preacher & 




















Notes on Figure 15. 
Path a= Direct effect of Condition on Approach Avoidance behaviour. 
Path b= Direct effect of Approach Avoidance behaviour on PHQ-9 change score. 
Path cd= Direct effect of Condition on PHQ-9 change score.  
Path cind= Indirect effect of Condition on PHQ-9 change score mediated through Approach 
Avoidance behaviour.  
 
 
There was a significant positive direct effect of condition on PHQ-9 change 
scores, β= 0.59, p<0.01. There was a significant negative direct effect of 
change in happy valence effect score on PHQ-9 change score, β= -0.33, 
p=0.05. The indirect effect of change in happy valence effect score on change 





(measured using changes in 









PHQ 9 change score  
(between T1 and T2) 
b a 
Figure 15. Mediation pathway for relationship between condition and change in PHQ-9 as 















Notes on Figure 16. 
** = significant at p<0.01 level, * = significant at p<0.05 level. 




4.4.3. Correlations between change in symptoms of depression and self 
report measures of avoidance 
Correlations were used to explore associations between change in PHQ-9 
scores and changes in the other self-report measures of avoidance (CBAS, 
BADS, AAQ and RRS) (see Table 7).   












behaviour – happy 





Table 7. Correlations between change in depressive symptoms and self report measures of 
avoidance between Times 1 and 2. 
 
Change score 
(Time 1 to 2) 
Change between Times 1 and 2 (n=40) 
Cognitive 
Behavioural 









 Patient Health 
Questionnaire-9 
0.39* 0.10 0.52** -0.53** 
*= significant at p=0.05 level. 
** = significant at p=0.01 level  
 
There was a significant positive correlation between change in PHQ-9 and 
CBAS, r= 0.39, p=0.01. This indicates that a decrease in depressive symptoms 
was associated with a decrease in CBAS score between Time 1 and 2, which 
represents reduced cognitive and behavioural avoidance. Similarly, there was a 
significant positive correlation between change in PHQ-9 and RRS scores, r= 
0.52, p=<0.01. Again, this suggests that a decrease in symptoms of depression 
was linked to a decrease in RRS score between Time 1 and 2, indicative of 
reduced rumination. There was a significant negative correlation between 
change in PHQ-9 and BADS scores, r= -0.53, p=<0.01. This indicates that a 
decrease in depressive symptomatology was associated with an increase in 
BADS score between Time 1 and 2, which indicates greater activation.  
 
4.4.4. Mediation analyses using self report measures of avoidance 
Further analyses were computed to explore whether changes in depressive 
symptoms were mediated by changes in self report measures of avoidance. 
Like the previous mediation analysis using AAT effect scores, the initial causal 
variable was condition (treatment or control), and outcome variable was change 
in PHQ-9 symptoms (between Time 1 and Time 2). In this mediation analysis, 
the proposed mediating variables were changes between Time 1 and Time 2 on 
self-report measures of avoidance (CBAS, BADS, AAQ and RRS).  
 
Correlations between change in PHQ-9 and change in AAQ scores were non-
significant. This indicated that scores in this self report measure of avoidance 
were be unlikely to mediate change in symptoms of depression, thus mediation 
analyses was not computed with this variable. Mediation analyses were 
computed with the other self report measures of avoidance.  
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 Mediation analysis using change in CBAS scores 
Mediation analysis was calculated to explore whether changes in Cognitive 
Behavioural Avoidance Scale scores mediated changes in symptoms of 














Notes on Figure 17. 
** = significant at p<0.01 level, * = significant at p<0.05 level. 
Standardised β coefficients reported.  
 
 
There was a significant positive direct effect of condition on PHQ-9 change 
scores, β= 0.54, p<0.01. There was a significant positive direct effect of change 
on CBAS total score to change on PHQ-9 score, β= 0.39, p= 0.01. There was a 
significant indirect effect of CBAS score on change in PHQ-9 scores, βind= 0.07, 
95% bootstrapped CI (0.003, 0.173). This represents a relatively small effect, κ2 
=0.07, 95% bootstrapped CI (0.014, 0.187)3.  
 
 
3 Kappa squared used as a measure of effect size. Values closer to 1 represent a larger effect. 







Condition PHQ-9 change 
score 
Change in self report 
measure of avoidance 
- CBAS  
 
Figure 17.  Mediation pathway for CBAS change scores 
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Mediation analysis using change in BADS scores 
Mediation analysis was calculated to explore whether changes in Behavioural 
Activation and Depression Scale scores mediated changes in symptoms of 


















Notes on Figure 18 
** = significant at p<0.01 level, * = significant at p<0.05 level. 
Standardised β coefficients reported.  
 
 
There was a significant positive direct effect of condition on PHQ-9 change 
scores, β= 0.54, p<0.01. There was a significant negative direct effect of 
change in BADS score on PHQ-9 change in scores, β= -0.53, p= <0.01. There 
was a significant negative direct effect of condition on change in BADS scores, 
β= -0.41, p= <0.01. A significant indirect effect of change in BADS score PHQ-9 
scores was found, βind= 0.15, 95% bootstrapped CI (0.005, 0.412). This 











Condition PHQ-9 change 
score 
Change in self report 
measure of avoidance 
- BADS 
 
Figure 18. Mediation pathway for BADS change scores 
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 Mediation analysis using change in RRS scores 
Mediation analysis was calculated to explore whether changes in Ruminative 
Response Scale scores mediated changes in symptoms of depression (see 

















Notes on Figure 19. 
** = significant at p<0.01 level, * = significant at p<0.05 level. 
Standardised β coefficients reported.  
 
 
There was a significant positive direct effect of condition on PHQ-9 change 
scores, β= 0.54, p<0.01. There was a significant positive effect of change in 
RRS score on change in PHQ-9 score, β= 0.52, p= <0.01. There was a non-
significant indirect effect of change in RRS score on change in PHQ-9 score, 
βind= 0.10, p= <0.01, 95% bootstrapped CI (-0.223, 0.308).  
 
4.5. Treatment compliance 
Treatment compliance was measured using the behavioural checkout sheet 
which was returned to the researcher at Time 2. Participants were on average 







Condition PHQ-9 change 
score 
Change in self report 
measure of avoidance 
– RRS  
 
Figure 19. Mediation pathway for RRS change scores.  
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0.93). Participants completed an average of 2.1 activities (SD= 1.21) over the 
treatment week interval.  
 
A compliance score was calculated for each participant by dividing the number 
of activities completed by the number of set target activities. Participants 
reported undertaking an average of 51.4% (SD= 29.14) of the target activities 
they had agreed to.  
  
4.5.1. Associations between change on self report measures and compliance 
to BATD during treatment interval  
Exploratory correlational analyses were used to explore whether treatment 
compliance was related to PHQ-9, CBAS, RRS, AAQ and BADS change scores 
(see Table 8).  
 
 
Table 8. Correlations between changes on self report measures and BATD compliance. 
Measure  
(Time 2 minus Time 1 change) 
Number of activities 
agreed at Time 1 
Number of completed 
activities during 
treatment interval 
Patient Health Questionnaire-9 
-0.24 -0.28 
Cognitive Behavioural Avoidance Scale† 
-0.08 0.05 
Acceptance and Action Questionnaire 
-0.32 0.11 
Ruminative Responses Scale† 
-0.50* -0.33 
Behavioural Activation for Depression 
Scale† 
0.57** 0.24 
*= significant at 0.05 level, **=significant at 0.01 level  
† Correlations computed using total scale scores 
 
 
There was a significant negative correlation between number of agreed 
activities and RRS total scale change score, r= -0.50, p=0.02. This suggests 
that agreeing to more activities was associated with a decrease in RRS scores 
between Time 1 and Time 2, representing reduced rumination. There was a 
significant positive correlation between number of agreed activities and change 
in BADS total scale score between Times 1 and 2, r= 0.57, p=<0.01. This 
indicates that agreeing to more activities was associated with an increase in 
BADS score between Time 1 and Time 2, representing increased activation. 
There were no significant correlations between number of completed activities 
and change in self-report measures.  
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 4.5.2. Associations between change on AAT effect scores and compliance to 
BATD during treatment interval  
Exploratory correlational analyses were also conducted to explore possible 
associations between changes on AAT effect scores between Times 1 and 2 
with BATD compliance during the treatment interval. No significant correlations 
were found.  
 
4.6. Ancillary analyses 
4.6.1. Correlations between change in symptoms of depression and baseline 
behavioural and self report measures of avoidance  
Correlations were used to explore associations between baseline behavioural 
(AAT effect scores) and self report measures (CBAS, BADS, RRS and AAQ) of 
avoidance with changes in depressive symptoms (PHQ-9 score). No significant 
correlations were found.  
 
4.6.2. Correlations between changes in self report measures and baseline 
AAT effect scores 
Correlations were used to explore associations between baseline (Time 1) AAT 
effect scores for different valence stimuli and changes between Time 1 and 2 on 
the self-report measures (see Table 9).  
 
 
Table 9. Correlations between Time 1 AAT effect scores and self-report measures change scores 
between Time 1 and 2. 
 
Change score 
(Time 1 to 2) 
Time 1 score (n=36) 




Sad effect score 
 Patient Health 
Questionnaire-9 








-0.04 -0.24 -0.10 -0.42** 
Ruminative 
Response Scale†   




Scale†   
-0.24 0.06 0.010 0.33* 
*= significant at 0.05 level, **=significant at 0.01 level 
† Correlations computed using total scale scores  
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There was a significant negative correlation between the effect score for sad 
faces and AAQ total score, r= -0.42, p=0.01. This suggests that faster 
avoidance to sad valence stimuli was associated with a decrease in AAQ 
scores between Time 1 and Time 2.  
 
There was a significant positive correlation between effect score for sad faces 
and BADS total score, r=0.33, p= 0.05. This suggests that faster approach to 
sad valence stimuli was associated with increase in BADS scores activation 
between Time 1 and Time 2, representing increased activation. 
 
4.6.3. Correlations between changes in behavioural and self report measures 
of avoidance  
Correlations were used to explore associations between change in the 
behavioural measure of avoidance (AAT effect scores) and change in self-
report measures of avoidance (CBAS, BADS, RRS and AAQ). No significant 
correlations were found.   
 
4.6.4. One month follow up (Time 3) changes on PHQ-9, CBAS, AAQ, RRS and 
BADS between time points  
Self-report measures at Time 3 were given to participants one month after Time 
1 meeting (either via email or post). There was some attrition at follow-up, with 
only 32 responses received (Treatment condition n=16, Waiting list control 
n=16). Participants varied in the number of days it took to complete Time 3 
measures: Treatment (M= 41.50, SD= 10.20) and Waiting list control (M= 36.19, 
SD= 11.62).  An independent samples t-test found that the group differences in 
time taken to complete Time 3 questionnaires was not statistically significant, t 
(30) = 1.36, p=0.18. (See Table 10 for a summary of Time 3 scores on the 
different self-report measures for n=32 sample).  
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Table 10. Times 1, 2 and 3 PHQ-9, CBAS, AAQ, RRS and BADS scores (n=32). 
 Time 1 Time 2 Time 3 
Measure Treatment (n=16) Control  (n=16) Treatment (n=16) Control  (n=16) Treatment (n=16) Control  (n=16) 
Patient Health Questionnaire-9 
 
16.00 (5.03) 16.19 (4.10) 11.44 (5.67) 14.69 (4.59) 9.81 (4.32) 11.56 (5.20) 
Cognitive Behavioural Avoidance Scale 
  Behavioural social 
  Behavioural non-social 
  Cognitive social 
  Cognitive non-social 

































21.00 (8.51)  
16.00 (5.40) 
17.13 (5.58) 
25.50 (8.50)  
90.94 (23.98) 
Acceptance and Action Questionnaire  
 
78.75 (8.53) 79.13 (13.32) 74.19 (9.49) 76.31 (12.24) 72.13 (11.46) 76.75 (10.52) 
Ruminative Response Scale  
  Depression 
  Reflection 
  Brooding 
































Behavioural Activation for Depression Scale    
  Activation 
  Avoidance/Rumination 
  Work/school impairment 
  Social impact 









































Statistical analyses were used to explore any significant differences between 
the treatment and control group on the self-report measures across all three 
time points.  
 
A repeated measures ANOVA was conducted to assess the impact of condition 
(treatment or control group) on participants’ scores on the PHQ-9, across three 
time periods (Times 1, 2 and 3). There was a significant main effect of time, F 
(2, 60)= 26.08, p<0.01, partial 2=0.47. There was a non-significant main effect 
of condition, F (1, 30)= 1.37, p=0.25 and non-significant interaction between 
condition and time, F (1, 60)= 2.08, p=0.14. Post hoc comparisons were 
completed for further exploration of the main effect of Time, using the 
Bonferroni method of adjustment for multiple comparisons (p=0.05/3, critical 
alpha level of p=0.02 used). Paired samples t-tests indicated significant 
differences between Times 1 and Time 2, t(39), 4.65, p<0.01; Times 1 and 3, 
t(39), 6.41, p<0.01 and Times 2 and 3, t(39), 2.87 p<0.01.  
 
A series of repeated measures mixed design ANOVAs were  performed using 
the self report measures (CBAS, RRS, AAQ and BADS) to investigate 
differences between groups (treatment and control) across time points (Times 
1, 2 and 3). The within subjects factor was the total scale score for the self 
report measure and the between subjects factor was condition.  
 
There were no significant main effects of condition. There were significant main 
effects of time for CBAS, F (2, 60) = 8.89, p=0.001; BADS, F (2, 60) = 9.81, 
p=0.00; RRS, F (2, 60) = 5.26, p=0.009 and AAQ, F (2, 60) = 8.09, p=0.001. 
There were no significant interactions between time and condition. Post hoc 
comparisons were completed using the Bonferroni method of adjustment for 
multiple comparisons to investigate differences across the three time-points 
(p=0.05/12, critical alpha level of p=0.004 used). Paired samples t-tests 
indicated significant differences between Time 1 and Time 3 CBAS scores, 
t(31), 3.57, p=0.001, AAQ scores, t(31), 3.39, p=0.002 and BADS scores, t(31), 
-3.39, p<0.001. There was a significant difference between Time 2 and Time 3 





4.7. Summary of Results  
4.7.1. Hypothesis 1 
It was hypothesised that in comparison to control participants, participants in the 
treatment condition would show greater reductions in depressive symptoms, 
following one session of behavioural activation. The results of this study 
supported this hypothesis. There was a significant Condition by Time 
interaction, with the treatment group showing a significant decrease in PHQ9 
scores over time, with significantly lower scores at Time 2. There was no 
significant change in depressive symptoms between Times 1 and 2 for the 
control group.  
 
4.8.2. Hypothesis 2 
It was hypothesised that compared to control participants, patients in the 
treatment condition would show significant increases in approach tendencies 
and reductions in avoidance tendencies of emotional faces, and greater 
improvements in avoidance and rumination on self report questionnaires, 
following behavioural activation treatment.  
 
Analysis of separate valence factors indicated that there was a significant 
Condition by Time interaction for happy faces, indicating that behavioural 
response to happy faces changed between Times 1 and 2. Further exploration 
of the data using post hoc comparisons indicated that behavioural response to 
happy faces was close to significance for the treatment group, with non-
significant differences for the control group. Analyses for the other valence 
stimuli were non-significant.  
 
Analysis of changes in the self report measures indicated a significant Condition 
by Time interaction for BADS scores. Post hoc analysis indicated that there was 
a significant difference between Time 1 and Time 2 BADS scores for the 
treatment group but not the control group. Analyses for the other self report 
measures were non-significant.  
 
4.8.3. Hypothesis 3 
It was hypothesised that the degree of changes in approach and avoidance 
would mediate the impact of treatment condition and changes in symptoms of 
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depression. Correlations between changes in symptoms of depression and AAT 
effect scores were initially explored to examine the feasibility of further 
mediation analysis. A significant correlation was only found with happy valence 
stimuli, which warranted subsequent mediation analysis. There was no 
evidence of change in response to happy valence stimuli mediating change in 
depressive symptoms.  
 
Correlations between changes in symptoms of depression and self report 
measures were used to explore to examine whether mediation analysis was 
indicated. Significant correlations were found between change in BADS, CBAS 
and RRS scores and PHQ-9. Mediation analyses showed evidence of small 
indirect effects of change in CBAS total scores and BADS total scores on 
change in PHQ-9 scores.  
 
4.8.4 Additional Results 
Supplementary analyses revealed some other interesting preliminary findings. 
Treatment compliance was relatively low, with participants completing an 
average of 51.4% of the target activities during the one week treatment interval. 
Correlations exploring associations between treatment compliance and changes 
in self report measures indicated that agreeing to more activities was 
associated was a decrease in RRS score and an increase in BADS score at 
Time 2, representing reduced rumination and increased activation respectively 
 
Small correlations were found between strength of behavioural avoidance and 
approach tendencies at Time 1 for sad faces and change in AAQ and BADS 
scores between Time 1 and Time 2. Faster avoidance to sad valence stimuli 
was associated with a decrease in AAQ score between Times 1 and 2. In 
contrast faster approach to sad valence stimuli was associated with an increase 
in BADS scores.  
 
Strong associations were found between changes on the PHQ-9 and other self-
report measures of avoidance. Greater reductions on the PHQ-9 were 
associated with greater reductions in rumination (RRS) and avoidance (BADS) 




There were no significant differences between the treatment and control 
condition when Time 3 data was explored, although there were significant 
improvements between the three time points for the self-report measures 




5. Discussion  
This is the first study to investigate the impact of one-session behavioural 
activation treatment on depressed participants in a clinical setting and to 
explore mechanisms of change. Participants were randomised to either 
treatment or waiting list control condition. Changes in depressive symptoms, 
self reported avoidance and behavioural approach and avoidance tendencies 
were taken at pre intervention (Time 1), post intervention (Time 2) and at one 
month follow up (Time 3).  
 
In this chapter the findings are described in relation to the study hypotheses and 
the current literature. The chapter then focuses on the clinical and theoretical 
implications of the findings, with future research pathways identified as well as 
the strengths and limitations of the current study.  
 
5.1. Hypotheses revisited - Summary of findings in relation to current 
literature  
5.1.1. Hypothesis 1 
Hypothesis 1 postulated that in comparison to control participants, participants 
in the treatment condition would show greater changes in depressive 
symptomatology after receiving one treatment session. This hypothesis was 
confirmed, as there were significant decreases in PHQ-9 scores for participants 
in the treatment condition between Times 1 and 2. There were no significant 
changes in depressive symptoms for participants in the control condition 
between Time 1 and Time 2.  
 
There has been accumulating evidence demonstrating the efficacy of 
behavioural activation treatments for depression, with studies finding 
behavioural activation comparable to cognitive therapy for depression (Cuijpers 
et al., 2007; Dobson et al., 2007; Dimidjian et al., 2006; Jacobson et al., 1996; 
Mazzucchelli et al., 2009).  In contrast there has been limited research exploring 
the efficacy of a single session of behavioural activation treatment on 
depressive symptoms. Gawrysiak et al (2009) utilised a single structured 
session of BATD to investigate the impact of treatment for a sample of college 
students with moderate depressive symptoms. Gawrysiak et al.’s results 
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showed that participants in the treatment condition showed significantly larger 
reductions in depressive symptoms post treatment.  
 
Whilst Gawrysiak et al.’s results were promising in demonstrating the 
effectiveness of a single session of BATD, further research using a clinical 
sample was indicated. The current study has employed a similar research 
design, with promising results. After receiving one session of BATD, participants 
in the treatment condition showed significant decreases in depressive 
symptoms. There was no significant change in depressive symptoms for 
participants in the control condition. These results provide strong support for the 
efficacy of a single session of BATD in attenuating symptoms of depression, 
building on Gawrysiak et al.’s work using a clinical sample of depressed 
individuals from a primary care psychological therapies service.  The changes in 
depressive symptoms for the treatment group occurred in the context of 
participants completing only 50% of assigned tasks. This suggests that with 
better compliance even better results in terms of depressive symptomatology 
may be achievable.  
 
5.1.2. Hypothesis 2  
Hypothesis 2 posited that participants in the treatment condition would show 
significant increases in behavioural approach tendencies and reductions in 
behavioural avoidance tendencies of emotional faces, and reductions in 
avoidance on self-report questionnaires. 
 
5.1.2.1. Self report measures of avoidance  
Separate analyses were conducted using the four self-report measures of 
avoidance – CBAS, AAQ, BADS and RRS. Hypothesis 2 was partially 
confirmed, as there was a significant Condition by Time interaction for BADS 
scores. Post hoc comparisons indicated that there was a significant difference 
between Time 1 and Time 2 BADS scores for the treatment group. The direction 
of the change in the treatment group indicated that increased activation 
occurred after receiving the behavioural activation treatment. Analysis of the 
other self-report measures did not yield any other significant results. This finding 
is line with reductions in PHQ-9 scores post treatment, as decreased 
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depressive symptoms are likely to be associated with increased activation 
following behavioural activation intervention.  
 
5.1.2.2. Behavioural measure of avoidance  
For the behavioural measure, separate analyses were computed for each 
valence. The hypothesis was again partially confirmed, as there was a 
significant interaction between Condition and Time for responses to happy 
faces. Post hoc comparisons indicated that this difference was non significant 
for the control group however there was a non- significant trend for the 
treatment group; this would have been significant if there had not been a 
Bonferroni correction for multiple comparisons. The pattern of these results was 
in the expected direction, with increased approach behaviours towards positive 
valence stimuli (happy faces) following behavioural activation treatment, 
although the effects failed to reach significance. This indicates that the ‘dosage’ 
of the intervention may not have been strong enough, as participants only 
completed 50% of target activities during the treatment interval, after receiving 
minimal intervention (one session only). Despite this, the pattern of results that 
emerged would merit further investigation in another study to explore whether 
more intensive therapeutic input would lead to larger changes in approach 
avoidance behaviours.    
 
The AAT is a relatively new measure, initially conceptualised by Rinck and 
Becker (2007) to assess behavioural approach avoidance reactions in anxiety 
disorders (e.g. Heuer, Rinck & Becker, 2007; Lange, Keijsers, Rinck & Becker, 
2008; Lange, Salemink, Windey, Keijsers, Krans, Becker et al, 2010; Roelofs, 
Putman, Schouten, Lange, Volman & Rinck, 2010). Although Vrijsen et al 
(2012) recently utilised the AAT to explore approach and avoidance behaviours 
towards emotional facial expressions after being induced to either to sad or 
happy mood, this is the first study to use the AAT with a clinical sample of 
depressed individuals to explore behavioural approach and avoidance 
tendencies. As a result there is a paucity of research to which the results of this 
study can be compared to; comparisons between studies are likely to occur as 




Despite a lack of studies previously exploring behavioural approach avoidance 
tendencies in depression using an experimental measure, there has been 
research investigating the processing of emotional faces in depression. A well-
documented association between depression and recognition of emotional 
faces exists in the literature (e.g. Cooley & Nowicki, 1989; Wexler, Levenson, 
Warrenberg & Price, 1994), in particular when identifying happy facial 
expressions (Jaeger, Borod & Peselow, 1987; Joorman & Gotlib, 2006). One of 
the key premises underpinning the AAT is that positive stimuli will elicit 
approach behaviours and negative stimuli will elicit avoidance (Cacioppo et al., 
1993; Chen & Bargh, 1999). Therefore it is promising that behavioural activation 
treatment can lead to changes in response to happy valence stimuli. Whilst the 
findings should be considered tentatively, evidence of a non-significant trend for 
the treatment group towards reduced behavioural avoidance post treatment, 
does suggest that despite participants initially responding in keeping with a 
negative bias characteristic of depression, behavioural activation treatment can 
lead to positive changes. This suggests that behavioural activation may help to 
counteract one of the negative biases in depression.  
 
5.1.3. Hypothesis 3  
Hypothesis 3 postulated that the degree of changes in approach and avoidance 
would mediate the impact of treatment condition on changes in depressive 
symptoms. 
 
This is one of the first studies to provide evidence of a possible mechanism of 
change within behavioural activation treatments. The results of this study 
demonstrate that behavioural activation treatment, as short as one week, can 
lead to changes in depressive symptoms, increases in activation and reductions 
in self-reported avoidance. As these were relatively small effects, with only 
partial mediation, this suggests that there are likely to be additional mechanisms 
at play.  
 
Meditational analyses were used to investigate whether changes in PHQ-9 
scores were mediated by changes in behavioural (AAT scores) or self-report 
measures of avoidance (CBAS, BADS, RRS and AAQ). Results showed small 
but significant indirect effects of change in CBAS scores and BADS scores on 
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depressive symptoms. This is consistent with the hypothesis that changes in 
approach / avoidance, as assessed by these measures, partially mediated the 
impact of condition (treatment or control) on change in depressive symptoms 
(PHQ-9 score). As the measures of approach / avoidance were taken at the 
same time as the changes in depressive symptoms, firm conclusions cannot be 
drawn about the causal direction; i.e. it is possible that changes in depressive 
symptoms led to reductions in avoidance. A complex, dynamic and reciprocal 
interaction between behavioural and other features of depression is likely be 
occurring. 
 
Investigating mechanisms of change with regards to behavioural activation is in 
an area very much in its infancy. The current literature supports the idea of 
approach avoidance behaviours being central to change in behavioural 
activation (e.g. Martell et al., 2004). The results of the current study add to the 
emerging body of evidence that behavioural activation approaches do work at 
least partly through addressing approach / avoidance behaviours.  
 
5.1.4. Additional findings  
Further analysis of the data was completed in order to highlight any other 
findings of note, with supplementary analyses revealing some several 
interesting results.  
 
5.1.4.1. Treatment compliance  
Treatment compliance was assessed as a way of quantifying the amount of 
activation that took place during the one-week treatment interval. Participants, 
on average, engaged in 51.4% of agreed activities. This approximated to 
completing around two activities, when three to five target activities were agreed 
with participants.  Compared to previous studies of behavioural activation 
treatment, this represents relatively low treatment compliance, with other 
studies reporting between 70% and 82% compliance (Gawrysiak et al., 2009; 
Hopko et al., 2005, 2008). It is possible that increasing therapeutic input would 
have led to increases in treatment compliance,  
 
Correlations were used to explore associations between treatment compliance 
(both agreement of activities to be completed during the treatment interval and 
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number of activities actually completed during the treatment interval). These 
correlations revealed that agreeing to more activities, rather than completing 
more activities, was linked to greater changes in rumination and activation, in 
the direction of decreased rumination and increased activation between Times 1 
and 2. This is contradictory to the principles of behavioural activation, which 
posit that it is the actual engagement in positively reinforcing activities which 
ameliorate symptoms of depression. This implies that the hope associated with 
agreeing to more activities is more strongly linked to changes in rumination and 
activation, rather than actually engaging in the activity itself. This suggests that 
there may be other mechanisms at play, warranting further investigation, as 
only tentative conclusions can be drawn from this study due to relatively low 
level of treatment compliance.   
 
5.1.4.2.One month follow up data 
Statistical analyses were used to explore differences at Time 3 (one month 
follow up). There were no significant main effects of condition. Analysis of the 
PHQ-9 data revealed a significant main effect of time. Post hoc comparisons 
indicated differences between all time points i.e. between Times 1 and 2, Times 
2 and 3 and Times 1 and 3. Analysis of the self-report measures of avoidance 
revealed significant main effects of time for all four measures (CBAS, RRS, 
AAQ and BADS). Post hoc comparisons indicated differences across Times 1 
and 3 for the CBAS, AAQ and BADS scores; difference between Times 1 and 3 
RRS score and differences across Times 1 and 2 AAQ score.  
 
The lack of group differences at follow up (Time 3) raises some questions, as 
significant group differences were found at Time 2. One possibility relates to the 
length of intervention itself. A single 90-minute session of behavioural activation 
was sufficient to lead to reductions in depressive symptoms after one week of 
treatment interval. However it is possible that whilst brief behavioural activation 
can minimise symptoms of depression in the short term, these gains may not 
hold over an extended period of time without the benefit of potential booster 
sessions. The absence of significant group differences at follow up may be 
indicative of the lack of possible long term effects of a single session of 




Following the Time 2 session, some participants expressed an interest in 
continuing to implement behavioural activation in their lives. Requests for 
further behavioural checkout sheets were made so participants could continue 
to incorporate activities in line with their values into their lives whilst waiting for 
treatment from the primary care psychology service. Unfortunately, this 
information was not quantified at Time 3 so it was not possible to explore 
whether an association exists between continued implementation of behavioural 
activation principles and symptoms of depression at follow up, in the absence of 
contact with a therapist.  
 
Lack of group differences at Time 3 may have been affected by the 
comparatively low treatment compliance (see Section 5.1.4.1. above). Higher 
treatment compliance may have helped to maintain reduced depressive 
symptoms and self reported avoidance.  
 
5.1.4.3. Correlations between changes in self report measures of avoidance and 
baseline behavioural measure of avoidance 
Correlations exploring associations between Time 1 AAT effect scores and 
changes in self-report measures of avoidance (between Time 1 and Time 2) 
revealed some interesting findings in relation to sad valence stimuli. Faster 
avoidance to sad faces at Time 1 was associated to decreases in AAQ scores 
during the treatment interval. In contrast, faster approach to sad valence stimuli 
was linked to increases in activation (BADS score) during the treatment interval.   
 
5.2. Strengths and limitations 
Strengths of this study include the randomised design in which one group 
received the intervention and the other group received no intervention. A further 
strength of this study was the use of a behavioural measure of approach 
avoidance behaviours (AAT) in addition to self-report questionnaires. The 
numerous disadvantages associated with relying solely on self-report measures 
have been well documented in the literature (e.g. Cronbach, 1970; Fiske, 1980). 
These include individuals being prone to demand characteristics and/or social 
desirability. A behavioural measure was included to help overcome the 
criticisms associated with self-report measures.  
   
91 
 
Whilst the results of this study adds to the limited body of research investigating 
the role of approach and avoidance in relation to depression, there are several 
limitations which suggest caution should be used when interpreting findings.  
 
5.2.1. Sequence of variables in proposed mediational models  
A temporal sequence mediational model was used in this study, with 
measurements of all variables in the proposed mediation models (predictor 
variable = condition, dependent variable = PHQ-9 change, mediator = change in 
behavioural or self report measure of avoidance) taken at the same time points 
i.e. AAT and self report measures all completed at Time 1 or all completed at 
Time 2. Measurement of all variables in the mediation models at the same time 
presents difficulties in establishing temporal precedence, due to a lack of 
evidence of a causal relationship. This means that firm conclusions cannot be 
made regarding whether changes in approach avoidance mediated changes in 
depressive symptoms, indeed it could be the other way round. Future studies 
should utilise a time lag design, whereby measures of approach and avoidance 
are taken prior to measures of depressive sequences e.g. at a mid point 
between completing pre and post treatment outcome measures. This would 
help to establish temporal precedence, as the hypothesised cause (change in 
approach avoidance behaviour) would occur before the hypothesised outcome 
(change in depressive symptoms).  
 
5.2.2. Use of self report measures of avoidance  
It could be argued that one limitation of the current study is in relation to the 
self-report measures used. Two of the self-report measures of avoidance 
(CBAS and BADS) have not been fully validated in clinical samples, whilst there 
is some debate by researchers regarding the use of the AAQ.   
 
CBAS 
The CBAS self-report measure was developed relatively recently, partly to 
address inconsistencies in the definition of avoidance which had led to 
difficulties in comparisons across studies (Ottenbriet & Dobson, 2004). As a 
multidimensional self-report measure of avoidance, the CBAS has been utilised 
since its inception to explore associations between depression and avoidance 
(e.g. Cribbs et al., 2006; Wong & Moulds, 2011). However, these studies have 
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been generally restricted to nonclinical samples of undergraduate students, with 
little evidence regarding the use of the CBAS with a clinical sample. A recent 
study by Ottenbriet, Dobson and Quiqley (2014) was the first to use CBAS with 
a sample of clinically depressed individuals. The current study, in which change 
in CBAS scores was a mediator of the impact of the treatment, adds to this 
literature, advocating and highlighting the utility of the CBAS with clinical 
samples. A possible key use of the CBAS in future studies may involve 
capturing changes in avoidance after behavioural activation treatment. Although 
there was a significant reduction on the CBAS over time, there was no 
significant difference between the two groups on this measure, unlike the 
BADS. Therefore further research is needed, for example to investigate whether 
more intensive behavioural activation interventions would result in changes in 
avoidance, as measured by the CBAS.  
 
BADS 
Like the CBAS, the BADS (Kanter et al., 2006) has been recently developed, 
thus there has been limited research using the measure, with even fewer 
treatment studies utilising it. Although Kanter et al. (2007) initially developed the 
BADS specifically for use with the Behavioural Activation protocol (Martell et al., 
2002), they have suggested that it can also be used with the BATD protocol. 
However the BADS has not been widely used with the BATD protocol.  
 
The finding in the present study that participants in the treatment condition 
showed a significantly greater increase in BADS scores than those in the 
control condition supports the use of this measure with the BATD treatment 
protocol. Future research studies using the BATD protocol should not shy away 
from using this measure despite being designed with the Behavioural Activation 
treatment in mind, as suggested by Kanter et al. (2007). However, the use of 
the shorter 9-item version of the BADS (Manos, Kanter & Luo, 2011) should be 
considered, particularly when other measures are being used and in the face of 
time constraints.  
 
AAQ 
Despite being designed and used as a measure of experiential avoidance and 
psychological inflexibility, there has been controversy regarding the AAQ. 
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Disadvantages cited include the complexity of some items e.g. “I rarely worry 
about getting my anxieties, worries and feelings under control” which is close to 
becoming a double negative statement or items which are difficult to 
comprehend and make sense of e.g. “When I evaluate something negatively, I 
usually recognise that this is just a reaction, not an objective fact”. Another 
common criticism relates to the internal consistency, which has been as low as 
α = 0.64 (Hayes et al., 2004), thus only just reaching the ‘satisfactory’ 
benchmark. Caution has been advised when using the AAQ as a process 
measure of experiential avoidance in clinical trials, as it may not be sensitive to 
change (Hayes et al., 2004).  
 
Future studies may benefit from using the Acceptance and Action Questionnaire 
II (AAQ-II; Bond et al., 2011), which is a shorter 9-item measure. The AAQ-II 
has better internal consistency than the original AAQ, as low correlated items 
were deleted to create a revised and more unidimensional measure.  
 
5.2.3. Experimental measure of behavioural approach and avoidance 
tendencies  
The results of the AAT analysis did not indicate as many effects as expected, 
with a significant Condition by Time interaction for happy valence stimuli only. 
Limitations associated with using the AAT may account for the reduced effects 
found.  
 
Whilst there is a well researched bias in depression regarding the processing of 
emotional faces (e.g. Wexler et al., 1994) there has been some debate about 
whether this bias in facial expressions is associated to a deficit in perception of 
emotional facial expressions (e.g. Surguladze et al., 2004) or labelling of 
emotional facial expressions (e.g. Feinberg, Rifkin, Schaffer & Walker, 1986). In 
this study, participants were simply asked to behaviourally respond to each 
stimuli using either a push or pull arm movement. Participants were not asked 
about their perception or labelling of each emotional facial expression. As this 
was not specifically addressed, it is possible that a perceptual deficit or deficit in 
labelling may have impacted on an individual’s behavioural response, and one 
session of behavioural activation may not have been sufficient for change to 
occur in these deficits.  
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Joorman and Gotlib (2006) suggested that one reason for individuals with 
depression struggling to correctly identify happy facial expressions may relate to 
their level of confidence. So individuals may perceive the happy facial 
expression as early as non-depressed participants but delay their response until 
they feel more confident in their accuracy. Again, this presents a plausible 
explanation for the lack of observed effects in the AAT. Participants response 
on the AAT may well have been affected by their confidence in completing the 
task i.e. some participants were more familiar with computers and gaming 
equipment (joystick), possibly contributing to increased feelings of confidence. 
Unfamiliarity with computers and such equipment may well have led to 
participants experiencing a lack of confidence when completing the task. The 
level of confidence may well have mediated behavioural responses, with a lack 
of confidence leading to longer response times. It is possible that despite 
experiencing a decrease in depressive symptoms, participants who were initially 
lacking confidence in completing the AAT remained apprehensive and 
unconfident about their abilities at Time 2.  
 
Another possible reason for the lack of observed effects relates to the sensitivity 
of the AAT. The AAT has previously been used in samples of individuals with 
anxiety disorders (e.g. Heuer et al., 2007), spider phobias (e.g. Klein et al., 
2007) and addictions (e.g. Wiers et al., 2010). The AAT has not been used in a 
treatment study to date, or even a sample of clinically depressed individuals. 
Whilst the AAT can measure behavioural approach avoidance tendencies it 
may lack the sensitivity for use in a treatment study, particularly when there is a 
short time lag between the pre and post stages. Changes in self-report 
measures of avoidance were found between time points. It is conceivable that 
changes occur at the attitude level before occurring at the behavioural level, 
with one-week treatment interval not adequate for changes at the behavioural 
level to occur.  
 
A key criticism of the use of joysticks in approach avoidance tasks is the 
ambiguity of arm movements (e.g. Kriegelmeyer & Deutsch, 2010; Stins et al., 
2010). Researchers have highlighted that pushing a joystick can signify either 
pushing away from the body (representing avoidance) or reaching out to grab 
something on the screen (representing approach). This lack of certainty may 
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increase the likelihood of error variance. In order to overcome this ambiguity the 
AAT employs a ‘zooming effect’ to create a visual impression of the stimuli 
either approaching or moving away from the individual depending on the 
joystick movement. Despite the use of this visual feedback, Kriegelmeyer and 
Deutsch (2010) argue that using a manikin task paradigm is superior to a 
joystick task. In a joystick task they argue that participants move stimuli on the 
screen whilst in a manikin task participants are required to move a figure on 
screen toward or away from the stimuli, which is more representative of 
individual movement. Kriegelmeyer and Deutsch (2010) describe this as being a 
more valid way of measuring automatic approach avoidance rather than the 
manipulation of stimuli on screen. It is possible that the AAT did not sufficiently 
activate approach avoidance tendencies in depressed individuals. Future 
studies may benefit from comparing measurement of approach avoidance 
tendencies using joystick and manikin tasks.  
 
5.2.4. Measuring reinforcement  
Participants were asked to complete a behavioural checkout sheet during the 
one-week treatment interval, however this was not always completed. Key to 
behavioural activation treatments is the idea of individuals ‘activating’ 
themselves, that is to say individuals begin to engage in activities which bring 
about a sense of pleasure and/or achievement. As this premise was central to 
the development of target activities, a measure of activation (BADS) was 
utilised. However there are some difficulties associated with the use of this 
measure.  
 
The BADS was designed for use as a weekly measure throughout the duration 
of treatment. It focuses on measuring the frequency of activation, escape and 
avoidance behaviours. However there is little focus on assessing reinforcement 
or subsequent mood resulting from engaging in such behaviours. Some items 
come close to including mood components e.g. “I am content with the amount 
and type of things that I did” but do not explicitly explore mood occurring in 
response to behaviour. This presents difficulties in drawing firm conclusions 
about an individual’s sense of pleasure and/or achievement from engaging in a 




A useful addition may well include the Environmental Reward Observation 
Scale (EROS; Armento & Hopko, 2007). Alternatively, Manos, Kanter and 
Busch (2010) have suggested that simultaneous use of both BADS and EROS 
would provide a measurement of functionally defined behaviour and contact 
with environmental reinforcement respectively.  
 
The EROS, BADS and CBAS have all been hypothesised as tapping into the 
processes of change implicated in behavioural activation treatment 
(Mazzucchelli et al., 2009). Whilst the BADS was designed to measure 
activation at a behavioural level, the EROS aims to measure activation from a 
reinforcement perspective. The EROS was designed to improve earlier 
measures of response contingent positive reinforcement  (e.g. Pleasant Events 
Schedule; PES, MacPhillamy & Lewinsohn, 1974; MacPhillamy & Lewinsohn, 
1982). As a short, 10-item questionnaire, the EROS measures response 
contingent positive reinforcement over an extended period of time. Example 
items include “The activities I engage in usually have positive consequences” 
and “A lot of activities in my life are pleasurable”. It is based on the idea that 
general contact with reinforcement can be used as a measure of overall 
satisfaction and pleasure over time, which are specifically targeted during 
behavioural activation treatments. As a relatively new measure, there is limited 
research evidence for the EROS. Evidence has started to emerge indicating 
that scores on the EROS are significantly correlated to changes in depressive 
symptomatology following behavioural activation (e.g. Daughters et al., 2008; 
Gawrysiak et al., 2009). 
 
5.2.5. Sample size  
Although the sample was sufficiently large enough with adequate power to 
detect any significant effects, the sample size was small. This study would 
benefit from replication using a larger sample, enhancing the possibility of 
detecting associations and differences whilst reducing the possibility of Type II 
error. Despite the small sample size, meditational analysis was conducted. 
However it has been recommended that meditational analysis is best completed 





5.2.6 Sample characteristics 
All participants were screened for, and met diagnostic criteria for Major 
Depressive Disorder, with patients varying in their level of depressive 
symptomatology. This heterogeneous sample of participants is likely to be a 
fairly representative sample of individuals seeking psychological help at a 
primary care service. However, whilst efforts were made to maximise external 
validity, it is important to consider whether participants in this study were 
differentially motivated to those who declined to participate in the study. Contact 
for research studies was gained at point of service entry, with individuals asked 
during initial assessments at the primary care psychological therapy service. 
Participants who were invited to participate in the study were not asked about 
motivation for participating. It is possible that there were some differences in 
motivation, which may have confounded the study results. Some participants 
may have engaged in the study for the financial remuneration, whilst others may 
have participated as a way of seeking treatment earlier than they would receive 
in the primary care psychology service.  
 
Previous research has highlighted the role of co-morbidity within depression 
with anxiety, substance use disorders and personality difficulties (e.g. 
Middeldorp, Cath, Van Dyck & Booomsma, 2005; Kessler et al., 2004; Rossi et 
al., 2001). In particular, a high degree of co-morbidity (between 50% and 75%) 
has been found with anxiety disorders (Kessler et al., 1996; Olfson et al., 1997). 
Although the screening process excluded any individuals with personality 
disorder diagnoses and substance misuse difficulties, a measure of anxiety was 
not incorporated into the study. This presents difficulties in disentangling the 
possible impact of anxiety on treatment, with results possibly confounded by 
any co-morbid anxiety.  Another issue is that participants’ answers to the 
screening questions were not cross-referenced with any other medical records. 
If participants omitted any information about comorbid symptoms or other 
issues during this stage, this could have impacted on the study results.  
 
5.2.7. Therapist issues 
One therapist completed all treatment sessions with participants so caution is 
advised when interpreting the results of this study. Replication is needed of 
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further one-session behavioural activation treatment studies using several 
therapists to validate the use of a single session treatment.  
 
Behavioural activation sessions were not recorded; therefore adherence to the 
BATD protocol could not be assessed. Adherence to the treatment may have 
affected the level of treatment compliance in this study.  
 
5.3. Theoretical implications  
Approach and avoidance processes have been cited as a possible active 
ingredient of behavioural activation treatment by many researchers (e.g. Martell 
et al., 2004). The small but significant effects within the meditational analyses 
support this suggestion and indicate that this proposed mechanism of change 
warrants further scrutiny.  From a theoretical perspective, there are several 
holes within the literature, which need to be addressed. Little is known about 
when changes in approach and avoidance tendencies occur during treatment, 
what type and nature of behavioural activation is most strongly associated with 
the reduction of depressive symptoms and how much treatment compliance is 
needed before changes become meaningful at a behavioural level. Some of 
these questions are beginning to be answered within the literature and are 
described further below.  
 
Questions are raised about the suitability of one treatment session in exploring 
approach avoidance as mechanisms of change. There was a significant group 
difference at post-treatment on the BADS but not the CBAS. For the AAT, a 
difference in behavioural approach / avoidance was found only within responses 
to happy faces. This was borderline significant with the treatment group and non 
significant with the control group. Therefore it might be more appropriate to use 
more intensive interventions to investigate mechanisms of change. National 
guidelines for depression recommend that behavioural activation treatment 
should consist of 16 to 20 sessions over a period of three to four months (NICE, 
2009). This study used a significantly shorter treatment protocol, which may 
have been sufficient for changes in depressive symptoms, but perhaps further 
consolidation of behavioural activation principles into participants’ lives was 
needed before differences could be observed in behavioural approach and 
avoidance tendencies. A longer treatment would also make it more feasible for 
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changes in behaviour to be more assessed mid-way through treatment so that a 
more robust design for analysing mediation could be utilised. 
 
Since the efficacy of behavioural activation has been demonstrated, studies 
have sought to explore factors contributing to positive change. One identified 
factor has been homework completion, with greater homework completion 
associated with more positive outcomes (Busch, Uebelacker, Kalibatseva & 
Miller, 2010). Treatment compliance, equivalent to homework completion4 within 
this study was relatively low, with participants completing an average of 51.4% 
activities during the one-week treatment interval. This may help to explain why 
the group difference in depressive symptoms at one-week was not maintained 
at one-month follow-up. Previous studies have reported between 70% and 82% 
compliance (Gawrysiak et al., 2009; Hopko et al., 2005, 2008). If the 
effectiveness of treatment was reduced then it is feasible that this may have 
diluted changes in approach and avoidance behaviour. A question then 
emerges about whether higher treatment compliance, or treatment compliance 
at least comparable to previous studies, would affect the observed behavioural 
approach and avoidance tendencies.  
 
Despite being an integral component of behavioural activation treatments the 
impact of different types of activities has attracted scant research. Previous 
studies have indicated that certain types of activities are associated with 
changes in mood. This includes engaging in pleasant activities (e.g. Lewinsohn 
& Graf, 1973) and functional activities (e.g. Posmontier). However, research has 
not focused on the differential impact of these activity types on mood. Do 
certain types of activities have more or less impact on depressive symptoms, 
approach and avoidance tendencies? Hershenberg, Paulson, Gros and Acierno 
(2014) explored the effect of type and amount of activities completed during 
behavioural activation. A sample of older adults with symptoms of depression 
and complicated bereavement completed five weeks of treatment. The results 
indicated that the number and nature of activities (pleasurable, functional or 
social) participants engaged in was not significantly related to change in 
4 Treatment compliance refers to the percentage of completed activities as a proportion of the 
number of agreed activities completed by the individual. This is comparable to homework 
completion which refers to number of completed homework activities. 
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depressive symptoms. Hersenberg et al. (2014) results have highlighted an 
important area warranting further research, particularly as their findings have 
limited generalisability due to the sample population (older adults). Replication 
of the study in relation to avoidance and approach behaviours using a working 
age adult population would certainly add to the literature.  
 
5.4. Clinical implications 
This study was the first efficacy study of a single session of behavioural 
activation using a modified version of BATD protocol (Hopko & Lejuez, 2007; 
Lejuez, Hopko & Hopko, 2011) with a clinical sample recruited from primary 
care psychology services. Although only preliminary, this evidence of clinical 
change in one session suggests that there should be consideration of the 
extension of the utility and applicability of behavioural activation treatment within 
the stepped care service model specified in Improving Access to Psychological 
Therapies Services (IAPT). Currently behavioural activation is situated within 
‘Step 3’ of the model, with 16 to 20 sessions recommended (NICE, 2009).  
 
Single session psychological interventions gained prominence in the 1980s and 
1990s as a way of preventing psychological difficulties after experiencing 
traumatic events (e.g. Bordow & Porditt, 1979; Lavender & Walkinshaw, 1998). 
In a recent review Hymen, Stalker and Cait (2013) argued that single session 
interventions were not as effective as initially thought, advocating the use of a 
stepped care model, similar to IAPT. However, the results of other studies 
provide an alternative view. Denner and Reeves (1997) used a single session of 
assessment and therapy in a Community Mental Health Team with promising 
results. Two therapists met with each patient, and completed an in-depth 
assessment. Formulations from a CBT perspective were key, with a focus on 
providing patients with recommendations that they could go away and 
implement in their lives. Although the sample size was small (n=32) the results 
indicated that patients were ‘fairly satisfied’ and ‘very satisfied’ with the service. 
This suggests that further study of the efficacy of single session psychological 
interventions like behavioural activation would certainly be warranted. Single 
session interventions may be an alternative first step for those patients who are 
unable to commit to regular, weekly appointments or as a way of managing 
lengthy waiting lists. Patients could receive a session of behavioural activation 
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to help reduce depressive symptoms if there is a long waiting time for on-going 
therapy. Further research would be needed to investigate treatment efficacy 
according to severity of symptoms and for patients on waiting lists for treatment.   
 
The results of this study suggest that some changes in approach and avoidance 
tendencies do begin to emerge after one session of behavioural activation and 
that these may be partial mediators of the treatment effect. This has clear 
implications for the focus of behavioural activation treatments, with more 
information needed about the type of activities that individuals need to engage 
in to result in maximum change. Further investigation using a longer treatment 
may facilitate understanding about the trajectory of change in approach and 
avoidance behaviours. Using dismantling studies would help pinpoint which 
treatment components are most necessary and effective in increasing activation 
and reducing avoidance thereby leading to reduced depressive symptoms.  
  
5.5. Future directions for research 
As discussed above, future research should consider using more intensive 
treatment interventions in the study of mechanisms of change in behavioural 
activation interventions, and investigate the nature and frequencies of activities 
most strongly associated with reductions in depression. Further possible 
research directions are outlined below.   
  
5.5.1. Measuring behavioural activation – use of modern technology  
Measuring activity level during the treatment interval using the behavioural 
checkout sheet presented difficulties for some individuals. Typical responses to 
overlooking the completion of this included not having enough time, forgetting 
about it or losing the sheet. Modern hand held technology may have a useful 
role to play here. Studies have started to emerge examining the effects of 
Internet-delivered and smartphone delivered therapy with promising results (e.g. 
Andersson, 2009; Boschen & Casey, 2008; Hoa Ly et al., 2014).  
 
Individuals are increasingly reliant on technology during their daily life. 
Technology such as smart phone applications would allow for an ecologically 
valid measure of activity level and provide a snapshot of an individual’s mood 
immediately before and after engaging in an activity. This would enable 
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exploration of associations such as type of activity and frequency of activity with 
mood. Technology could be used to feedback results to the clinician. In therapy 
sessions clinicians could present an individual with concrete examples of 
engaging in an activity and their corresponding mood. This could be a useful 
addition to therapy, in particular for those patients who struggle to recall and 
reflect on how engaging in a particular activity led to changes in mood and 
behaviour. Over time, it could be utilised as an outcome measure, and highlight 
changes over the course of therapy, and as a source of positive reinforcement 
for the individual. The use of application technology would mean that patients 
would no longer need to rely on their memory to fill in something, rather the data 
could be collected as and when activities occurred.  
 
5.5.2. The role of motivation 
Treatment compliance was relatively low within this study (51.2%). One 
possible reason for this relates to the motivation levels of participants. 
Motivational problems are a key symptom of depression. Motivation was not 
operationalised during this study, and may have mediated the effect of 
behavioural activation on depressive symptoms, and even approach avoidance 
behaviours. As work outside of the therapy room is key in behavioural 
activation, some ability to take action despite motivational difficulties is required. 
Whilst the treatment protocol aims to encourage the individual to make 
changes, the duration of the session (up to 90 minutes) leaves limited time for 
building the individual’s level of motivation or willingness to increase behaviour 
despite motivational difficulties. Future studies utilising a one session design 
may choose to explore whether screening for motivational issues may help to 
identify individuals who would be the most likely to be able to benefit from such 
a brief intervention.  
 
5.5.3. Use of behavioural measure of approach avoidance tendencies 
The results of this study found differences in only happy valence stimuli 
following behavioural activation treatment; possible reasons for this have been 
discussed earlier. Future research would benefit from exploring these potential 
reasons to elucidate the feasibility and appropriateness of using the AAT as a 




The addition of confidence ratings before and after completing the AAT would 
help to control for whether confidence in self/ability on task mediates 
performance on the task itself. Comparison of manikin and joystick tasks would 
highlight which task is most appropriate to use when measuring approach 
avoidance tendencies in clinical samples of individuals with depression.  
 
5.6. Conclusions  
This is the first study to report evidence of a reduction in depressive 
symptomatology in depressed participants after receiving one-session 
behavioural activation treatment compared to a no-intervention control group. 
Decreases in avoidance and increases in approach behaviour may partially 
mediate this effect, providing preliminary support for the theoretical 
underpinnings of the behavioural treatment. An important strength of this study 
was the use of a behavioural measure of approach / avoidance tendencies in 
addition to self-report measures. Replication is now required using a time lag 
design to establish whether a causal relationship between changes in 
depressive symptoms and approach avoidance behaviour exists, with 
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Appendix A – National guidelines for depression and other 
recommended treatments 
  
National guidelines for treatment of depression  
The National Institute for Health and Clinical Excellence (NICE) has developed 
guidelines for the treatment of depression, offering best practice advice for 
clinicians and services. The NICE guidelines advocate the use of a stepped 




Figure 19. Stepped care model of delivery for treatment of depression (NICE, 2009). 
 
 By using the stepped care model individuals are provided with the appropriate 
level of therapy depending on their current clinical presentation and 
symptomatology. Therapeutic interventions begin at Step 2, known as ‘Low 
intensity’ interventions, offered for mild to moderate depression. Treatment at 
this step includes guided self-help based on Cognitive Behavioural Therapy 
(CBT) principles, which can incorporate behavioural activation and problem-
solving techniques, Computerised Cognitive Behavioural Therapy, and group 
based CBT. At Step 3 treatment options include anti-depressant medication or 
‘High intensity’ psychological interventions. The NICE recommended treatments 
include CBT, Interpersonal Therapy (IPT), Behavioural Activation or 
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Behavioural Couples Therapy, in conjunction with pharmacological treatment. 
At Step 4 the suggested treatment possibilities include inpatient care, crisis 
resolution, home treatment teams and Electroconvulsive therapy.  
 
Within this stepped care model, behavioural activation is positioned as a 
standalone treatment in Step 3. Treatment at step 2 could include elements of 
behavioural activation as part of guided self-help within a CBT framework. 
 
Cognitive-Behavioural Therapy for Depression  
Several models have contributed to the study of depression from a cognitive 
perspective. Key researchers have included Ellis (1962), Beck (1967) and 
Bower (1981). Beck’s model of depression is the approach underlying the form 
of CBT used most widely in the National Health Service in the UK today. This 
model involves three key components; the negative cognitive triad, schemas 
and cognitive errors. The negative cognitive triad suggested that a depressed 
individual would display negative patterns in their thinking with regard to 
themselves (e.g. ‘I’m defective’), their future (e.g. ‘I’ll feel like this forever’) and 
the world (e.g. ‘the world is against me’). Beck postulated that other symptoms 
of depression would follow as a direct consequence of these patterns of 
thinking. This cognitive triad remains influenced and maintained by a set of 
idiosyncratic ‘schema’ guiding the person’s response to particular events. Beck 
hypothesised that these schemas developed following on from early 
experiences leading to biases in information processing or ‘cognitive errors’ 
such as ‘overgeneralisation’, ‘personalisation’ and ‘absolutistic’ or ‘dichotomous’ 
thinking. 
 
Beck’s (1976) therapy approach focusing on the ‘here and now’, exploring the 
individual’s maladaptive thinking styles and patterns which could contribute to 
the maintenance of depression. Another key component of CBT is the 
development of a strong therapeutic alliance, with collaborative and active 
engagement between the individual and therapist. CBT aims to educate the 
individual, and provide them with skills to become their own therapist. 
Ultimately, the individual should be able to carry these skills forward, beyond 
the end of therapy. Relapse prevention is strongly emphasised and forms an 
integral part of the final sessions. Sessions are structured using an agenda and 
are time limited from the onset of therapy.  Strong research evidence exists 
highlighting the efficacy of CBT for unipolar depression (e.g. Butler, Chapman, 
Forman & Beck, 2006). 
 
NICE guidelines recommend CBT at step 3, with individuals expected to receive 
between 16 to 20 sessions initially and a further 3 to 4 follow up sessions over 





Antidepressants were initially developed in the 1950’s and several different 
kinds are available, including tricyclics and selective serotonin reuptake 
inhibitors (SSRI). They work by increasing levels of neurotransmitters within the 
body; in particular levels of serotonin and noradrenaline are targeted by 
antidepressants. NICE guidelines recommend the use of medication at step 2 
within the stepped care model for depression.  
 
Interpersonal therapy  
Interpersonal therapy (IPT; Klerman, Weissman, Rounsaville & Chevron, 1984) 
can also be found within the NICE guidelines for depression. IPT is a time 
limited and pragmatic therapy, which posits that depression, occurs within an 
interpersonal context. Within IPT, depression has been described as illness 
which can be treated. Links to social roles have been highlighted, suggesting 
that depression affects social roles as aversive events lead to depressed mood, 
thus leading to poorer social functioning and more aversive events occurring. 
Another key component of IPT involves linking interpersonal events to affect. 
Research studies have demonstrated the efficacy of IPT (e.g. Weissmann, 
Prusoff, DiMascio, Neu, Goklaney & Klerman, 1979; Barber & Muenz, 1996; 
Ryder, Quilty, Vachon, Bagby, 2010). Weissmann et al (1979) showed that a 
combination treatment of IPT and ADM was more effective than either treatment 
alone. Like CBT, IPT is recommended at step 3 of the stepped care model. 
Individuals should receive between 16 to 20 sessions over a three to four month 




Appendix B – Patient Health Questionnaire  

























1. Little interest or pleasure 
in doing things   
 
0 1 2 3 
2. Feeling down, depressed, 
or hopeless. 
 
0 1 2 3 
3. Trouble falling/staying 
asleep, sleeping too much.  
 
0 1 2 3 
4. Feeling tired or having 
little energy. 
 
0 1 2 3 
5. Poor appetite or 
overeating 
 
0 1 2 3 
6. Feeling bad about 
yourself – or that you are a 
failure or have let yourself or 
your family down 
 
0 1 2 3 
7. Trouble concentrating on 
things, such as reading the 
newspaper or watching 
television. 
 
0 1 2 3 
8. Moving or speaking so 
slowly that other people 
could have noticed.  Or the 
opposite – being so    fidgety 
or restless that you have 
been moving around a lot 
more than usual. 
 
0 1 2 3 
9. Thoughts that you would 
be better off dead or of 
hurting yourself in some 
way. 
0 1 2 3 
      PHQ-9 total score  
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Appendix C – Behavioural Activation and Depression Scale   
 
   
 
  









 Appendix D – Acceptance and Action Questionnaire  
Below you will find a list of statements. Please rate the truth of each statement 




1. I am able to take action on a problem even if I am uncertain what is the right 
thing to do.  
 
2. A person who is really “together” should not struggle with things the way I do. 
 
3. When I feel depressed or anxious, I am unable to take care of my 
responsibilities. 
 
4. I try to suppress thoughts and feelings that I don’t like by just not thinking 
about them. 
 
5. There are not many activities that I stop doing when I am feeling depressed 
or anxious. 
 
6. It’s OK to feel depressed or anxious. 
 
7. It’s unnecessary for me to learn to control my feelings in order to handle my 
life well.  
 
8. I rarely worry about getting my anxieties, worries, and feelings under control.  
 
9. In order for me to do something important, I have to have all my doubts 
worked out. 
 
10. I’m not afraid of my feelings. 
 
11. When I compare myself to other people, it seems that most of them are 
handling their lives better than I do. 
 
12. I try hard to avoid feeling depressed or anxious. 
 
13. Anxiety is bad. 
 
14. Despite doubts, I feel as though I can set a course in my life and then stick 
to it. 
 
15. If I could magically remove all the painful experiences I’ve had in my life, I 
would do so. 
 
16. I am in control of my life. 
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Appendix E – Ruminative Response Scale  
People think and do many different things when they feel depressed. Please 
read each of the items below and indicate whether you almost never, 
sometimes, often, or almost always think or do each one when you feel down, 
sad, or depressed. Please indicate what you generally do, not what you think 
you should do. 
 
1 almost never  2 sometimes   3 often  4 almost always 
 
1. Think about how alone you feel. 
 
2. Think “I won’t be able to do my job if I don’t snap out of this”. 
 
3. Think about your feelings of fatigue and achiness. 
 
4. Think about how hard it is to concentrate. 
 
5. Think “What am I doing to deserve this?” 
 
6. Think about how passive and unmotivated you feel. 
 
7. Analyse recent events to try to understand why you are depressed. 
 
8. Think about how you don’t seem to feel anything anymore. 
 
9. Think “Why can’t I get going?” 
 
10. Think “Why do I always react this way?” 
 
11. Go away by yourself and think about why you feel this way. 
 
12. Write down what you are thinking about and analyse it. 
 
13. Think about a recent situation, wishing it had gone better. 
 
14. Think “I won’t be able to concentrate if I keep feeling this way.” 
 
15. Think “Why do I have problems other people don’t have?” 
 
16. Think “Why can’t I handle things better?” 
 
17. Think about how sad you feel. 
 
18. Think about all your shortcomings, failings, faults, mistakes. 
 
19. Think about how you don’t feel up to doing anything. 
 
20. Analyse your personality to try to understand why you are depressed. 
 
21. Go someplace alone to think about your feelings. 
 




Appendix F – Cognitive Behavioural Avoidance Scale  
 
Instructions: Different people use different strategies to deal with situations and problems in 
their lives.  Below are a number of strategies that people may use to deal with situations and 
problems.  A number of the items below refer to dealing with situations at work or school.  If you 
are not currently working or attending school, answer these items instead using your daily 
duties and activities.   Please read each statement carefully and indicate how true, in general, 
each statement is for you using the following key: 
1= Not at all true for me 
2= Somewhat true for me 
3= Moderately true for me  
4= Very much true for me 
5= Extremely true for me 
19. I try not to think about my future and what I will do with  























2.  When uncertain about my future, I fail to sit down and think  











3.  I would like to achieve things at work/school, but I have to 











4.  I fail to do what is needed to follow through with  











5.  In order to avoid feelings of disappointment, I just try not to 











6.  Rather than try new activities, I tend to stick with the things  











7.  I choose to turn down opportunities to further my  











8.  I do not answer the phone in case people are calling with  











9.  I quit activities that challenge me too much. 1 2 3 4 5 
10. I try not to think about problems in my personal  











11. I think to myself that I will not be able to complete really    











12. While I know I should make decisions about my personal  











13. I avoid trying new activities that hold the potential for     











14. I do not go out to events when I know there will be a lot of           









15. Instead of thinking about problems in my social life, I tell    











































20. I just wait out tension in my relationships hoping that it will  























                   
 
22. There is nothing I can do to improve problems in my  





















24. I tend to remain to myself during social gatherings or   





















26. When I experience confusion in my relationships, I do not  











27. While I know that I have to make some important decisions  











28. Rather than getting out and doing things, I just sit at home  























30. I do not bother thinking about how to solve problems in my 











31. I find myself avoiding tasks and assignments that are really  
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Please complete the following questions:  
 
1. What gender are you? 
Male   Female 
  
2. Which age bracket do you fall into?     
18 – 29 years   30- 49 years  50 – 64 years 
 
3. What is your marital status? 
Single    Married   Divorced 
Widowed    Separated    
 
4. Which ethnic group do you belong to?  
White    Black African  Black Caribbean 
Indian    Pakistani   Bangladeshi 
Chinese    Other – please state……………………………......... 
 
5. What is your current occupation?   
Full-time employed  Part-time employed Unemployed
 Studying    Retired   
 
6. What is the highest level education that you have achieved?   
High school    NVQs   A levels  
Diploma   Undergraduate degree Postgraduate 
degree 
 
7. Have you previously experienced depression? 
Yes    No 
If yes, when was this? ……………………………………………………………………….................. 
 
8. Any other history of mental health problems?  
Yes    No 
If yes, please provide some more information ……………………………………................ 
 
9. Are you currently taking and/or prescribed any medication for depression?  
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Yes    No 
If yes, please provide some more information (name, dosage and how often 
you take it) ………………………………………………………………………………........................... 
 
10. Have you previously received any psychological treatment?  
Yes    No 
If yes, please provide some more information ……………………………………................ 
 
Thank you for completing these questions. 
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 Appendix H – Participant Information Sheet  
 
Participant Information Sheet  Version 3 (14th March 2013) 
      We are inviting you to take part in a research study that is being completed as part of a Doctorate in Clinical Psychology. Before you make a decision, it will be important for you to understand why the research is being carried out, and what it will involve. Please take time to read the following information carefully so that you can confidently decide whether or not you would like to take part in this study. You may also want to discuss this decision with your partner, relatives or friends. Please feel free to contact us if there is anything that is not clear or if you would like more information.  
What is the purpose of the study? We are interested examine the effects of an intervention for depression called Behavioural Activation (BA) for Depression. BA is recommended for the treatment of depression. It has been found to have positive effects for individuals experiencing depression by reducing the number of symptoms experienced. BA involves activity scheduling. This looks at structuring your day with activities that you may be avoiding but are actually consistent with the values and beliefs that are important to you.   We are interested in learning more about what specifically leads to a reduction in symptoms of depression. Several studies have found BA to be helpful for reducing emotional difficulties like depression. However, research has not yet looked at what parts of BA lead to symptom reduction. We hope that the results of this study will help us to continue to improve BA and help develop it further in order to individuals experiencing other emotional difficulties.   
Why have I been chosen? We are asking 40 people with symptoms of depression and anxiety to take part in this study. You have been given this information sheet because you were referred to Lambeth Psychological Therapies Service and expressed an interest in the study.  
Do I have to take part? No, it is completely up to you whether or not you decide to take part. We will go through this information sheet with you, and you will be able to ask any questions you have about it. If you agree to take part after this then we will ask you to sign a consent form. You will be free to withdraw from the study at any time, without giving a reason, and this will not affect your future NHS treatment or legal rights.  





What will the study involve if I take part? You will be randomly assigned to one of two groups. In both cases, you will receive a single, 90-minute session of Behavioural Activation. If you are assigned to the 'treatment' group then you will receive the BA session as we are able to arrange an appointment. If you are assigned to the ‘waiting list control’ group then you will be asked to wait for 3 weeks before receiving the BA session.   During the BA session, you will work with the researcher to develop a behavioural plan, after which you will be asked to engage in several desirable activities for a period of one week. During this time you will be asked to complete an activity log.    The study will involve meeting with the researcher on 2 occasions. On both occasions you will be asked to complete 5 short questionnaires in order for us to monitor how you are feeling. You will also be asked to complete a short computerized task. The questionnaires and the computer tasks will take around 30-45 minutes to complete. If you are in the ‘treatment’ group then your first meeting will take up to 2 hours and 30 minutes. If you in the ‘waiting list control’ group then your first meeting will take up to 1 hour. The second meeting for both groups will take up to 1 hour.   At the end of treatment you will be given £20 to cover any expenses you may have incurred while taking part in this study (e.g. for travel). 
 
What are the possible disadvantages and risks of taking part? As is the case with all therapies, we cannot guarantee that BA will benefit everyone who receives it. Therefore, there is a possibility that your mood may worsen or not completely improve by the end of treatment. If your mood does get worse and you express an intention to harm yourself or another person, we will withdraw you from the study and refer you back to Lambeth Psychological Therapies Service for more support. Similarly, if you still experience significant symptoms of depression or anxiety at the end of treatment you will also be withdrawn from the study and referred back to Lambeth Psychological Therapies Service.   
What are the possible benefits of taking part? You will receive a type of therapy that has been shown to benefit people with depression. We hope that the information we get from this study might help us to develop more ways of helping individuals experiencing other emotional difficulties in the future.  
What if there is a problem? If you have any concerns about the way you have been approached or treated during this study, then please contact Miss Farjana Nasrin, Addictions Science Building, 3rd Floor, 4 Windsor Walk, Denmark Hill, London, SE5 8AF, Tel: 07804 804610. Alternatively, you can contact Dr. Katharine Rimes at the same address. If you wish to complain formally, then you can do this through the NHS Complaints Procedure (details of which can be obtained from South London and Maudsley NHS Trust).  
Will my taking part in this study be kept confidential? 
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All information collected about you and from the BA session will be anonymous. You will be given a unique identification number so that it will not be possible to identify you from the information. All information will also be kept strictly confidential, and will only be seen by members of the research team. All information will be stored securely in locked cabinets at NHS sites or at the Institute of Psychiatry.  
Will my doctor be informed? If you take part in the study, we will write to your GP to inform them of this and again when you have finished participating in the study. We will also contact your GP if we become concerned for your safety or another person's safety whilst you are taking part in the study (e.g. if you express an intention to harm yourself or another person). This is so that you can be referred for more support. 
 
What will happen to the results of the study? When we have collected all the information we need, we will analyse them and then publish the results. We will also send you a summary of the results. You will not be identified in any publication from this study. 
 
Who has reviewed the study? This study has been reviewed and given favourable opinion by the London City Road and Hampstead NRES ethics committee (REC reference – 13/LO/0018). Miss Farjana Nasrin’s educational supervisors, Dr. Katharine Rimes and Dr. Andrea Reincke, have also reviewed it. 
 
Who can I get independent advice from about taking part in the study? You can get independent advice about taking part in the study from South London and Maudsley/Institute of Psychiatry Research and Development Office, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, Tel: 020 7848 0251. 
 
Who do I contact for further information? If you have any questions or require any further information about this study, then please contact Miss Farjana Nasrin, Addictions Science Building, 3rd Floor, 4 Windsor Walk, Denmark Hill, London, SE5 8AF, Tel: 07804 804610.     
Thank you for considering taking part in this study 
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 Appendix I – Consent form  
 
 Consent Form for Participants  Version 3 (14th March 2013) 
 
 Investigating Mechanisms of Behavioural Activation Treatment for Depression  Please initial the boxes:   I confirm that I have read and understand the information sheet dated 14th 
March 2013 (Version 3) for the above study.     I have had the opportunity to consider the information and ask questions about the above study.  I understand that relevant sections of my medical notes and data collected during the study may be looked at by the researcher where it is relevant to my taking part in this research.  I give permission for these individuals to have access to my records  I understand that my GP will be informed of my participation in this study.  
 
I understand that Lambeth Psychological Therapies Service will be informed of my participation in this study.   I understand that Lambeth Psychological Therapies Service will be contacted if I express an intention to harm myself or another person.  
 















treatment for depression which involves engaging in desirable activities of my choice for a period of 7 days, and completing an activity log during this time.   If I am not asked to undertake the behavioural activation treatment for depression immediately, then I will be offered this intervention following the end of my participation in this study.   I agree to take part in the above study.     Name of participant ………………….….………………………………………………... (IN CAPITALS)  Participant’s signature .............................................… Date: ................................    The researcher has explained the study to the participant and has answered the participant’s questions honestly and fully.  Name of researcher ……………………………….…………………………………….... (IN CAPITALS)  Researcher’s signature ...........................................… Date: .................................    










Letter to GP      Version 1 (16th January 2013) 
 
Investigating Mechanisms of Behavioural Activation Treatment for Depression 
 
Institute of Psychiatry, 
Addictions Sciences Building, 
3rd Floor, 4 Windsor Walk, 
Denmark Hill 





Re: <NAME OF PARTICIPANT> D.O.B.:  
 
I am writing to inform you that <NAME OF PARTICIPANT> has consented to taking part in the 
above study. As part of the study X was randomly assigned to receiving a single, 90 minute 
session of Behavioural Activation treatment for Depression in one month’s time/or on <DATE>.  
<NAME OF PARTICIPANT>  was seen on two occasions and her first session was on <DATE 
OF SECOND SESSION>. S/he will be contacted in a month about receiving this single 
treatment session.  
 
I have enclosed a copy of the Participant Information Sheet for your reference. This study has 
been favourably reviewed by the Research Ethics Committee and has received ethical approval 
(REC reference 13/LO/0018). I will contact you if we become concerned about <NAME OF 
PARTICIPANT> safety during the course of the study (e.g. due to expressing suicidal ideation).  
 








Farjana Nasrin  
Trainee Clinical Psychologist & Chief Investigator 
142 
 
 Appendix K – Modified BATD treatment protocol    
• UNITS 1 through 4. 
• “You may not presently feel as though you are able to get much done or that you are 
always tired and lack motivation. You also may be waiting to feel better or think more 
positively before you become more active and start participating in activities that once 
brought you pleasure. As you know, however, getting yourself to feel better is not an easy 
thing to do. Therefore, we’d like you to try something different. The idea of the treatment we 
are about to begin is that your thoughts and feelings are affected by your interactions with 
others and your overall quality of life. So, we believe that for you to have more positive 
thoughts and feelings and to feel better, you must first become more active and put yourself 
into more positive situations. Although this may be difficult right now, it will become easier 
as more and more positive experiences occur. The treatment requires you to work hard, 
and I understand that you may be questioning your ability to make changes at this time in 
your life, but I will help you throughout this process, and we will work at a pace at which you 
feel comfortable.”  
 
• Explain/instruct participants on the following:  











• READ ALOUD TO PARTICIPANT: 
• Symptoms of depression may produce significant impairment in your life such as an inability 
to take classes, hang out with your friends, work, cook, exercise, and so forth. You may also 
have decreased optimism/motivation, low self-esteem, difficulties concentrating, fatigue and 
possibly extreme behaviors such as self-injury and or suicidal thoughts. Medical 
consequences may include heart disease, inability to fight off illness, abusing drugs or 
alcohol, and poor eating habits.  
 
• Explain/instruct participants on the following:  
Unit 3 – The Rationale for BATD 
 
• When depressive symptoms are recognized, a number of treatment alternatives are 
available. The treatment you will be provided with is a modified form of another treatment 
that has already been supported as being effective in treating people with depression. This 
treatment is environmental/behavioural in nature, which means that it targets changes in 
your environment and behaviour as a method for improving your thoughts, mood, and 
overall quality of life. Although we are focusing on behaviour change, we are not ignoring 
thoughts and feelings. Instead we suggest that negative thoughts and feelings often will 
change only after positive events and consequences are experienced more frequently. Said 
more simply, it is difficult to feel depressed and have low self-esteem if you are regularly 






You may or may not have experienced symptoms of depression that include; 
- Poor appetite or over eating 
- Not getting enough sleep, or sleeping too much, or tiredness 
- Low energy or self esteem 
- Low self esteem 
- Poor concentration or difficulty making decisions 
- Feelings of hopelessness 
- An unrealistic sense of guilt or worthlessness 
- Frequently thinking about failings in the past 
- Thoughts about death 
- Decreased desire to engage in activities that you once found rewarding 
 
Do you think any of these symptoms apply to you?   
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• Explain/instruct participants on the following:     
Unit 5 GETTING STARTED  
 
LIFE AREAS ASSESSMENT SHEET: 
• Identifying potential activities:  
• As a first step in this protocol, you must determine some activities you would like to target. 
In determining these activities, you might want to consider activities related to your values 
and goals as they relate to certain life areas:  
 
The participant and investigator then collaboratively establish structured goals by completing 
the following “Life Areas Assessment.” Using the Life Goal assessment and using some of 
these questions as prompts, discuss each of the life areas and write down what the patient 
would like to accomplish in each of the areas. 
 
1.   Family Relationships (e.g., What type of brother/ sister, son/ daughter, father/ 
mother do you want to be? What are your strengths? Weaknesses? Which relationships would you like to 
improve? What qualities are important in close family relationships? What might you be able to do to 
make the relationships better?) 
2.  Social Relationships (e.g., What would an ideal friendship be like to you? Are certain relationships 
poor at the moment? What areas could be improved in your relationships with your friends? Do you have 
enough friends?) 
3. Intimate Relationships (e.g., What would your role be in an intimate relationship?Are you currently 
involved in this type of relationship, or would you like to be?) 
4. Education/ Training/Learning (e.g., How are your classes currently going? Do you need to have 
more study time? Scheduled study time? What would you like to learn more about?) 
5. Hobbies/ Recreation/Leisure (e.g., Are there any special interests you would like to pursue, or new 
activities you would like to experience?) 
6. Physical/ Health Issues (e.g., Do you wish to improve your diet, sleep, exercise, should you lose some 
weight?) 
7. Spirituality (e.g., What, if anything, does spirituality mean to you? Are you satisfied  
with this area of your life? Would you like to become more spiritual?) 
8. Mental Health Issues (e.g., Are there other issues besides depression that you would like to explore in 
this treatment? Do you avoid certain situations because of fear or anxiety? Would you like to face these 
situations? Do you need to relax more?). 
 
Life Goal Assessment 
Instructions: Describe goals that you would like to accomplish in these areas. 





































MASTER ACTIVITY LOG: 
o Based on the Life goal assessment, identify 8-10 activities that the student will monitor 
over the next two weeks.  
 
• In general, if you believe that completing a particular activity would bring a sense of 
pleasure and/or accomplishment, then it probably would be good to include it. When 
selecting activities, they should be both observable by others and measurable.  
 
• Now that you have identified the 8-10 target activities, you will need a plan for how you will 
assess your progress.  
• The master activity log is a useful way of tracking your progress on a weekly basis. In the 
first column, we will list your activities. In the columns next to the activity we will list the 
following: 
• The number of times you will complete the activity in each of your two weeks (e.g. ideal 
frequency) and  
• The duration of the activity (you may write UF, signifying that the activity will continue until 
finished regardless of the duration).  
 
• For each activity selected, write down the frequency (#) and duration (Time) goals in the 
appropriate columns. Only the experimenter needs to have a copy of the master 
activity log.   
 
 
• BEHAVIOR CHECKOUT 
• Now you are ready to record your progress on a daily basis using the weekly behavior 
checkout. Let’s write down your behaviors as well as the frequency and duration goals in 
the appropriate columns for each activity. 
• You have two behavior checkouts. One for Week 1 and one for Week 2. 
• Each day you circle Y if you completed the activity and N if you did not.  
• To ensure that you maintain accurate records, it is best if you allocate a specific time of the 
day to complete this task (e.g., before bedtime). Once you complete the desired frequency 
and duration goal for the week, you may circle G (goal) as well as Y or N. 
• Circling G acknowledges that regardless of whether you engaged in that activity on that 
day, you have successfully met our goal for the week. Furthermore circling G should help to 
keep you from feeling guilty about not completing an activity on a given day if you are 
regularly completing your weekly goals.  
• Remember – It is essential that you bring BOTH behavioral checkouts back with you 





 Appendix L – Life activities checklist   
EXCURSIONS/COMMUNITY  ENTERTAINMENT   
1. Taking a trip  1. Watching a different TV show  
2. Going to a fair, carnival, circus or 
zoo 
 2. Going to watch a film at the cinema  
3. Going to the beach  3. Going to the theatre  
4. Going on a picnic  4. Going to a sporting event  
5. Going out to dinner  5. Watching the sunrise  
6. Taking a road trip  6. Watching the sunset  
7. Going to a different part of 
London 
 7. Having a bubble bath  
8. Staying at a hotel or bed and 
breakfast 
 8. Other……………………………………….. 
…………………………………………………….. 
 
9. Camping  SPORTS AND GAMES  
10. Going to a museum or exhibit  1. Going for a swim  
11. Shopping at a car boot market  2. Going for a bike ride  
12. Going to the library or book store  3. Going for a short jog  
13. Going out for a short walk  4. Going bird watching   
14. Other 
…………………………………….. 
 5. Playing a board game  
INTERACTIONS WITH OTHERS 
OR SOCIAL ACTIVITIES 
 6. Completing a puzzle, crossword or brain 
teaser 
 
1. Going to or giving a party  7. Playing a card game  
2. Reminiscing and talking about old 
times 
 8. Playing a computer game  
3. Group activities  9. Other …………………………….  
4. Having an open conversation  EDUCATION  
5. Meeting up with friends  1. Learning something new (e.g. making a new 
food item) 
 
6. Discussing a topic of interest  2. Learning something artistic (e.g. painting)  
7. Having family or visiting family  3. Reading a book or magazine  
8. Meeting someone new  4. Writing a short story or poem  
9. Eating out with friends  5. Other ……………………………………….  




11. Speaking to someone on the 
telephone who you haven’t spoken 
to in a while 
 1. Working in the garden for a short time  




Appendix M – Behavioural checkout sheet  
Weekly Behaviour Checkout  
Behaviour Checkout - Week ___1____ 
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Each day you circle Y if you completed the activity and N if you did not.  To ensure that you maintain accurate records, it is best if you allocate a specific time of the 
day to complete this task (e.g., before bedtime). Once you complete the desired frequency and duration goal for the week, you may circle G (goal) as well as Y or N.  
Circling G means that regardless of whether you engaged in that activity on that day, you have successfully met your goal for the week. Furthermore circling G 
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Limited research has been carried out exploring the presence of personality 
disorder in IAPT patient populations and subsequent impact on engagement 
with therapist and the service. This study aimed to evaluate the pilot use of a 
brief personality disorder measure, Standardised Assessment of Personality -
Abbreviated Scale (SAPAS). The SAPAS was used at the assessment stage, in 
addition to the measures specified in the IAPT minimum dataset, to explore 
whether SAPAS scores can predict engagement with the service and allocation 
to step in the care pathway. The results of this study indicate that the SAPAS 
did not predict engagement – patients scoring high on the SAPAS were just as 
likely to engage as those with lower scores.  However, they were more likely to 
have been allocated to high intensity therapy.  This suggests that patient with 
high scores on the SAPAS should not be screened out because of likely 
disengagement.  However, a longer-term study with larger sample is needed to 





2.1 Southwark Psychological Therapies Service 
Southwark Psychological Therapies Service (SPTS) is an Improving Access to 
Psychological Therapy (IAPT) service, one of the first wave of IAPT services 
rolled out in 2008.   
 
IAPT services, such as SPTS, were commissioned to provide psychological 
therapy for adults experiencing common mental health disorders, primarily 
anxiety and depression. The majority of referrals come from GPs, with self-
referrals also being accepted. Some referred patients have a significant history 
of engagement with mental health services, with previous psychiatric 
assessments and diagnoses. However, as a primary care service SPTS 
receives many referrals from patients who are having their first encounter with 
mental health services. Consequently, there may be little, if any, existing 
information about their likely mental health needs.  
 
IAPT services are characterised by several key features. These include the use 
of a stepped care framework, routine outcome measures and the use of 
National Institute for Health and Clinical Excellence (NICE) recommended 
therapies which are evidence based.   
 
SPTS utilises a ‘stepped care’ approach as described in IAPT Implementation 
Plan: National guidelines for regional delivery (Department of Health, 2008). 
The guidelines suggest that there are two fundamental principles of stepped 
care; using the least burdensome treatment with the highest likelihood of 
delivering a positive outcome and a system whereby patients can be ‘stepped 
up’ or ‘stepped down’ if a different treatment would be more effective or 
appropriate.  
 
Another feature of IAPT services is the use of routine outcome monitoring. 
Patients are required to complete outcome measures at every clinical contact in 
order to assess progress and trigger a review of the patient’s needs and 
possibility of stepping up or down when appropriate. 
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NICE-recommended low and high intensity interventions are shown in Figure 1.  
The most commonly used low intensity interventions in SPTS are guided self 
help. These are delivered by Psychological Wellbeing Practitioners (PWP) and 
referred to as low intensity (LI) therapy. The most commonly used high intensity 
(HI) intervention in SPTS is  Cognitive Behavioural Therapy (CBT), which are 
delivered by High Intensity therapists. Patients are allocated to a low or high 
intensity intervention based on presenting problem, symptom chronicity and 
severity, response to previous treatment, clinical judgement and patient choice.  
However, the possible presence of personality disorder, and its implications for 
treatment has not been considered in any systematic way.  If personality 
disorders are not recognised at the triage and assessment stage, this may lead 












2.2 Personality Disorder  
The current International Classification of Diseases, 10th edition (ICD-10; World 
Health Organization, 2004) describes several categories of personality 
disorders (see Figure 2). Once general criteria for personality disorders are met, 
further clinical information is gathered in order to identify the most appropriate 
subtype for diagnosis.  
 
 
General Criteria for a Personality Disorder 
A. Evidence that the individual’s characteristic and enduring patterns 
of inner experience and behaviour deviate markedly as a while 
from the culturally accepted range (or ‘norm’). Such deviation must 
be manifested in more than one of the following areas: 
1) Cognition (i.e. ways of perceiving and interpreting things, 
people and events; forming attitudes and images of self and 
others); 
2) Affectivity (range, intensity, liability, and appropriateness of 
emotional arousal and response) 
3) Control over impulses and need gratification; 
4) Relating to others and manner of handling interpersonal 
situations. 
 
B. The deviation must manifest itself pervasively as behaviour that is 
inflexible, maladaptive, or otherwise dysfunctional across a broad 
range of personal and social situations (i.e. not being limited to 
one specific ‘triggering’ stimulus or situation). 
 
C. There is personal distress or adverse impact on the social 
environment, or both, clearly attributable to the behaviour referred 
to under B.  
 
D. There must be evidence that the deviation is stable and of long 
duration, having its onset in late childhood or adolescence. 
 
E. The deviation cannot be explained as manifestations or 
consequence of other adult mental disorders, although episodic or 
chronic conditions from sections F0 to F7 of the ICD-10 
classification may co-exist, or be superimposed on it.  
 
F. Organic brain disease, injury or dysfunction must be excluded as 
possible causes of the deviation (if such organic cause is 








 Personality disorders appear to be quite common, with varying prevalence rates 
within the literature, depending on the sample population. Research studies 
have typically recruited patients from secondary and tertiary level services due 
to higher prevalence levels (Keown et al., 2002; Merson et al., 2002; Ranger et 
al., 2006).  
 
Within community samples between 5-13% prevalence rates have been found 
(Casey & Tyrer, 1986; Coid, Tyrer, Yang, et al., 2006; Grant, Hasin, Stinson, et 
al., 2004; Torgersen, Kringlen & Cramer, 2001).  Moran, Jenkins, Tylee, Blizard 
and Mann (2000) found 24% of primary care attendees met diagnosis for 
personality disorder. Epidemiological studies suggest 40-52% of patients in 
community mental health teams (CHMT) have a diagnosis of personality 
disorder (Keown, Holloway, Kuipers, 2002; Merson, Tyrer, Onyett, et al., 2002), 
44% of psychiatric inpatients (Cutting, Cowen, Mann & Jenkins, 1986), rising 
steeply to between 70-92% in tertiary psychiatric services and prisons (Fazel & 
Danesh, 2002; Ranger, Methuen & Rutter 2004). 
 
Patients with personality disorders are likely to meet diagnostic criteria for more 
than one personality disorder. Keown et al. (2002) found 52% of patients in a 
CHMT met criteria for more than one personality disorder. Furthermore, 
research evidence has shown that personality disorders are highly co-morbid 
with other Axis I psychiatric diagnoses. In their study Keown et al. (2002) found 
personality disorders to be co-morbid with psychotic and affective disorders. In 
a multi-site study of chronic depression, Keller, Gelenberg, Hirschfeld et al., 
(1998) found that 51% of the sample population had a co-morbid personality 
disorder. Poorer treatment outcomes are associated with Axis I disorders in the 
presence of personality disorders (Newton-Howes, Tyrer & Johnson, 2006). 
Reich & Vasile (1993) found that treatment of depression was less successful 
when there was evidence of a personality disorder.   
 
Personality disorders are associated with significant burden on the individual, 
their family and on the wider society. There has been some research examining 
the economic cost of personality disorder. Some studies suggest that patients 
with personality disorder access psychiatric services excessively in comparison 
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to other clinical populations (Saarento, Nieminten, Hakko, et al., 1997; 
Seivewright, Tyrer, Casey, et al., 1991). However, other studies suggest that 
patients with personality disorder are less likely to contact services compared to 
patients with depression (Andrews, Issakidis & Carter, 2001). Rendu, Moran, 
Patel, Knapp and Mann (2002) examined the economic impact of personality 
disorder in the UK health service. Rendu et al., (2002) found costs for patients 
with personality disorder were significantly higher with a co-morbid common 
mental health disorder. One way of reducing the associated economic costs 
could be the use of primary care services, rather than the use of more specialist 
services which would incur greater costs.  
 
2.3 Personality Disorder within Talking Therapy Services 
In February 2011 the Department of Health (DoH) published a four year plan of 
action (Talking Therapies: A four year plan of action, 2011) for Talking Therapy 
services, such as SPTS. In this document DoH discuss the need for local 
commissioners and providers of services to realise the benefits of talking 
therapies for individuals with severe mental illness, such as personality 
disorder. DoH suggested that appropriate care pathways are needed to ensure 
that talking therapy services are available to these individuals.  
 
Furthermore, the DoH publication, Recognising Complexity: Commissioning 
guidance for personality disorder (Department of Health, July 2009) highlights 
the importance of commissioning services across all levels of the healthcare 
system, as specialist personality disorder services alone are unable to meet the 
needs of all individuals. The guidelines suggest that commissioners should 
ensure that primary care services are able to identify individuals with personality 
disorders in order to provide the most appropriate treatment within the service. 
At the same time, individuals with more serious problems should be recognised 
and referred on to other services. By identifying this at the triage/assessment 
stage, patients could be seen more quickly within the most appropriate service, 
whether this is SPTS or another service. This would help prevent delays in 
patients starting treatment.  
 
Furthermore, the epidemiological evidence has highlighted the need to screen 
for patients with personality disorders as studies have shown varying 
163 
 
prevalence rates of personality disorder within primary care populations. Moran 
(2002) describes 20% prevalence rate in his study whilst Parsons (1997) found 
a borderline personality disorder prevalence rate of 18.5% amongst attendees 
of primary care health services. These studies demonstrate the need to screen 
for personality disorders within primary services, as such factors can impact the 
development of a therapeutic relationship and subsequent engagement with 
therapy. Furthermore, research has shown that there are poorer treatment 
outcomes associated with the presence of personality disorders. Identifying the 
presence of personality disorders will help to ensure that patients are seen 
within the most appropriate services.  
 
2.4 Current Assessment Process in SPTS 
In September 2011 SPTS was not using any measures of personality disorder 
in their screening process. During the assessment process clinicians were using 
clinical judgement in collaboration with information from standardised measures 
(GAD-&, PHQ-9) and the minimum IAPT dataset. This information was used to 
decide whether the referral should be accepted by the service, and if accepted, 
which step and intervention allocation would be most appropriate.   
 
2.5 Incorporating a Personality Disorder Measure within SPTS’ 
assessment  
The Standardised Assessment of Personality – Abbreviated Scale (SAPAS; 
Moran, Leese, Lee, Walters, Thornicroft, & Mann, 2003) was identified as an 
appropriate screening measure within SPTS for personality disorder. Initially a 
structured interview, the SAPAS was further adapted into a self report measure 
(Germans, Van Heck, Moran & Hodiamont, 2008).  The self-report version of 
the SAPAS consists of eight items and is simple to use (see Appendix A).  
 
The SAPAS aims to produce a dimensional score representing the likelihood 
that an individual has a personality disorder in general, rather than screening for 
specific types of personality disorders. Completion of the SAPAS produces a 
score ranging from 0 to 8. The SAPAS is a brief measure, taking no more than 
five minutes to complete. This makes it a feasible addition to SPTS’ opt-in 
questionnaires, when patients are asked to complete a range of questionnaires 
and forms in order to ‘opt-in’ to access the service  (see Section 2.5 SPTS’ new 
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assessment process). Consequently, a lengthy personality disorder measure 
would be inappropriate, placing additional burden on the patient, possibly 
leading to non-completion.   
 
In the original study, Moran et al. (2003) validated the use of the SAPAS using 
a general psychiatric population. A score of 3 or more on the SAPAS correctly 
identified the presence of personality disorder, validated using the Structured 
Clinical Interview for the DSM IV, in 90% of the patients. Using this cut-off score 
of 3 on the SAPAS, good sensitivity and specificity values were found (0.94 and 
0.85 respectively) suggesting that the SAPAS displays good psychometric 
properties.  
 
The SAPAS has been validated using a sample of patients with substance 
dependency (Hesse & Moran, 2008). The SAPAS correlated highly with Cluster 
A (paranoid and schizoid) and Cluster C (avoidant, dependent and obsessive-
compulsive) criterion for personality disorders. Germans et al., (2008) found 
using the SAPAS as a self-report did not adversely affect the specificity and 
sensitivity of the measure (0.83 and 0.80 respectively), although the values 
were somewhat lower than those found by Moran et al., (2003). The authors 
suggested that the variance in specificity and sensitivity scores maybe 
attributable to differences in prevalence and severity rates of personality 
disorders within the Danish population.   
It was proposed that the SAPAS would be incorporated into SPTS’ new initial 
assessment screening process.  
 
2.6 SPTS new initial assessment screening process  
SPTS new assessment process involves individuals receiving an opt-in pack 
following their referral, which they are required to complete and return to the 
service.  Once the opt-in pack is received by SPTS it is triaged by a team 
leader. Using the contents of the opt-in pack, including scores on the various 
measures, usually supplemented by a telephone call, individuals are allocated 




The initial assessment packs are composed of the following questionnaires: 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001), 
Generalised Anxiety Disorder Assessment (GAD-7; Spitzer, Kroenke, Williams 
& Lowe, 2006), Work and Social Adjustment Scale (W&SAS; Mundt, Marks, 
Shear & Greist, 2002), Psychiatric Diagnostic Screening Questionnaire (PDSQ; 
Zimmerman and Matthia, 2001), IAPT phobia scales and SAPAS questionnaire. 
Further information relating to the clinical cut-off points for these measures can 
be found in Appendix B.  
 
As well as the above measures, patients are asked about their employment 
status and required to complete a registration form collecting demographic 





3. Aims of this Service Evaluation Project  
This service evaluation project planned to evaluate the pilot use of the 
Standardised Assessment of Personality – Abbreviated Scale (SAPAS) 
questionnaire as part of the standard initial assessment in SPTS.  
 
The current assessment process in SPTS involves the use of clinical judgement 
and a range of measures (GAD-7, PHQ-9, W&SAS) to determine the presence 
of any personality difficulties. This decision affects allocation to either LI or HI 
therapy. There is currently no personality disorder screening measure 
incorporated into this process. By using an additional screening questionnaire 
the service would like to explore whether scores can predict allocation to LI or 
HI therapists and subsequent engagement with the service The SAPAS will be 
used alongside the existing measures – GAD 7 and PHQ 9 during the initial 
assessment process.This will provide preliminary information to help SPTS 
evaluate whether the service is meeting the needs of individuals with 
personality difficulties when presenting with symptoms of anxiety or depression. 
 
This project seeks to understand the allocation of individuals with personality 
difficulties in SPTS and their subsequent engagement with the service. This 
overall aim of the project will be explored through the following objectives; 
1) Understand likely prevalence of personality disorder in the SPTS patient 
population by looking at associations between basic demographic 
information (e.g. age, gender and ethnicity) from IAPTUS (information 
system used by SPTS) and scores on the SAPAS questionnaire using 
descriptive statistics. This will help to establish whether there are any 
factors which are associated with higher or lower SAPAS scores.  
2) Moran et al (2003) established that a cut-point of 3 on the SAPAS 
produces a good balance of sensitivity and specificity for the 
identification of personality disorder.  The data will be examined in order 
to explore the relationship between SAPAS score and treatment 
allocation.  
3) Exploring the relationship between SAPAS scores and engagement with 
SPTS. This will provide some preliminary data about how SAPAS scores 
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may affect engagement with the service and whether this varies 
depending on treatment allocation.  
 
Henceforth, for ease of reading, SAPAS scores of 2 and below will be 
referred to as low SAPAS scores and SAPAS scores of 3 and above will be 





4.1 Data Collection 
Data was extracted from the IAPTus patient database, an online, password 
protected system used by clinicians to record patient data. Data for patients’ 
initial assessments are entered onto IAPTus as routine procedure. Weekly IAPT 
measures are entered by therapists, in line with national guidelines. Copies of 
all initial assessments were already uploaded to IAPTus from where SAPAS 
scores were retrieved.   
 
4.2 Data Analysis  
Using the reporting system, a subset of data was generated using the following 
parameter: 
• Completed an initial SPTS assessment between 31st January 2012 and 
31st March 2012. This three month time period was used, as although 
SPTS had started rolling out their new assessment procedure in 
December 2011, this has not been fully achieved until January 2012. 
 
The report was generated as a Microsoft Excel spread sheet. As SAPAS scores 
were a recent addition to SPTS’ assessment procedure these scores were not 
recorded in a specific field on IAPTus. Instead, the completed initial assessment 
forms were uploaded onto the ‘Documents’ section of the system by an 
administrator within the service. It was necessary to look up each patient 
included on the generated report on IAPTus in order to calculate their SAPAS 
score. This score was then added to the Excel spread sheet containing their 
other details.  
 
Whilst completing the task of retrieving and scoring each patient’s SAPAS score 
it became evident that a number of individuals would need to be excluded from 
the analysis. This was due to a number of reasons; individual not completing 
the new opt-in questionnaires, individuals only partially completing the opt-in 
questionnaires, no opt-in questionnaires being available for a patient, patients 
being accepted to the service using the previous referral pathway (self or GP 
referral form) or other missing data. Unfortunately, details of the number of 
patients excluded for each specific aforementioned reason was not recorded. 
169 
 
However, this did lead to a reduced number of patients (n= 178) being eligible 
























Following recording of SAPAS scores, each patient’s allocation to therapy was 
recorded on the Excel spread sheet. This was determined by looking at the 
patient’s ‘Care Pathway’ tab on IAPTus. Table 1 shows the codes used to 
record patient’s allocation to therapy and the associated frequencies associated 




 361 referrals 
 
(Total number of referrals between 





(After excluding patients who did not 
complete the new assessment forms) 
 
 178 referrals 
 
(After excluding patients with other 
missing data) 
Figure 4. Data flowchart. 
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Table 3. Codes used to show patient's allocation to therapy 
Code  Allocation Frequency  Percentage 
1 Allocated to High Intensity therapy in SPTS 78 43.8 
2 Allocated to Low Intensity therapy in SPTS 85 47.8 
3 Decided that no longer wanted treatment in 
SPTS 
2 1.1 
4 Allocated to group intervention in SPTS 13 7.3 
Total  178 100% 
 
Once patients’ SAPAS scores were recorded on the Excel spread sheet, it was 
necessary to code engagement in therapy. This was determined by the author 
by classifying patients as either engaged, did not engage or not appropriate. 
Each of these categories encapsulated further sub-categories, which can be 
seen in Table 2. Engagement with the therapist was based on stage in the care 
pathway in October 2012. This was felt to be long enough for patients to have 
at least had the opportunity to engage in therapy, enabling preliminary 
exploration of therapy outcomes for this project. Patients were defined as 
having engaged in therapy if they were currently in treatment, awaiting 
treatment or being discharged following the completion of treatment. Patients 
were classified as not engaging with therapy if they had been coded as ‘failed to 
engage’ or ‘dropped out’ on IAPTus by individual therapists. This does not take 
into account the number of attended and non-attended sessions, and was found 
to vary between patients with some patients not attending after one session and 





Table 4. Defining patient’s engagement with their allocated therapist 












- In HI treatment 
- In LI treatment 
- Completed HI treatment, stepped down 
to LI  
- Completed LI treatment, stepped up to 
HI 
- Discharged following HI treatment 
- Discharged following LI treatment 
(including groups and workshops) 

































- Discharged from SPTS after not 
attending LI therapy appointment 
- Discharged from SPTS after not 
attending HI therapy appointment 
- Allocated to LI intervention but decided 
no longer wanted treatment 
- Allocated to HI intervention but decided 
























- Allocated to LI intervention but referred 
on to another service 
- Allocated to HI intervention but referred 











Total  178 100% 
 
Once all the above additional information (SAPAS score, allocation to therapist 
and engagement with therapist) was added to the report generated in IAPTus, 
this was considered to be the master data file. This Excel spread sheet was 
then imported into SPSS to enable statistical analyses to be completed.  It 
should be noted that the mean scores were based on patients’ scores from their 
initial assessment questionnaires. 
 
4.3 Final data sample  
There was a final sample of 178 patients, following the process of data analysis 
described in section 4.2. Of these 178 patients, 64% were female and 36% 
were male. The main sources of referrals for this sample were GPs (86.5%), 
followed by Other Service/Agencies (8.4%), Self referrals (3.9%) and, finally, 
Health Visitors (1.1%). Table 3 shows the breakdown of the patients’ ethnicities 
in the final data sample.  
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 Table 5. Breakdown of patients according to ethnicity 
Ethnicity  Frequency Percentage British 85 54.1 Any other White background 42 26.7 Irish 6 3.9 Black British  13  8.3 Any other mixed background 3 1.9 Any other Asian background 3 1.9 White & Black 2 1.3 Indian 2 1.3 Bangladeshi 1 0.6 Not available on IAPTus (excluded from %) 21 - 
TOTAL 178 100% 
 
The histogram in Figure 4 shows the age distribution of this sample of patients. 
Within this audit sample, the majority of patients were aged between 16 and 55 
years. There were fewer people over the age of 60 referred to the service 
between January and March 2012 who had correctly completed all the 
assessment questions. However this is to some extent likely to be a reflection of 
the Southwark borough, which had a relatively large proportion of working age 
residents in the 2011 Census survey (Office for National Statistics, 2011).  
 
 





IAPTus allows therapists to record provisional diagnoses for patients. 
Percentages of the recorded diagnoses can be seen in Figure 6. Unfortunately, 
for a number of patients (n = 90) a provisional diagnosis had not been recorded.  
 
 
Figure 6. Provisional primary diagnoses recorded by therapists.2 
 
The most frequently recorded provisional diagnoses were F41- Other anxiety 
disorder (17%) and F33- Major Depressive disorder, recurrent (13%). However, 
these figures should be interpreted with caution because as stated above, 




2 Diagnoses as recorded along the x-axis: F32 = Major Depressive Disorder, single episode; F33= 
Depressive episode, recurrent; F40 = Phobic anxiety disorders; F41 = Other anxiety disorder; F42 = 
Obsessive Compulsive Disorder; F43 = Reaction to severe stress, and adjustment disorders; F45 = 
Somatoform disorder; F99 = Mental disorder not otherwise specified.  
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5. Results 
This project aimed to understand the allocation of individuals with personality 
difficulties in SPTS and their subsequent engagement with the service. In 
particular, whether SAPAS score can predict allocation to step 2 (low intensity) 
or step 3 (high intensity) therapy and subsequent engagement using the 
following objectives: 
 
1) Exploring associations between basic demographic information (e.g. age, 
gender and ethnicity) and scores on the SAPAS questionnaire using 
descriptive statistics. 
2) Exploring the relationship between treatment allocation and SAPAS 
score.  
3) Exploring the relationship between engagement with SPTS and SAPAS 
score.  
 
The mean SAPAS score for this sample population (n = 178) was 3.76 (SD = 
1.81). Figure 6 illustrates the percentage of patients for each SAPAS score. The 




Figure 7. Frequency histogram of SAPAS scores. 
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For convenience, findings will be reported with reference to each of the three 
objectives described above.     
 
5.1 Associations between demographic information and SAPAS scores 
Below are a range of histograms and statistical analyses comparing patients 
with a SAPAS score of 2 and below and SAPAS scores of 3 and above based 
on different demographic variables. This cut off point was established by Moran 
et al (2003) who found that a score of 3 on the SAPAS produced a good 
balance of sensitivity and specificity for the identification of personality disorder. 
48 patients had a SAPAS score of 2 or below, whilst 130 patients had a SAPAS 
score of 3 and above. The demographic profile of these two groups, based on 
their SAPAS scores will be explored in further detail in this section.  
 
5.1.1 Gender and SAPAS scores 
Before exploring the data in terms of low and high SAPAS scores, Figure 7 was 
produced to look at the gender profile across the different SAPAS scores. 
Similar percentages of male and female patients within each SAPAS score can 
be seen in Figure 7.   
 
 
Figure 8. Comparison of SAPAS scores by gender. 
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 The descriptive statistics for gender and SAPAS score are described in Table 4. 
For both genders, there were a larger number of patients with a high SAPAS 
score.  
 
Table 6. Descriptive statistics for gender and SAPAS scores. 
Gender n Low SAPAS score 
(% of patients) 
High SAPAS score 
(% of patients) 
Mean (sd) 
Male 64 27.0 39.2 3.97 (1.60) 
Female   113 73.0 60 3.65 (1.93) 
Total 177 100 99.2 - 
 
A chi-square analysis found no association between gender and high/low 
SAPAS score (x2 (1) = 2.35, p = 0.13).  
 
5.1.2 Age category and SAPAS scores 
Percentages of low and high SAPAS scores within each age category can be 
seen in Table 5. A similar age distribution for both groups of patients (high and 
low SAPAS scores) can be observed in the bar-chart.  
 
 




Descriptive statistics for SAPAS scores and age categories are shown in Table 
5.  A correlational analysis was completed in order to explore the relationship 
between age and SAPAS score. There was a no relationship between age and 
SAPAS score, r = -0.09, p = 0.22 (two-tailed).  
 
Table 7. Descriptive statistics for age category and SAPAS score.  
Age Category Total n  Low SAPAS score  
       n              (%) 
High SAPAS score  
n              (%) 
Mean(sd) 
16 - 25 years 34 10 29.4 24 70.6 4.0 (1.97) 
26 – 35 years   48 15 31.3 33 68.7 3.8 (1.99) 
36 – 45 years  38 9 23.7 29 76.3 3.9 (1.66) 
46 – 55 years 30 7 23.3 23 76.7 3.7 (1.69) 
56 – 65 years 19 5 26.3 14 73.7 3.3 (1.60) 
66 – 75 years 5 1 20 4 80 3.0 (1.41) 
76 – 85 years  3 1 33.3 2 66.7 3.7 (3.06) 
86 – 95 years  1 0 0 1 100  4.0 (n/a) 
Total 178 48 - 130 - - 
 
 
5.1.3 Ethnicity and SAPAS scores 
As can be seen in Table 6, the majority of patients, within low and high SAPAS 
scores, described their ethnicity as British (60%). However, it should be noted 
that ethnicity was not recorded for all patients.  
 
Table 8. Descriptive statistics for ethnicity and SAPAS score. 
Ethnicity n Low SAPAS score 
(% of patients) 
High SAPAS score 
(% of patients) 
Mean (sd) 
White British 85 60.4 43.1 3.6 (1.87) 







14.6 26.8  
 
3.9 (1.61) 
Caribbean  13 4.2 8.5 4.4 (1.94) 












4.2 0.8  
 
1.7 (1.16) 
Indian 2 2.1 0.8 3.0 (2.9) 







  0 2.3    3.7 (1.16) 
Not recorded  21 6.2 13.8 4.2 (1.67) 




A chi-square analysis was used to explore whether there was a significant 
association between ethnicity (White British and Any other background) and 
SAPAS score (high/low). A non-significant association was found, x2 (1) = 2.69, 
p =0.10 suggesting that there was no association between ethnicity and SAPAS 
score.  
 
5.1.4 PHQ-9, GAD-7, & W&SAS scores and SAPAS scores 
Correlation analyses were completed in order to explore the relationships 
between scores on the various IAPT outcome measures (GAD-7, PHQ-9 and 
W&SAS) and the SAPAS. The results of these analyses can be seen in Table 7.  
 
 
Table 9. Correlations between GAD-7, PHQ-9, W&SAS and SAPAS. 
Outcome measure r p-value 
PHQ-9 0.35 <0.05 
GAD-7   0.23 <0.05 
W&SAS 0.31 <0.05 
 
 
Significant correlations were found between scores on the different IAPT 
outcome measures and SAPAS scores. The analyses was extended further to 
look at whether there were differences between low and high SAPAS scoring 
patients on the PHQ-9, GAD-7 and W&SAS measures. Table 8 summarises 
patients’ mean scores on the various questionnaires, depending on whether 
they had a low or high SAPAS score. High mean scores for the high SAPAS 
score group were observed across all three measures (PHQ-9, GAD-7 and 
W&SAS).  
 
Table 10. Summary of Independent samples t-tests results comparing scores on PHQ-9; GAD-7; 
W&SAS depending on SAPAS score.  
Measure SAPAS score <2 
Mean (SD) 






PHQ-9 10.42 (6.09) 15.54 (6.38) -4.81 0.000 
GAD-7 10.35 (5.73) 12.76 (5.11) -2.70 0.008 





Independent samples t tests were performed comparing patients scores on the 
PHQ-9, GAD-7 and W&SAS, based on whether their SAPAS score was <2 or 
>3. The results showed that there was a significant difference between high and 
low SAPAS scores on the PHQ-9, GAD-7 and W&SAS.   
 
5.2 Relationship between treatment allocation and SAPAS scores 




Table 11. Comparison of interventions offered depending on SAPAS scores. 
Type of Intervention SAPAS score <2 
(% of patients) 
SAPAS score >3 
(% of patients) 
High Intensity therapy 35.4 46.9 
Low Intensity therapy 54.2 45.4 
Group treatment 2.1 6.9 
Decided to no longer pursue 




Table 9 shows that a higher percentage of patients with a low SAPAS score 
were allocated to a LI therapist (54.2%). In contrast, a higher percentage of 
patients with a high SAPAS score were offered HI therapy (46.9%). This would 
suggest that a lower SAPAS score is more likely to result in a LI therapy 
allocation whereas a higher SAPAS scores would be more likely to result in a HI 
therapy allocation. It is interesting to note that a greater proportion of patients 
with a low SAPAS score decided they no longer wished to pursue treatment at 
SPTS following their initial screening assessment. However only limited 
information could be found using percentages to compare interventions offered 
based on SAPAS scores.   
 
A stepwise binary logistic regression analysis was conducted to predict the 
amount of variance in therapist allocation (HI or LI) using scores on the SAPAS, 
PHQ-9, GAD-7, WS&AS, age or gender as potential predictors. Gender was 
specified as being a categorical variable. Patients allocated to group treatment 




 A test of the full model against a constant only model was statistically 
significant, indicating that the predictors, scores on SAPAS and PHQ-9, reliably 
distinguished between allocation to either HI or LI (chi square = 12.32, p <0.05 
with df = 2). This can be seen in Table 10, SAPAS score (p = 0.041) and PHQ-9 
score (p = 0.045), as demonstrated by the Wald criterion. All other predictors 
were non-significant. Nagelkerke’s R2 of 0.097 indicated a weak relationship 
between the predictors and therapist allocation. Prediction success overall was 
65% (60.3% for HI and 69.4% for LI).  
 
 
Table 12. Summary of results of logistic regression looking at therapist allocation.  
Predictor 
variable 
B S.E. Wald Sig. Exp(B) 
SAPAS score -0.19 0.10 4.19 0.041 0.82 
PHQ-9 score -0.05 0.03 4.01 0.045 0.95 
Constant  1.59 2.1 10.95 0.001 4.88 
 
 
 The logistic regression analysis suggests that there is a relationship between 
therapist allocation and SAPAS score. The results of the logistic regression 
showed that the SAPAS score and PHQ-9 score helped to predict therapist 
allocation, with the other variables not adding anything to the prediction model.  
 
5.3 Relationship between engagement with SPTS and SAPAS scores  
For the purpose of this study ‘engagement’ was defined using a series of codes 
(see Table 2, page 21). Using these codes engagement was operationally 
defined, with three levels – engaged, did not engage and not appropriate. 
61.3% of the study sample were considered engaged in therapy (n=109), 36.5% 
not engaged (n=65) and 2.2% not appropriate for the service.  
 
Table 11 compares the engagement of patients with high SAPAS scores and 




Table 13. Comparing engagement with therapist in SPTS depending on SAPAS score.   
Code Description SAPAS <2 
        n                (%) 
SAPAS>3 















- In HI treatment 
- In LI treatment 
- Completed HI treatment, 
stepped down to LI  
- Completed LI treatment, 
stepped up to HI 
- Discharged following HI 
treatment 
- Discharged following LI 
treatment (including groups 
and workshops) 







































































- Discharged from SPTS 
after not attending LI 
therapy appointment 
- Discharged from SPTS 
after not attending HI 
therapy appointment 
- Allocated to LI intervention 
but decided no longer 
wanted treatment 
- Allocated to HI 
intervention but decided no 




























































- Allocated to LI intervention 
but referred on to another 
service 
- Allocated to HI 
intervention but referred on 





























Total  48 100 130 100 
 
 
Table 11 provides an interesting preliminary summary of data extracted from 
IAPTus regarding patient engagement with their therapist, depending on 
therapy intensity and SAPAS score. One noteworthy finding is the comparison 
of non-attendance patterns of patients with high and low SAPAS scores. There 
appears to be rather similar percentages of patients discharged from SPTS 




Table 12 shows a breakdown of patients in therapy and discharged patients. It 
is interesting to note that there were a greater number of patients with a high 
SAPAS score still in therapy.  
 
Table 14. Comparison of patients in therapy and discharged from therapy. 
Position in 
therapy 
Low SAPAS score  
           n                       % 
High SAPAS score 
   n                   % 
Total n   
In therapy  14 23.0 47 35.0 61 
Discharged    14 77.0 26 65.0 40 
 
A chi-square analysis was used to explore whether there was a significant 
association between SAPAS score (high/low) and patients position in therapy 
(in therapy or discharged). A non-significant association was found, x2 (1) = 
1.75, p = 0.19 suggesting that there was no association between SAPAS score 
and whether a patient was still in therapy or not.  
 
A stepwise binary logistic regression analysis was conducted to explore how 
much of the variance in engagement (engaged or disengaged) with therapist 
could be predicted using scores on the SAPAS, PHQ-9, GAD-7, WS&AS, age 
or gender as potential predictors. A test of the full model against a constant only 
model was non significant, indicating that none of the predictors made a 
significant contribution to the predictive power of the model (=13.89, p=0.05 




6.1. Discussion of Main Findings 
This study aimed to explore whether the introduction of a personality disorder 
screening measure, SAPAS, could predict therapist allocation and subsequent 
engagement with the therapist.  Data from a three-month period from SPTS was 
analysed. The main findings of the study are discussed in relation to the three 
objectives.    
1) Associations between demographic information and SAPAS scores  
Bukh, Bock, Vinberg, Gether and Kessing (2010) used the SAPAS with patients 
experiencing a first episode of depression in Denmark. 53.3% of the sample 
achieved a low SAPAS scores and 46.7% of the sample achieved a high 
SAPAS score. In comparison, the results of this study found that only 27% had 
a low SAPAS score whilst 73% had a high SAPAS score.  
 
Variability in patient characteristics between the two groups (low and high 
SAPAS scores) was explored in terms of several demographic variables 
(gender, age and ethnicity) and scores on IAPT outcome measures. Key 
findings are summarised below;  
• High SAPAS scores were not associated with any particualr age, ethnicty 
or gender group. However, the small numbers within this sample limit the 
conclusions that can be drawn from this.  
• High SAPAS scores were associated with high scores on the GAD-7, 
PHQ-9 and W&SAS.  
 
One possible hypothesis for the latter finding could be that the presence of 
personality disorder issues may lead to increased symptoms of depression and 
anxiety, or vice versa. This finding correlates with Patience, McGuire, Scott & 
Freeman (1995), who found that patients scoring more highly on a personality 
disorder measure (Personality Assessment Schedule, Tyrer, Alexander & 
Cicchetti et al., 1979) were more likely to be experiencing severe symptoms of 
depression, as measured on the Hamilton Depression Rating Scale (HDRS) 





2) Relationship between treatment allocation and SAPAS scores 
This objective aimed to explore the relationship between SAPAS score and 
treatment allocation in order to see whether SAPAS scores could predict 
treatment allocation. A logistic regression analysis illustrated that only the 
SAPAS score and PHQ-9 score helped to predict therapist allocation, with other 
variables (age, gender, W&SAS score and GAD-7 score) not adding to the 
prediction model. The overall prediction success rate was 68%, with a higher 
percentage of correct predictions for LI (75%) rather HI allocation (60%). These 
prediction success figures indicate that the model was a good fit.  
 
Patients with a high SAPAS score were more likely to be offered HI treatment 
and group treatment. In contrast, patients with a low SAPAS score were more 
likely to be offered LI treatment. This is what intuitively might be expected to 
occur; that patients with a higher SAPAS score, suggesting an increased 
likelihood of the presence of personality disorder issues, would be seen by HI 
therapists who are able to offer more complex treatments. 
 
These results suggest that therapists are taking factors, other than anxiety and 
depression symptom scores, into account when deciding allocation to therapy.  
 
3) Relationship between engagement with SPTS and SAPAS scores.  
For this objective, engagement was operationally defined with three levels – 
engaged disengaged and not appropriate, based on codes derived by the 
author. Using these codes, the findings showed that 61.3% of the patients 
engaged in therapy, 36.5% did not engage in therapy and 2.2% of the sample 
were not appropriate for SPTS. However it is important to note that there was a 
large variance in how non-engagement was defined, in terms of how many 
sessions were not attended before it was classified as not engaged. Non-
engagement varied from a patient not attending following an assessment to 
patients not attending after several sessions.  Despite this caveat, a number of 
interesting findings were observed.  
 
In order to explore the relationship between engagement with SPTS and 
SAPAS score a logistic regression was completed. The results of this logistic 
regression analysis showed that none of the predictor variables (age, gender, 
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GAD-7, PHQ-9 score, W&SAS score and SAPAS score) helped to predict 
engagement with the therapist.   
 
Looking at the initial findings of this study showed that patients with a low 
SAPAS score were more likely to decide that they no longer wished to pursue 
treatment from SPTS. This could be due to a number of reasons e.g. accessing 
help elsewhere, deciding that it was no longer a priority for them, other changes 
in their lives affecting their ability to access the service. However, one possible 
reason could be that they were unhappy about their allocation of therapy. 
Exploring reasons for why this subset of patients decided to not continue with 
treatment at SPTS may provide useful information about what leads patients to 
drop out from services. The use of quantitative and qualitative methods would 
provide rich, meaningful information about non-attendance. Such information 
could help with service development by highlighting factors linked to non-
attendance. Identification of such factors could then lead to the development of 
strategies to help reduce the number of appointments not attended.  
 
The findings also showed that a higher percentage of low SAPAS scoring 
patients were discharged from SPTS following completion of LI treatment 
(18.8% for patients with SAPAS score <2 vs 7.7% for patients with SAPAS 
score >3). It would be interesting to gain further information about this group of 
patients and explore whether engagement changes following completion of LI 
treatment e.g. does engagement remain the same, increase or decrease. For 
example, engagement could increase following completion of LI treatment as an 
individual is stepped up to HI treatment, which may have been their preferential 
treatment.   
 
Another interesting non-significant finding was found within the subset of 
engaged patients. A further breakdown of these patients showed that there 
were a higher number of patients with a high SAPAS score still in therapy. This 
would be an interesting trend to follow in future studies.   
 
6.2 Limitations  
One factor greatly impacting on the study was the small sample size. It is 
possible that the sample population is not representative of the people typically 
186 
 
referred into SPTS, as a large number of patients were excluded from the 
analysis due to incomplete questionnaire. This may have impacted on 
demographical profile of the patients excluded from the analysis e.g. people 
with reading/writing difficulties may have been refrained from completing the 
assessment pack due to the number of questionnaires that need to be 
completed. As such, conclusions of this study need to be considered carefully, 
as the sample may not be wholly representative of the patients typically seen 
within SPTS.  
 
The sample size was primarily affected by the SAPAS being a new introduction 
to the existing SPTS assessment process. The main parameter for inclusion in 
this study was the completion of an initial SPTS assessment between January 
2012 and March 2012, with the new assessment procedure only rolled out in 
December 2011. Consequently, initial data extraction from IAPTus revealed a 
large number of patients were referred using the old assessment process. 
Therefore they had not completed a SAPAS and were excluded from the 
analysis. Potentially the sample could have been drawn from a later time period, 
but this would have resulted in an insufficient time period in which to explore 
engagement with the therapist.  
 
Another limitation of the study was the lack of a robust definition of 
engagement. Engagement has been a difficult concept to define, with mixed 
views within the literature. Levy (1988) identified a number of psychological 
processes, which are implicated in engagement, e.g. empathy, negotiating 
goals and coping strategies. Gender differences have also been observed in 
the perception of the engagement process. Watkins, Shaner & Sullivan (1999) 
found that as well as differences in their perception of engagement, men and 
women had different needs regarding engagement. In this study, engagement 
was very much led from the data extracted from IAPTus, where individual 
therapists coded patient discharges from the service. Unfortunately, the 
discharges coded on IAPTus did not take into account the number of attended 
or non-attended sessions. This resulted in large variability, with some patients 
recorded as discharged after attending several sessions and others after only 




6.3 Implications for Service Development  
This project has yielded some interesting, preliminary findings. The principal 
finding from this study was that an individual’s SAPAS score and PHQ-9 score 
were the best predictors of allocation to therapist. However, this finding is based 
on results drawn from the initial 3 months when a new assessment procedure 
was rolled out in the service. It would be interesting to replicate the 
methodology used in this study 6 months after the new assessment procedure 
has been established. This would provide data from a time point when the 
assessment procedure has been established, thus allowing for a larger sample 
size and extended data analysis. Furthermore, it would be useful to track 
patient’s engagement with the service over a longer time period to see whether 
engagement fluctuates over time. This would provide meaningful information for 
clinicians about when engagement may change, and development of 
interventions to specifically target poor engagement.  
 
One way of tracking engagement would be the addition of a measure of 
engagement. This would have several benefits; provide another outcome 
measure by which to assess treatment outcomes, enable the identification of 
individuals with poor engagement, which could progress to the development of 
specific interventions or strategies to increase engagement. One measure of 
engagement mentioned in the literature is the Service Engagement Scale (SES; 
Tait, Birchwood & Trower, 2002). This measures engagement from the 
therapist’s perspective, additional measures could be incorporated to look at 
engagement from the patient’s perspective. There are number of avenues that 
future research regarding engagement within SPTS could focus on e.g. impact 
of gender, ethnicity, which could then be used to promote engagement.  
 
Looking at non-attendance patterns would also be of great benefit to the 
service. Of particular benefit would be to explore non-attendance of HI 
appointments, as there is an increased cost attached to these appointments.  
 
6.4 Conclusions  
Patients with high SAPAS scores are just as likely to engage in therapy with 
SPTS as those patients with lower scores. Patients with low SAPAS scores 
were more likely to be allocated to low intensity therapy and patients with high 
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SAPAS score more likely to be allocated to high intensity therapy. This may 
account for why patients with high SAPAS scores are just as likely to engage in 
therapy. Allocation decisions in SPTS are based on more than depression and 
anxiety symptom scores, and one factor would appear to the presence of 
personality disorders.  
 
Exploring the subset of engaged patients showed that there were a higher 
number of patients with a high SAPAS score still in therapy. This would be an 
interesting trend to follow in future studies, in order to investigate whether 
SAPAS scores impact on the length of treatment, rather than allocation to 
therapist or engagement with SPTS.  
 
Engagement with therapist was a difficult concept to explore in this study, partly 
limited by how engagement was defined within this study. To obtain meaningful 
data that will facilitate service development, a more robust measure of 
engagement is required. This would involve either having a service wide 
definition of how non-engagement is coded on IAPTus or controlling for the 
number of sessions attended and not attended in future studies. Engagement 
could be extended by the addition of a measure of engagement completed by 
the patient.  
 
On the whole, these findings suggest that therapists are able to successfully 
complete treatment with patients in the presence of a personality disorder. Such 
findings would advocate that patients with personality disorders can be seen in 
primary care services such as SPTS. However, this conclusion is based on the 
findings of one study and as such would benefit from other studies using a 
similar methodology exploring the same issues. It would be prudent for future 
research to focus on the subset of patients with high SAPAS scores who fail to 
attend appointments, and explore their reasons for doing so. Addressing these 
factors by the use of specific interventions and/or strategies may have a positive 
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Appendix A - Standardised Assessment of Personality – Abbreviated Scale 
(SAPAS)  
 
Standardised Assessment of Personality – Abbreviated Scale 
Only circle Y (yes) (or N (no) in the case of question 3) if the patient thinks that 
the description applies most of the time and in most situations. 
 
1. In general, do you have difficulty making and keeping friends? 
 ...................... Y/N         (yes=1, no=0) 
2. Would you normally describe yourself as a loner? 
 ...................... Y/N         (yes=1, no=0)  
3. In general, do you trust other people? 
 ...................... Y/N          (yes=0, no=1)  
4. Do you normally lose your temper easily? 
 ...................... Y/N          (yes=1, no=0)  
5. Are you normally an impulsive sort of person?  
 ...................... Y/N          (yes=1, no=0)  
6. Are you normally a worrier? 
 ...................... Y/N          (yes=1, no=0)  
7. In general, do you depend on others a lot? 
 ...................... Y/N          (yes=1, no=0)  
8. In general, are you a perfectionist? 
 ...................... Y/N          (yes=1, no=0) 
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Appendix B – Further information on measures used in SPTS initial 
assessment screening process 
 
Patient Health Questionnaire (PHQ-9); Kroenke, Spitzer & Williams (2001). 
The PHQ-9 is based on the diagnostic criteria for Major Depressive Disorder in 
the DSM IV. It consists of nine items used to measure depression 
symptomatology. Scores range from 0 to 27. The PHQ-9 provides a depression 
severity index score as follows; 
 0 – 4   = No depression symptoms present 
 5 – 9   = Symptoms of Mild depression present 
 10 – 14  = Symptoms of Moderate depression present 
 15 – 19  = Symptoms of Moderately severe depression 
present 
 20 – 27  = Symptoms of Severe depression present 
 
The recommended cut-off for the PHQ-9 severity index is a score of 9. An 
individual scoring 10 or above can be considered to be suffering from clinical 
significant symptoms of depression, and described as meeting ‘caseness’ for 
depression.  
 
Generalised Anxiety Disorder Assessment (GAD-7); Spitzer, Kroenke, 
Williams, & Lowe (2006). 
The GAD-7 measures symptoms of anxiety. Scores range from 0 to 21. The 
GAD-7 provides an index score as follows; 
 0 – 4   = No symptoms of anxiety present 
 5 – 10   = Symptoms of Mild anxiety present 
 11 – 15   = Symptoms of Moderate anxiety present 
 16 – 21  = Symptoms of Severe anxiety present  
 
The recommended cut-off for the GAD-7 severity index is a score of 7. An 
individual scoring 8 or above can be considered to be suffering from clinical 





Work & Social Adjustment Scale (W&SAS); Mundt, Marks, Shear, & Greist 
(2002).  
The W&SAS is a five item self-report measure. It is used to assess the impact 
of an individual’s mental health difficulties on their ability to function within a 
variety of domains; work, home management, social leisure activities, private 
leisure activities, and personal or family relationships 
 
Psychiatric Diagnostic Screening Questionnaire (PDSQ); Zimmerman and 
Matthia (2001). 
The PDSQ screens for the most common Diagnostic and Statistical Manual of 
Mental Disorders – 4th edition (DSM IV) Axis I disorders encountered in 
outpatient settings. It screens for; Major Depressive Disorder, Generalised 
Anxiety Disorder, Panic Disorder, Post-traumatic Stress Disorder, Alcohol 
Abuse/Dependence, Drug Abuse/Dependence, Psychosis, Bulimia/Binge-
Eating Disorder, Somatisation Disorder, Obsessive-Compulsive Disorder, Social 
Phobia, Hypochondriasis and Agoraphobia.   
 
IAPT phobia scales  
These are used to identify patients scoring below the clinical cut-off points for 
the PHQ-9 and GAD-7 despite their lives being significantly impaired by an 
anxiety disorder. These phobia questions have not yet been validated as 
screening tools. However, the clinical cut-off point is considered to be a score of 
4 or above, as this indicates that further assessment is needed to establish the 
impact of the phobia on the patient’s functioning. The questions are based on 
the Marks & Matthews Fear questionnaire (Marks & Matthews, 1979) used to 
measure the severity of phobias, and are typical of the questions asked in many 
other similar fear questionnaires. 
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